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Abstract 
Biocatalysis has grown in industrial application to the point where there are now hundreds of 
established enzyme-catalysed processes spanning various industries. However, many 
compounds of interest in such chemical syntheses are poorly water-soluble. If these compounds 
are to be used as substrates for enzyme-catalysed reactions they will form heterogeneous 
reaction mixtures because water is the predominant solvent for biocatalysis. With the 
introduction of multiple phases comes new challenges for experimental assessments and process 
performance. A chief challenge lies in identifying and addressing the extent of substrate mass 
transfer limitations into the aqueous phase where biocatalysis takes place. 
This thesis aims to explore systematic methods for handling poorly water-soluble substrates in 
reaction evaluations, which are crucial for biocatalytic reaction design. A standardised method of 
scoping reactions and gauging their performance is developed and presented. The method 
involves comparing reaction trajectories performed under varying conditions (enzyme and 
substrate concentrations) and can distinguish process ‘bottlenecks’ of enzyme kinetics, enzyme 
stability or non-enzyme related limitations. The method was shown to enable the qualitative (and 
to an extent quantitative) identification of substrate mass transfer limitations through time-
course measurements of substrate conversion. 
Major advances in protein engineering techniques have facilitated the ‘tailoring’ of enzymes for 
specific process requirements (e.g. improved thermostability, solvent tolerance, substrate 
scope/affinity, and catalytic activity). However, the investment in research effort, time and costs 
for protein engineering are disproportionate to the number of realised industrial processes. 
Furthermore, this thesis suggests this is due to a disconnect in the earliest stages of reaction 
design and conceptualisation where the required process performance is typically not considered 
or understood. Therefore, process performance requirements are suggested as a series of metrics 
in this thesis such that they may be used to guide reaction assessments and for benchmarking. 
These metric requirements are based on the value-class of the product (i.e. process margins) and 
cost of biocatalyst formulation, and include: reaction conversion, reaction yield, yield on co-
substrate (where appropriate), selectivity, product concentration, productivity/space-time yield, 
specific productivity and biocatalyst yield. These metrics were shown to be appropriate and 
informative in two case studies. 
These two cases studies involved biocatalysis of poorly water-soluble substrates and were chosen 
in order to demonstrate the application of the proposed reaction assessment and subsequent 
benchmarking with the process performance metrics. 
The first case study, which is the enantioselective desymmetrisation of a diester by recombinant 
pig liver esterase, highlights the importance of quantifying mass transfer limitations when 
gauging process metrics (especially biocatalyst yield). The required process metrics for a high-
value product (100 € kg-1) were all satisfied with the exception of biocatalyst yield. In order to 
increase the biocatalyst yield to the required range of 10-40 g gbiocat-1, the exceptional metrics of 
space-time yield (20 g L-1 h-1) or product concentration (74 g L-1) could be reduced by an order of 
magnitude and still satisfy target process performance metrics. The second case study features 
the biocatalytic Baeyer-Villiger oxidation of a macrocyclic ketone to its corresponding lactone, 
and resulted in an even more complex solid-liquid-gas reaction medium. Here, the necessity and 
usefulness of alternative, online, analytical methods involving oxygen mass balances in the gas-
phase and activity assays by sacrificial sampling are demonstrated. The use of co-solvents to 
improve substrate mass transfer in this case is also presented. Due to the lower value-class of 
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macrocyclic lactones (5-20 € kg-1) more stringent process metrics are required when compared 
with the first case study. Oxygen transfer was found to limit the rate of reaction, and as a result 
all process performance metrics fell short by an order of magnitude. However, the rate of oxygen 
transfer can still be improved through scale-up, sparging pure oxygen instead of air, or operating 
the reactor under pressure, which may improve performance metrics sufficiently. 
Based on the two case studies, a generic and pragmatic procedure for conceptualising biocatalytic 
reactions is proposed with a special focus towards those involving poorly water-soluble 
substrates. This comprehensive route for development includes the precise order and types of 
experiments required to design a reaction from initial considerations up to the point where later-
stage process development tools and directed improvement strategies can be applied in 
addressing the challenges of poorly water-soluble substrates in industrial biocatalytic processes. 
  
iii 
 
Dansk Resume 
Anvendelsen af biokatalyse er vokset i industrien, til et punkt hvor der nu er hundredevis af 
etablerede processer, inden for adskillige forskellige industrier. Men de fleste af de stoffer, der er 
af interesse inden for kemisk syntese, er ikke vandopløselige. Hvis disse stoffer skal bruges som 
substrater i enzym-katalyse reaktioner, vil de danne heterogene reaktionsblandinger, fordi vand 
er det mest almindelige opløsningsmiddel til biokatalyse. Dannelsen af flere faser skaber nye 
problemer for den eksperimentelle udførelse og processens effektivitet.  Et hovedproblem er at 
identificere og adressere begrænsningen af substraters masseoverførsel i de vandfaser, hvor 
biokatalysen finder sted.  
Denne afhandling søger at afklare systematiske metoder til at håndtere ikke vandopløselige 
substrater på, hvilket er kritisk for biokatalytiske reaktionsdesign. En standardiseret metode til 
at vurdere reaktioner og justere deres effektivitet er blevet udviklet og præsenteret. Denne 
metode indebærer at sammenligne reaktionskurver opnået under varierende forhold (enzym og 
substrat koncentrationer) og kan skelne mellem flaskehalse forårsaget af enzym kinetik, enzym 
stabilitet, og begrænsninger der ikke er enzym-relaterede. Metoden har vist sig at være i stand til 
at identificere kvalitative (og i en hvis grad kvantitative) begrænsninger for substraters 
masseoverførsel via målinger af substratomdannelse over tid.  
Massiv udvikling inden for protein engineering gør det nu muligt at “skræddersy” enzymer til 
specifikke proceskrav (som at forøge termostabiliteten, solvent tolerance, affiniteten over for 
substrater eller den katalytiske aktivitet). Men investeringen i tid, penge og forskningsaktivitet 
er disproportional i forhold til antallet af succesfulde industrielle processer. Denne afhandling 
foreslår, at dette højst sandsynligt skyldes, at de tidlige stadier inden for reaktionsdesign og 
konceptudvikling, hvor processens effektivitet ikke er i fokus eller helt forstået, ikke er koblet til 
processens slutmål. Derfor vil proceseffektivitet i denne afhandling være målt på en række kerne 
procesparametre, således at de kan bruges til at guide vurderingen af reaktioner, samt som 
sammenligningsgrundlag. Målene for disse procesparametre er basseret på hvilken værdi-klasse 
produkter er i (altså procesmargen) og omkostninger for biokatalytiske formuleringer, og 
inkluderer reaktionsomdannelse, reaktionsudbytte, udbytte af co-substrater, selektivitet, 
produktkoncentration, produktivitet/space-time yield, specifik produktivitet og biokatalytisk 
udbytte.  
To casestudier med biokatalyse og dårligt vandopløselige substrater blev valgt for at 
demonstrere denne måde at vurdere og efterfølgende sammenligne processers præstationer på.  
Det første studie, som er en rekombinant pig liver-esterases enantio-selektive afsymmetrisering 
af en diester, viser vigtigheden i at kvantificere massoverførsel når man vurderer 
procesparametre (særligt biokatalytisk udbytte). De nødvendige procesparametre for et produkt 
af høj værdi var alle tilfredsstillede, bortset fra det biokatalytiske udbytte. For at få det 
biokatalytiske udbytte op til de nødvendige 10-40 g gbiokat-1, kunne den høje produktivitet på 
20 g L-1 h-1 eller den høje produktkoncentration på 74 g L-1 blive reduceret med en tiendedel, og 
stadigvæk opfylde processens procesmål. Det andet casestudie er en biokatalytisk Baeyer-Villiger 
oxidation af en makrocyklisk keton til dens respektive lacton, og resulterede i et endnu mere 
kompleks reaktionsmedie med faststof, væske og gas. Her blev nødvendigheden af at bruge en 
alternativ, online, analytisk metode, der involverede iltoverførsel i gasfase og at ofre prøver i 
aktivitets-assays, vist. Yderligere blev effekten af at bruge co-solventer for at øge substraters 
masseoverførselsevne også studeret.  På grund af makrocykliske lactoners lave værdiklasse, var 
det nødvendigt at opnå højere procesparamtre for denne reaktion, sammenlignet med den 
tidligere. Det vidste sig at iltoverførsel var en begrænsning for reaktionshastigheden, og derfor 
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var alle procesparamtre en tiendedel for små. Tilførelsel af oxygen kan dog stadig forbedres enten 
ved opskalering, brusning af ren ilt i stedet luft, eller ved at køre reaktionen unden tryk. Alle tre 
kan føre til forbedringer i processens effektivitet.  
Baseret på disse to studier er en general og pragmatisk procedure for at danne koncepter for 
biokatalytiske reaktioner blevet foreslået, med et specielt fokus på de reaktioner der involverer 
dårligt vandopløselige substrater. Denne omfattende metode til reaktionsdesign har den præcise 
rækkefølge og typer af eksperimenter der behøves for at designe en reaktion, fra de første 
overvejelser og op til et punkt, hvor procesudviklingsværktøjer og målrettede 
forbedringsstrategier kan bruges til at adressere de udfordringer der er for dårligt 
vandopløselige substrater inden for industrielle biokatalyserende processer. 
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performed in a laboratory-scale stirred tank reactor.  
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Abbreviations 
API Active pharmaceutical ingredient 
BVMO Baeyer-Villiger monooxygenase 
CDMO Cyclododecanone monooxygenase 
CDW Cell dry weight 
CFE Cell-free extract 
CWW Cell wet weight 
DOT Dissolved oxygen tension 
E. coli Escherichia coli 
EC Enzyme Commission 
ECS-PLE06 Recombinant pig liver esterase 
FC Gas flow controller 
FM Gas flow meter 
GC Gas chromatography 
HPLC High-performance liquid chromatography 
ISPR In situ product removal/recovery 
OTR Oxygen transfer rate 
vvm Volumes (of air) per volume of reaction medium per minute 
YO2M Gas-phase oxygen fraction meter 
 
Nomenclature 
Greek symbols 
η Efficiency factor (for immobilised preparations) [-] 
ν Volumetric gas flow rate [sL min-1] 
   
Roman characters 
a Specific activity [U mgbiocat-1] 
CO2 Dissolved oxygen concentration in the bulk medium [mol L-1] 
C*O2 Dissolved oxygen concentration at saturation [mol L-1] 
E0 Initial enzyme concentration [mgbiocat L-1] 
kcat Turnover number [min-1] 
kd First-order rate constant for deactivation [s-1] 
Kic Competitive inhibition constant [mmol L-1] 
Kiu Uncompetitive inhibition constant [mmol L-1] 
kLa Overall volumetric mass transfer coefficient [h-1] 
KM Michaelis constant [mmol L-1] 
ṅO2 Molar flow rate of oxygen [mol h-1] 
p Product concentration [mmol L-1] or [g L-1] 
P Pressure [atm] 
R Ideal gas constant [L atm K-1 mol-1] 
RO2 Oxygen consumption rate [mol L-1 h-1] 
Rglucose Glucose consumption rate [mol L-1 h-1] 
S0 Initial substrate concentration [mmol L-1] or [g L-1] 
ix 
 
STY Space-time yield [g L-1 h-1] 
t Time [min] or [h] 
T Temperature [°C] or [K] 
TTN Total turnover number [-] 
Vmax Maximum reaction velocity at substrate saturation [mmol L-1 min-1] 
yO2 Gas-phase oxygen fraction [-] 
 
Definitions 
Catalyst kinetics Rate of catalysis according to the Michaelis-Menten expression (also 
including inhibition and enzyme stability). 
gbiocat Refers to grams of lyophilised cell-free extract in the context of this thesis. 
We postulate that this is indeed the preferred biocatalyst formulation for 
simpler process handling (e.g. storage stability and ease of dosing) in 
industrial processes. 
Half-life (t½) Time required for an enzyme to lose half of its specific activity. According to a 
first-order deactivation model: t½ = ln(2)/kd . 
Inhibition The phenomenon where enzymes are inhibited through negative interactions 
with a medium component (e.g. substrate or product). 
Reaction kinetics Rate of reaction including catalyst kinetics, rate of (substrate) mass transfer, 
effects of mixing and environmental conditions (e.g. pH, temperature, 
presence of co-solvents).  
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Chapter 1. Introduction 
1.1. Biocatalysis as an established branch of chemical synthesis 
Catalysis is fundamental to industrial chemical processing. A catalyst is defined as something 
which “accelerates a chemical reaction without affecting the position of equilibrium” – Wilhelm 
Ostwald, 1895. As many as three quarters of all industrial processes require catalysts, with more 
than 90% of newly developed processes being catalytic (Hagen 2015). Catalysts vastly improve 
the atom efficiency of reactions as they are not stoichiometric reagents and may be reused 
(Sheldon 2000; Sheldon and Blaser 2003). Catalysts may be gases, liquids or solids and may be 
heterogeneous (i.e. forming an additional phase in the reaction medium) or homogeneous (i.e. 
soluble and well-dispersed in the reaction medium). It is also possible to immobilise 
homogeneous catalysts onto a solid particle, e.g. zeolites, to transform them into heterogeneous 
catalysts. Most steps of crude oil processing and the petrochemical industry are catalytic, as well 
as for the polymer industry, pharmaceuticals, dyes and pigments, herbicides and pesticides, 
organic intermediate syntheses, and environmental control (e.g. purifying automobile and power 
generation exhaust gas emissions). Indeed, it would be impossible to imagine the world as we 
know it without the influence of catalysts in our everyday life. 
Most catalysts are reliant on a metal ion acting as an active centre. Whilst some metals 
such as gold, platinum, and silver are already scarce and correspondingly expensive, there is now 
an ever larger rarity of almost all catalytic metals (Figure 1.1). Inevitably, this will drive prices 
even higher and cause market instability for metals in the future. This is due to mining out the 
accessible reserves and not effectively recycling these metals (Dodson et al. 2012). Furthermore, 
there is only a growing demand for minerals, metals and semi-conductors from new ‘renewable’ 
energy industries (e.g. wind turbines, electric cars, or solar panels) and little focus towards 
recycling or reusing the already mined resources. Therefore, it should be expected that a shift in 
the traditional processing routes of chemical industry must occur in order to sustain the global 
demand for what have today become common commodities (e.g. plastics, pharmaceuticals, food, 
fuel, etc.). 
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Figure 1.1. The remaining years until depletion of elements based on current extraction rates 
(reproduced from Hunt et al. (2015), with permission from the Royal Society of Chemistry). 
Nature has however already solved this issue of metal scarcity for the most effective use in its 
own catalysis. Enzymes are biological catalysts that often incorporate metal active centres and 
allow almost all biological reactions to take place under, relatively speaking, mild conditions (e.g. 
37 °C, pH 7.5, in an aqueous medium – although exceptions are prevalent depending on the 
biological environment). The metal ions are often bound to cofactors, substrates, nucleic acids or 
amino acid chains thereby forming active proteins, the unique structure of which gives them 
extraordinary scopes of specific activities. Enzymes are classed based on the type of reactions 
they catalyse (Table 1.1). Since the 1980’s, recombinant DNA technology has allowed the 
expression of proteins through the fermentation of renewable sugars in highly productive, benign 
host organisms (Bornscheuer and Buchholz 2005). This has allowed a vast expansion of enzyme 
applications because virtually any enzyme can now be produced, even at large volumes, in a 
renewable manner by means of altering genes and overexpression in high copy number plasmids. 
Recombinant DNA technology has also spawned the field of protein engineering where specific 
structural alterations (or mutations) can be made through modifying an amino acid sequence. 
Changing the structure of an enzyme in a rational manner allows protein engineers to: improve 
the catalytic rate of an enzyme, better accept native substrates as well as new non-natural 
substrates, increase selectivity, improve the stability of an enzyme towards different reaction 
conditions (e.g. temperature, pH, organic solvents), and reduce substrate/product inhibition 
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(Strohmeier et al. 2011). Protein engineering itself has also grown as a field since its conception 
(Bornscheuer et al. 2012). Whilst structure-function understanding allows the rational 
improvements to enzymes by point mutations, there is also now the approach of directed 
evolution, which does not require a known crystal structure of a given protein (Figure 1.2) 
(Arnold 2001; Turner 2009; Reetz 2011). The simplest procedure of directed evolution is to take 
a wild-type enzyme, perform random mutagenesis, and then screen the resultant library for 
variants that have the desired characteristic. This process may then be repeated with these new 
variants to further strengthen the enzyme’s capabilities. All these advances have now effectively 
led to an open field of customisable catalysts. In the future, these techniques will likely become 
even more sophisticated as computational tools and bioinformatics are better integrated to allow 
rationally designed synthetic enzymes (Lutz 2010). 
Table 1.1. Major enzyme classes nomenclature. EC – Enzyme Commission (of the International Union 
of Biochemistry and Molecular Biology). 
EC Major Class 
Number 
Enzyme Class Chemical Functionalisation 
1 Oxidoreductases Oxidation/reduction 
2 Transferases Group transfer 
3 Hydrolases Hydrolysis 
4 Lyases 
Formation of double bonds through cleaving 
groups; Breaking double bonds through 
introducing groups 
5 Isomerases Isomerisation 
6 Ligases (synthetases) 
Bonding large molecules, simultaneously cleaving 
smaller leaving group(s) through hydrolysis 
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Figure 1.2. Procedure for protein engineering by rational design and directed evolution. Colours 
indicate mutations or corresponding structural ‘hotspots’. Adapted from Strohmeier et al. (2011). 
Therefore, due to their (1) highly selective and sought after activities, (2) renewable origin and 
stable cost price*, as well as (3) the facility to tailor the structure of enzymes enhancing activity, 
scope (substrate affinity) and/or stability, enzymes – or biocatalysts – have since found their 
application in research and industry and now play an increasingly important role in synthetic 
chemistry. 
Enzyme-based processes are employed in various industries to produce complex 
intermediates and final products in an efficient and sustainable way (Sheldon and Woodley 
2018). This broadening of focus in the chemical industry towards encompassing biocatalysis took 
place mainly due to the impressive selectivity of enzymes (Hughes and Lewis 2018). Additionally, 
biocatalysts have become important for organic synthesis because their unique functionalisations 
might allow a reduced number of synthesis steps when compared to conventional routes (Nestl 
et al. 2014). All of these benefits lead to ‘greener’ processes through atom efficiency, reduced 
                                                             
* The production of enzymes from sugars means their cost is directly linked to the sugar market. Therefore, 
their cost is more stable in comparison with other catalysts (especially considering future price volatility 
that might be caused by projections of depletion (Figure 1.1)). 
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waste and by-products, mild process conditions, and use of non-toxic solvents (Sheldon 2017; 
Sheldon and Woodley 2018). Indeed, biocatalysts have become an established option at a range 
of different scales, mainly for the synthesis of biologically active compounds. In order to illustrate 
this, a selection of examples of industrial biocatalysis are compiled in Table 1.2. More details can 
be found and further examples in each of the sources used in Table 1.2 – the review by Sutton et 
al. (2012) being particularly comprehensive and written from the perspective of fine chemicals 
and pharmaceutical industries. 
Lastly, it is common for biocatalysts to take on a number of different forms in industrial 
applications (Table 1.2). Usually the cheapest, crudest acceptable form of a biocatalyst will be 
used due to economic constraints (Pollard and Woodley 2007). The simplified processing routes 
for the most common industrial biocatalyst formulations are shown in Figure 1.3. All formulations 
naturally begin with fermentation, which requires the input of fermentation medium and an 
inoculum of the microbial host strain. Whole-cells may be desired for more sensitive enzymes, 
internal co-factor recycling mechanisms, or for their low cost. However for most other cases, cell-
free extracts (or isolated enzymes) are preferred in order to bypass potential mass transfer 
limitations of substrate/product across the cell membrane, make a biotransformation 
independent of cell viability, decrease oxygen demand, as well as for longer term storage and 
more convenient process handling (Duetz et al. 2001). Typically, cell-free extracts are further 
filtered after homogenisation to remove solid particulates, but also to concentrate the active 
enzyme in the formulation. Purified target proteins are almost never used in industrial settings 
because of additional costly chromatography separation steps. Both whole-cells and cell-free 
extracts can also be lyophilised into powders by freeze-drying for long-term storage. Lastly, 
although costly (Tufvesson et al. 2011b), enzymes can also be immobilised typically onto a carrier 
material for use in continuous flow reactors and for biocatalyst recycling (Hanefeld et al. 2009; 
Sheldon and van Pelt 2013). 
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Figure 1.3. Block flow diagram of the upstream production for different biocatalyst formulations. The 
dashed lines indicate optional steps (freeze-drying), and the dotted lines differentiate extracellular or 
intracellular enzyme expression. *Lyophilised cell-free extract is the preferred formulation for longer 
term storage of enzymes and easier process handling. 
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1.2. Early-stage process development and assessment 
There are many examples of industrial biocatalysis, however the process development path for 
each case has never been straightforward and is often exceptional. However, what has been 
established through these cases are the general tools that can be used to effectively develop 
processes. The various tools can be classed into two categories: reaction engineering or 
biocatalyst engineering. 
One important aspect of reaction engineering involves changing and/or optimising the 
reaction environment to enhance the performance of a biocatalyst. There are many process 
variables to balance (e.g. temperature, pH, type and fraction of co-solvent) that may sometimes 
conflict with the biocatalyst’s optima. For example, high product concentrations might be 
required to ensure a cost-effective downstream separation. If the correspondingly high substrate 
load for the reaction inhibits the biocatalyst, then substrate feeding strategies must be 
considered. For the case of liquid substrates, this simply involves optimising the substrate feed 
rate. However, solid or gaseous substrates are more challenging to feed, and might need to be 
delivered to the aqueous enzyme reaction environment through a second phase (a process 
sometimes called in situ substrate supply (ISSS)) (Kim et al. 2007). In these cases, the theoretical 
feed rate of a substrate is dependent on its partition coefficient between each phase – this is 
covered in more detail in Section 1.3. High product concentrations might also instigate product 
inhibition. A means of addressing this is to integrate product separation with the reaction step, a 
process called in situ product removal (ISPR). Systems that are limited by thermodynamic 
equilibria can also be driven by ISPR through selectively removing a product (Tufvesson et al. 
2014). There are many methods of ISPR mostly relying on exploiting unique physical properties 
of the product to ideally concentrate it out of the enzyme’s immediate environment in the reaction 
medium (Lye and Woodley 1999; Woodley et al. 2008; van Hecke et al. 2014). Some of these 
methods include: adding water-immiscible organic co-solvents into which product will 
preferentially partition (Klibanov 1990), using more non-conventional solvents such as ionic 
liquids (van Rantwijk and Sheldon 2007), deep eutectic solvents (Smith et al. 2014) or 
supercritical CO2 (Matsuda 2013), adding a solid phase to either absorb or adsorb the product 
(Vicenzi et al. 1997; Hilker et al. 2004; Fam and Daugulis 2012), physically transporting the 
product via a selective membrane (Carstensen et al. 2012), crystallising or precipitating the 
product from the liquid phase (Buque-Taboada et al. 2006), to name a few. A challenge to 
implementing ISPR actually lies in the multitude of different techniques. With little consensus or 
standardised methodologies for selecting and applying ISPR to any given system, the application 
of ISPR is often bound to ad hoc experimental approaches on a case-by-case basis. Another 
challenge of ISPR is that, as a mass transfer process, the rate of removal is directly related to the 
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concentration gradient between the reaction phase and ‘ISPR phase’. Since the purpose of ISPR is 
to lower the effective concentration of product in the reaction phase, this concentration gradient 
or driving force will too be reduced, potentially leading to an inefficient and costly removal 
process. This trade-off must be carefully considered. A means of improving the rate of ISPR in 
such cases might be achieved through protein engineering an enzyme’s tolerance for product 
inhibition by allowing higher product concentration limits. 
Another aspect to reaction engineering is the collection of kinetic information to be used 
for process modelling and conceptual design (Ringborg and Woodley 2016). These process 
models are especially useful for the selection of reactor type and the process of scale-up in later 
stages of biocatalytic process development (Tufvesson et al. 2013). 
On the other hand, protein engineering as discussed in Section 1.1 is still the most 
powerful way of improving a biocatalyst’s performance (Woodley 2013). Another subsidiary 
branch of biocatalyst engineering is genetic engineering which encompasses improving enzyme 
expression or the host organism. Experience shows that more than 100-fold improvement to a 
biocatalytic process may be realised through protein engineering, whilst reaction engineering can 
only improve processes up to 10-fold, and genetic engineering a few fold. However, the vast 
benefits of protein engineering come at the greatest cost both in terms of research investment as 
well as time for development (Truppo 2017) when compared to reaction engineering approaches. 
This alludes to a necessary balance or prioritisation of the different biocatalytic process 
development strategies. For example, in the development of a biocatalytic process for the 
production of atorvastatin, ISPR was initially considered to mitigate product inhibition. Yet a 
2500-fold improvement in enzyme activity was achieved instead through the protein 
engineering. After such improvement the limitation of product inhibition was surpassed and a 
successful process is now in operation (Ma et al. 2010). It is clear that competencies in protein 
engineering, fermentation and protein expression, as well as reaction engineering are all 
essential, and must be integrated, in order to succeed in biocatalytic process development. 
However, rarely are the two approaches of reaction engineering and biocatalyst engineering 
cohesive and directed towards a specific goal. Massive strides in one or the other has historically 
led to a breakthrough in process performance, which has then inspired further development until 
the biocatalytic reaction is found feasible for full-scale production. 
In order to better succeed in biocatalyst implementation, a more systematic methodology 
and guidelines for process development must be established – especially regarding the early 
stages. The early stages of biocatalytic reaction conceptualisation and assessment are critical 
towards the speed of process development, which has been perceived to be too lengthy at present 
and stands as a major hindrance for industrial implementation (especially in the pharmaceutical 
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industry) (Truppo 2017). Specifically, such a systematic methodology would entail first 
specifying the target reaction of interest and the required process performance. Secondly, the 
exact order and type of reaction characterisation experiments must be outlined in order to learn 
the primary limitations of a given biocatalyst as efficiently as possible. Thereafter the feasibility 
of implementing different tools for process development (Tufvesson et al. 2013) can be assessed 
in terms of their effectiveness towards the final targets, cost, and development speed. Only in this 
way can research efforts be streamlined from all sides affording a successful biocatalytic reaction 
at an industrial scale. Yet there remain further challenges during reaction assessments brought 
about by poorly-water soluble substrates. These challenges must also be considered, and their 
solutions integrated into this systematic methodology. 
1.3. Prevalence of poorly water-soluble systems and common features 
The majority of biocatalysis is performed with water as the preferred solvent (Sheldon and 
Woodley 2018). This is due to the understanding that most enzymes naturally occur in aqueous 
systems, and also because they require water in their immediate environment in order to be 
active (Zaks and Klibanov 1988; Rupley and Careri 1991; Bell et al. 1995). As the application of 
biocatalysis to complement conventional chemical and catalytic approaches in organic synthesis 
continues to expand, an ever increasing number of reactions involve poorly water-soluble 
substrates. Furthermore, at the required industrial concentrations necessary for cost-effective 
industrial implementation (Lima-Ramos et al. 2014), this frequently leads to heterogeneous 
reaction mixtures composed of multiple phases (Erbeldinger et al. 1998). The introduction of 
ISSS/ISPR can also create a multiphasic reaction medium. Indeed, of the selection of industrial 
examples of biocatalysis presented in Table 1.2, exactly half of these processes feature poorly 
water-soluble compounds (of less than 10 g L-1) especially amongst the bulky molecules. These 
heterogeneous reactions can take the form of gas-liquid, liquid-liquid, or solid-liquid mixtures (or 
combinations thereof). 
There are many challenges associated with multiple reaction phases. The first is a 
practical issue regarding experimental practice in that it is problematic to measure 
representative component concentrations when sampling a non-homogeneous medium. Unusual 
questions arise such as: how many samples are necessary, what is an appropriate sampling 
fraction (volume), how should samples be taken, or whether physical sampling of the medium 
itself is the best analytical method in such cases? Secondly, poor solubility can introduce mass 
transfer limitations because transport must occur between phases. Mass transfer is improved 
through convection in the medium, i.e. mixing. Better convection through mixing achieves a 
dispersion of second phase, e.g. smaller liquid droplets or bubble sizes, which in turn improves 
the specific interfacial area of this phase. However, this dependence on mixing also introduces 
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new limitations at different scales (physical reactor sizes) because mixing is a function of specific 
power input (Noorman 2016). Simply put, it is effortless to homogenise a smaller volume, usually 
leading to unrealistic power inputs per unit volume when compared to large volumes. This is why 
good dispersion is challenging at larger scales and why potentially misleading results may be 
found in the laboratory. Lastly, and most importantly, poor aqueous solubility sets an upper limit 
on the concentration of substrate available for reaction. The rate of catalysis is a function of 
dissolved substrate concentration and is generally described by Michaelis-Menten kinetics for 
enzymes. Therefore, there is a risk that, because these substrates are not accessible for catalysis, 
heterogeneous reactions may simply be too slow to be industrially useful. Nevertheless many 
cases, such as oxygen-dependent biocatalytic reactions, prove that reactions featuring poorly 
water-soluble substrates (where oxygen only has a solubility of 0.27 mM at 25 °C and 1 atm when 
in equilibrium with air) are indeed realisable. Oxidations can theoretically reach volumetric 
productivities in excess of 100 mmol L-1 h-1 at scale (Charles 1985), which corresponds to a 
reasonable 10 g L-1 h-1 for a product of average 100 g mol-1 molecular weight (higher molecular 
weight products will exhibit higher productivities). 
The most effective means to improving aqueous solubility (Caq) is to use organic solvents. 
The selection and use of solvents in biocatalysis falls under reaction engineering, and is a 
fundamental component of industrial processes featuring poorly water-soluble substrates. 
Organic solvents fall under two categories: those which are themselves miscible in water and 
those which can be considered water-immiscible (although still remain very slightly soluble in 
water). In almost all circumstances, the solubility of poorly water-soluble substrates will be vastly 
higher in organic solvents (Caux) based on the principle of ‘like dissolves like’. Therefore for water-
miscible solvents, the overall capacity for dissolved substrate (Coverall) is improved based on the 
fraction of solvent present. The mass balance for such systems is as follows: 
V𝑡𝑜𝑡𝑎𝑙 ∙ 𝐶𝑜𝑣𝑒𝑟𝑎𝑙𝑙 = 𝑉𝑎𝑞 ∙ 𝐶𝑎𝑞 + 𝑉𝑎𝑢𝑥 ∙ 𝐶𝑎𝑢𝑥 (1.1) 
An example to illustrate this principle is the production of the poorly water-soluble pesticide 2-
hydroxybiphenyl. In one case, solvents were investigated for the purpose of ISPR to mitigate its 
toxicity towards whole-cell biocatalysts (Held et al. 1999). As a result, the compound is well 
characterised in terms of its solubility in water (< 1 g L-1) as well as many organic solvents (Table 
1.3). Applying eq. 1.1 to varying co-solvent fractions for fully water-miscible solvents (methanol, 
acetone, acetonitrile) shows how the overall solubility of the entire reaction volume can be 
modified (Figure 1.4). Therefore for cases such as these, the addition of water-miscible solvents 
can vastly improve substrate availability in the liquid-phase, even in excess of 200 g L-1. It is 
important to note that some compounds are so poorly water-soluble that enzymatic activity can 
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only be observed in the presence of solvents. Contrarily, this improvement would be 
disadvantageous for systems where high substrate/product concentrations are inhibitory. 
However, the exact concentration can still be controlled through the volume fraction of co-
solvent. High concentrations of co-solvents can also sometimes induce the inhibition or 
deactivation of enzymes (Owusu and Cowan 1989; Iyer and Ananthanarayan 2008). Therefore, 
enzyme stability and activity in the presence of co-solvent fractions must always be studied. 
Table 1.3. Saturation concentration of 2-hydroxybiphenyl in different 
solvents. 
Medium 
2-Hydroxybiphenyl 
Solubility [g L-1] 
Source 
Water 0.7 (Cavender and O’Donohue 2001) 
Methanol 396 (Tomlin 2004) 
Acetone 376 (Tomlin 2004) 
Acetonitrile 418 (Tomlin 2004) 
n-Octanol† 436 (Tomlin 2004) 
Toluene† 404 (Tomlin 2004) 
n-Hexane† 318 (Tomlin 2004) 
 
 
Figure 1.4. Overall liquid-phase saturation concentration 
of 2-hydroxybiphenyl at varying water-miscible co-
solvent fractions. ● – methanol; ▲ – acetone; ■ – 
acetonitrile.  
                                                             
† Water-immiscible. 
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For the case of water immiscible solvents, a second organic phase will form during reaction. The 
saturation concentrations of n-octanol, toluene and n-hexane in water are 0.30, 0.53 and  
9.5 × 10-3 g L-1, respectively. Therefore, the aqueous phase solubility of compounds such as 2-
hydroxybiphenyl are only slightly improved through use of these co-solvents (Table 1.4). 
However, the overall medium capacity for these compounds is increased to a great extent, and 
most importantly concentrated in smaller volumes of auxiliary phase. This allows easier and 
cheaper downstream product purification in later stages (Straathof 2003a). The partition of 
substrate/product between the aqueous and auxiliary phases can be exploited for ISSS and ISPR 
when inhibition plays a role (Straathof 2003b). In such cases, high substrate and product loadings 
can still be realised without the effects of inhibition. 
Table 1.4. Maximum component fractions of 2-hydroxybiphenyl in the total reaction volume (Coverall), 
aqueous phase (Caq), and auxiliary phase (Caux) at various volume fractions of water-immiscible 
solvents. 
 n-Octanol Toluene n-Hexane 
Vol. Fraction Co-
Solvent [% (v/v)] 
Coverall 
[g L-1] 
Caq 
[g L-1] 
Caux 
[g L-1] 
Coverall 
[g L-1] 
Caq 
[g L-1] 
Caux 
[g L-1] 
Coverall 
[g L-1] 
Caq 
[g L-1] 
Caux 
[g L-1] 
0 0.70 0.70 - 0.70 0.70 - 0.70 0.70 - 
10 44.2 0.86 434 41.0 0.95 402 32.5 0.70 318 
50 218 0.86 436 202 0.95 404 160 0.70 318 
100 436 - 436 404 - 404 318 - 318 
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1.4. Thesis aims 
Despite poorly water-soluble compounds being so prominent in industrial cases of biocatalysis, 
little focus in literature is given towards their challenges and systematic ways of handling them. 
Therefore, the overall aim of this thesis is to describe special considerations when handling 
poorly water-soluble substrates during early-stage biocatalytic reaction characterisations. A 
second aim of this thesis is to establish how to approach such early-stage development as there 
are no generic guidelines or methodologies for such. Together, these aims complement each other 
to give a comprehensive outlook on reaction engineering for poorly-water substrates in 
biocatalysis, which should satisfy an important knowledge gap for future biocatalytic process 
development. 
1.5. Thesis structure 
Towards these aims, the following are discussed in the appropriate chapter of this thesis, 
respectively. The results chapters are divided into two parts corresponding to each primary aim 
as stated above: 
Early-stage reaction assessments 
 An experimental procedure for carrying out reaction scoping is outlined in Chapter 2. The 
outcome is the determination of a primary process limitation or bottleneck as early as 
possible in the development cycle of biocatalysts with a minimum number of three 
experiments. 
 In Chapter 3 the use of process performance metrics to guide development is described. 
Values for these metrics are suggested based on techno-economic process requirements 
of different product value-classes. 
Experimental challenges associated with poorly-water soluble substrates during reaction 
characterisations 
 The influences of mass transfer limitations on process metric evaluations when assessing 
heterogeneous reactions is addressed in Chapter 4. This was illustrated by means of a 
case study, which was the enantioselective desymmetrisation of a poorly water-soluble 
substrate using pig liver esterase. The optimal biocatalyst dose and space-time yield at 
small-scale was assessed without incurring mass transfer limitations (ascertained using 
the methodology described in Chapter 2). Perspectives on further process development 
were also suggested based on benchmarking process performance with metric targets 
from Chapter 3. 
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 Chapter 5 illustrates the analytical challenges in assessing conversions of poorly water-
soluble substrates through a case study of a complex biocatalytic Baeyer-Villiger 
oxidation of macrocyclic ketones in a gas-solid-liquid reaction. The need and accuracy of 
alternative analytical techniques is discussed with comparison to conventional 
techniques of sampling liquid media and spectrophotometric activity assays.  
 In Chapter 6 the analytical methods described in Chapter 5 are applied in combination 
with the methodology detailed in Chapter 2 to scope the biocatalytic Baeyer-Villiger 
oxidation of a macrocyclic ketone to its corresponding lactone, eventually elucidating the 
overall process limitation for this given reaction and focus for future process 
development and scale-up based on benchmarking with the process metric targets from 
Chapter 3. 
The overall findings of this thesis are discussed in Chapter 7 and, based on these, a route for early-
stage reaction conceptualisation is proposed. Even more importantly, this discussion also 
highlights a better way of handling poorly-water soluble substrates in future biocatalysis. Based 
on this, conclusions were drawn in Chapter 8, and future perspectives given in Chapter 9. 
1.6. Scope 
The scope of this thesis is such that only cases featuring poorly water-soluble substrates are 
considered. That being stated, the sections addressing early-stage reaction assessments in 
Chapters 2 and 3 are generic for any given biocatalytic reaction (i.e. not poorly water-soluble 
substrates alone). 
Later process development steps and improvement strategies are not directly addressed 
in this thesis as they have been described elsewhere in literature and are beyond the scope of this 
thesis. However, the most important general aspects for implementing future biocatalytic 
conversions of poorly water-soluble substrates are discussed in line with the findings of the 
specific case studies in this thesis. 
Literature is further reviewed throughout this thesis in each respective chapter where 
appropriate. 
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Chapter 2. ‘Bottleneck’ identification in early-stage biocatalytic 
reaction assessments 
This chapter describes a novel methodology that is used as a framework for initial experimental 
characterisations of the enzyme-catalysed reactions in case studies described later in this thesis 
(Chapters 4-6). The method makes use of a minimum number of three experiments that vary only 
two factors (biocatalyst loading and initial substrate concentration) to determine a major process 
limitation for a given reaction system. Most important, in the context of reactions featuring poorly 
water-soluble substrates, is the ability of this method to qualitatively distinguish mass transfer 
limitations from any other limitations, such as enzyme stability or reaction rates and binding 
affinities (i.e. kinetics). 
 
The following manuscript, which has been submitted for publication, has been reworked from this 
chapter:  
Mathias Nordblad, Mafalda Dias Gomes,† Murray P. Meissner,† Hemalata Ramesh, John M. Woodley. 
2018. Scoping Biocatalyst Performance using Reaction Trajectory Analysis. Organic Process Research 
& Development, (submitted). †These authors contributed equally. 
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2.1. Introduction 
A significant challenge to biocatalytic process development is the complex nature of the design 
task in terms of finding a viable synthesis route, enzyme candidate with the desired specific 
activity, and compromise between optimal reaction conditions for a process and that of the 
enzyme (Woodley 2017). Essential to a successful process development is the need for a broad 
range of scientific and engineering disciplines to align. First, the specific synthetic route must be 
decided upon while at the same time identifying an appropriate enzymatic activity towards this 
functionalisation with the inputs of chemists and molecular biologists. Thereafter, the enzyme 
needs to be expressed in an appropriate host organism and prepared in a final formulation for 
use in a process by biotechnologists. Process engineers and chemists also need to envisage 
process constraints based on the economic value class of the product in question. 
Certainly, the enzyme will need to be screened to assess its suitability for the target 
reaction (Lima-Ramos et al. 2014; Ringborg and Woodley 2016) , a process herein referred to as 
“reaction scoping”. This characterisation must be carried out as early as possible in order to 
feedback required improvements to the respective partners involved in early-stage process 
development. The efficacy of this characterisation could ultimately accelerate the rate of overall 
process development by establishing the primary limitations and relevant improvement 
strategies at an early-stage. Indeed, an improved speed of development has been highlighted as a 
requisite need to successful enzyme implementation, especially in the pharmaceutical industry 
(Truppo 2017). Thus, standardised tools and methods for designing, producing and evaluating 
enzymes should be considered highly valuable towards this end (Wohlgemuth 2007). However, 
to date there is little consensus as to how this characterisation is best carried out and most cases 
are established following an ad hoc approach. 
Examples of experimental methods currently used to perform such characterisations are 
the measure of reaction progress after a certain time (single-point measurements) or ‘initial rate 
measurements’ (Cornish-Bowden 2012). In the context of characterising enzymes, these 
techniques can elucidate kinetic parameters or enzyme stability towards different reaction 
environments, although are laborious in terms of the number of experiments required (Gardossi 
et al. 2010). If extensive experimentation is followed using these methods, an indication of 
feasibility or optimisation of reaction conditions can be made. However, the major process 
performance limitation (or bottleneck) of the overall system cannot be inferred from such 
experiments. 
This chapter details a systematic methodology that can be used to resolve exactly this 
problem. The relative simplicity of the methodology is key to its applicability in early-stage 
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process development. It follows that if the primary process limitation of an enzyme were to be 
made known at an early-stage, more directed process (Tufvesson et al. 2011a) and protein 
engineering (Woodley 2013) improvement strategies could be identified and implemented. The 
methodology relies on specific experiments that can offer a qualitative, and to some extent 
quantitative, description of the bottleneck/process limitations of a given enzyme reaction. 
Similar to the works of Blackmond (2005; 2015) and Duggleby (1994; 2001), the 
methodology makes use of high frequency time-course conversion progressions of reactions to 
elucidate underlying reaction kinetics. The mechanism of such kinetics is then distinguished 
using normalised plots, similar to an earlier approach by Selwyn (1965). Building on Selwyn’s 
work (which was a method to identify biocatalyst inactivation), the methodology presented in 
this chapter can identify limitations in (substrate) mass transfer, enzyme kinetics and stability.  
The methodology that follows describes and discusses the relevance of graphical reaction 
trajectories, normalised axes and reaction conditions. Thereafter, the actual experiments and 
their order are presented. Lastly, the identified bottlenecks are discussed in relation to the 
experimental conditions. For the purposes of illustrating the method, simulations were made 
using empirically determined enzyme kinetic parameters of glucose oxidase, wherein 
expressions for oxygen mass transfer and enzyme inactivation models could also be included. The 
exact expressions used in the model fall outside the scope of this chapter, however are described 
in detail in Nordblad et al. (submitted). Further experimental validations of this method, which 
confirm the simulated responses, are also given as three separate case studies in Nordblad et al. 
(submitted). Notwithstanding, validations of the method also appear in the later chapters of this 
thesis wherein it was applied.  
2.2. Methodology 
2.2.1. Time-course reaction profiles and normalised axes 
Central to the methodology are experimental time-course reaction progressions. Different kinetic 
phenomena (such as mass transfer or enzyme kinetics) are aggregated into each data point of a 
reaction trajectory, and over longer periods, the shape of this conversion profile will be dictated 
by the fundamental limiting phenomenon. In this way, a full time-course progression can reveal 
better understanding of kinetic limitations than single-point measurements or initial rate 
measurements can provide. The accuracy in determining the shape of a reaction trajectory is 
enhanced through higher frequency measurements, such as those which direct, online analytical 
techniques can provide (Meissner et al. 2018). As already mentioned, single-point measurements 
aggregate all effects of catalyst kinetics, mass transfer and loss of activity over time, and the extent 
of these effects are all dependent on changes in reaction composition (i.e. over time), and 
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therefore cannot be decoupled from each other. Further, whilst initial rate measurements can 
account for catalyst kinetics over brief periods, they cannot identify the other effects over the 
entire course of a reaction. 
The methodology makes use of normalised axes in plots to distinguish time-dependent 
effects. A similar graphical approach was described by Selwyn (1965). For example, if the 
biocatalyst concentration is doubled whilst maintaining all other reaction conditions, then it 
should be expected that the reaction time will be exactly halved due to the increased rate of 
reaction. (Time-dependent) deviations from this expected behaviour would be difficult to visually 
inspect if the ordinary time vs. conversion plots of each data set were to be compared. However, 
if the time axis is normalised by the independent variable by multiplying it with biocatalyst 
concentration, then the resulting plots of (time · biocatalyst concentration) vs. conversion should 
directly overlap if there are no time-dependent effects (or no biocatalyst concentration-
dependent activity effects). Conversely, if any other response is observed in such a normalised 
plot, then there exists a time-dependent limitation, which is in itself a function of the enzyme’s 
response to the changing reaction composition. Similarly, an experiment performed with double 
the substrate concentration (with all other reaction conditions maintained) should take exactly 
double the time to reach full conversion. Normalising this response by dividing by the 
independent variable (i.e. substrate concentration) will then further elucidate the mechanism of 
such a limiting effect if no graphical overlap is observed. Such profiles are discussed and 
presented in Section 2.2.3. 
2.2.2. Reaction conditions 
In order to effectively learn how an enzyme will cope with certain reaction conditions in an 
industrial process, as much as possible, similar conditions must be used when performing these 
time-course evaluations. In this way, the experimental conditions should be relevant towards 
helping meet process targets for a given industrial application. 
Industrial processes regularly require high substrate loadings, often in excess of 50 g L-1, 
in order to realise cost-effective downstream separations. Choosing similarly high substrate 
concentrations in lab-scale experiments will allow the detection and quantification of the effects 
of substrate and/or product inhibition on an enzyme which may occur at these high 
concentrations. 
In addition, the cost of enzymes matter on an industrial-scale. Therefore, the dose of 
biocatalyst at lab-scale should reflect this constraint. This, together with high substrate loadings, 
should also give indication to a more realistic reaction duration. If enzyme inactivation occurs 
during this reaction period then its effect on reaction progress will be made evident. 
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Finally, industrial processes frequently require the addition of solvents and other agents, 
such as antifoam, to enable smooth process operation. Solvents help solubilise poorly water-
soluble substrates (refer to Chapter 1 and Chapter 6), can help remove inhibitory products in situ, 
and can also simplify downstream product isolation. Adding them at this (early) stage of process 
scoping immediately informs of an enzyme’s robustness towards different solvents. 
2.2.3. Order of experiments 
The methodology relies on three key experiments, all of which follow the conversion (reaction 
progress) over time, and are presented as respective steps in Figure 2.1. Here, the conversion can 
be defined as either the fractional or percentage conversion of substrate to product, or the 
conversion of substrate to product relative to the thermodynamic equilibrium limit (if 
applicable). The first step (i.e. experiment) is used as a benchmark. This experiment establishes 
the general type of reaction behaviour: specifically, if the rate of reaction varies with time and/or 
conversion (termed “higher-order kinetics”) or if it does not (zero-order kinetics). In the second 
experiment, the catalyst load is varied relative to the first experiment, and its impact on the 
reaction trajectory is assessed thereby identifying the main limitation of the system (in all of the 
example plots in Figure 2.1, the variable of interest is increased relative to the base case). More 
specifically, this experiment distinguishes between limitations related to the catalytic activity 
(through kinetics or stability) and limitations not related to the catalyst, such as mass transfer 
limitations. In the third experiment, the substrate concentration is varied, again, relative to the 
baseline experiment. This experiment only applies to systems limited by either enzyme kinetics 
or stability, and gives an indication of the underlying mechanism in either category. 
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Figure 2.1. Experimental order and the resulting reaction trajectory responses for different process 
performance limitations. Catalyst activity limited: kcat – turnover number; kinetically limited: KM – 
Michaelis constant, Kic – competitive inhibition constant, Kiu – uncompetitive inhibition constant; 
enzyme stability limited: kd – first-order rate constant for inactivation, TTN – total turnover number; 
mass transfer limited: kLa – overall volumetric mass transfer coefficient. Uncompetitive inhibition and 
competitive inhibition have been respectively simplified to typical scenarios of product inhibition and 
substrate inhibition. 
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Zero- vs. higher-order kinetics 
The methodology starts with a single time-course experiment, meant to assess the general 
behaviour of the reaction under the chosen reaction conditions. In this analysis, reactions 
exhibiting a constant reaction rate throughout the course of reaction are classed as exhibiting 
zero-order kinetics. This type of behaviour implies that, within the conditions of the experiment, 
neither a change in substrate/product composition (through enzyme kinetics) nor reaction time 
(through inactivation) affect the course of reaction. Conversely, a reaction that exhibits a reaction 
rate that changes over the course of the reaction is classified as having higher-order kinetics. This 
behaviour also includes all reactions that fail to reach completion (relative to the reaction 
equilibrium). It is worth noting that it is common for reactions to show zero-order behaviour 
initially and transition into higher-order kinetics at higher conversions or after some time. 
Impact of catalyst loading 
For the second step of the methodology, the catalyst load is varied to separate the three main 
classes of limitation: catalyst kinetics, catalyst stability or non-enzyme related. 
In a reaction controlled entirely by enzyme kinetics, the plots of reaction courses with 
different catalyst loads should superimpose when the reaction time is normalised for the catalyst 
load. 
In a system limited by catalyst stability, the reaction rate should vary less with conversion 
at higher catalyst loads. This is because inactivation is a time-dependent process, and therefore 
less inactivation would have occurred in a reaction that proceeds more quickly. 
Finally, in some cases the reaction rate will be disproportionately lower at higher catalyst 
loadings. This is because something other than intrinsic catalyst kinetics or stability is limiting 
the reaction: most typically, the rate of substrate mass transfer between phases or compartments 
in a reaction system. It is important to note that in such cases, any further analysis of the catalyst 
performance will be hindered by extensive mass transfer (non-catalyst related) limitations. If 
such an analysis is desired, reaction conditions must be modified to either improve mass transfer, 
or to reduce the need for high mass transfer by reducing the catalyst load (as indicated in Figure 
2.1). The assessment should then be done from the beginning with a new baseline experiment 
again. 
A reaction exhibiting zero-order behaviour is not significantly affected by catalyst 
inactivation during the course of the reaction and is saturated by the substrate throughout the 
reaction. Further improving such a reaction requires improving the maximum activity of the 
catalyst relative to the substrate. 
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Impact of substrate loading 
In the third step of the methodology, the substrate concentration is varied in addition to the 
biocatalyst loading to distinguish between mechanisms for both kinetic and stability limitations. 
Changing the substrate concentration directly modifies the conditions for the catalyst, and 
consequently the entire reaction course will be different. Additionally, changing the substrate 
concentration also changes the duration of the reaction because more substrate typically takes 
longer to convert with a given amount of catalyst. 
In a case where it has been determined that the reaction is primarily limited by catalyst 
kinetics, it will be of interest to determine the dominating kinetic limitation. For soluble enzyme 
catalysis in a homogeneous system exhibiting higher-order behaviour, the rate of reaction will 
depend solely on the enzyme kinetics. These will be linked to either a high saturation constant 
for the substrate (i.e. high KM), or competitive or non-competitive inhibition by one or more of the 
reaction components. To distinguish between these effects, reaction data for different substrate 
loads should be compared in a plot of conversion against reaction time normalised by both 
enzyme and substrate load. 
In this example, for a reaction that becomes slower at higher substrate conversions due 
to a high KM for the substrate, the rate of conversion will become disproportionally faster at 
increased substrate concentrations. This is because the catalyst becomes more saturated at a 
given conversion with more substrate. On the other hand, if the kinetic limitation is due to 
competitive inhibition by the product, the combined effect of inhibition and increased substrate 
load results in an overlap of the reaction data in the normalised plot. Finally, non-competitive 
inhibition by the product results in a disproportionally lower rate of conversion at increased 
substrate concentrations (this effect can also be seen when one substrate acts as a competitive 
inhibitor for another in a two-substrate reaction). These effects are illustrated in Figure 2.1. 
If it turns out that the reaction rate diminishes over the course of a reaction due to 
inactivation of the enzyme, it could be of interest to determine how this activity is lost. This work 
considers three mechanisms for inactivation: total turnover number (TTN) type-stability where 
the rate of inactivation is proportional to the rate of reaction, conversion-independent stability 
where the rate of inactivation is proportional to the concentration of remaining active enzyme 
(and linked to a parameter that is fixed in the experiment, such as temperature), and conversion-
dependent stability where the rate of inactivation varies with the concentration of enzyme and 
the concentration of a reaction component (for example: product-induced inactivation) 
(Bommarius and Paye 2013). 
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For soluble enzyme catalysis in a homogeneous system, the performance of a reaction 
limited by product (or substrate) induced inactivation will become progressively worse at higher 
substrate loads in a plot of conversion vs time normalised by catalyst and substrate load. If the 
inactivation is instead linked to TTN or conversion-independent inactivation, the reaction curves 
for different substrate loads will superimpose in the normalised plots. These two inactivation 
mechanisms cannot be separated in this type of experiment if stability is the only limiting factor. 
2.2.4. Dominating bottleneck regimes 
It is important to realise that underlying kinetic mechanisms can be masked by the dominating 
limitation. For example, little or no useful information regarding the catalyst kinetics or stability 
can be gleaned from a substrate load experiment in a system that is limited primarily by mass 
transfer. It is therefore suggested that the main limitation is first determined using the catalyst 
load experiment. If it turns out that mass transfer is the main limitation, the reaction system 
should be modified to address and overcome this limitation, before further investigation of the 
catalyst properties are attempted (e.g. by changing the mixing conditions, scaling up the reaction 
(for improving gas-liquid mass transfer (Stocks 2013)), or by implementing a reactor design that 
improves mass transfer (Gasparini et al. 2012)). Likewise, significant activity loss over the course 
of the reaction affects the analysis of kinetics. Stability issues should therefore be addressed and 
solved before kinetics are studied in detail, after being quantified over longer reaction periods 
(i.e. at higher substrate or decreased enzyme loadings). 
The impact of these two varied parameters on the different limitations is illustrated in 
Figure 2.2. For the purposes of the illustration, it has been assumed the catalyst kinetics are 
dominated by substrate binding to a certain point (up to the order of magnitude of KM), beyond 
which the enzyme operates under fully saturated conditions until, above a certain concentration, 
the substrate or product cause inhibition. These two effects are independent of the enzyme 
concentration and thus run parallel to this axis. The catalytic rate is proportional to the enzyme 
load up to a point, beyond which substrate mass transfer can become a limiting factor. An increase 
in substrate load results in increased mass transfer, and consequently moves the limitation to 
catalyst load. Finally, the reaction can also be limited by catalyst stability. Since the reaction time 
scales with the catalyst load (linearly under zero-order kinetics), the amount of enzyme required 
to avoid stability limitations is proportional to the substrate load. 
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Figure 2.2. Illustration of the different types of process limitations and how they relate to substrate 
and biocatalyst load – A: Inhibition, B: Mass transfer, C: Kinetically limited, D: Stability. The optimal 
region of operation (OR) in the window where no limitations occur is circled, here substrate 
concentrations are maximised whilst using the least amount of biocatalyst. 
In the given example, the system is limited by different factors under different conditions, i.e. 
combinations of substrate and catalyst load. It should be noted that not all of the indicated 
domains/limitations will necessarily be relevant for any given case. Figure 2.2 provides a 
blueprint of an expected regime that can guide the changes in enzyme or substrate loading which 
an experimenter should make in order to be able to evaluate these different bottlenecks. 
After the limitations of a given reaction have been established, it could also be possible to 
define a similar looking “operating window” inside which a reaction can proceed without 
constraints. The optimal region of operation is shown on Figure 2.2, where substrate 
concentration is maximised with the least biocatalyst dose, assuming the rate of reaction is 
sufficient. 
2.3. Discussion 
In the context of process development, once the limiting factor for process performance has been 
identified the next logical step is to address that limitation. When the main limitation is enzyme 
kinetics or stability, there is potential for improvement in modifying the structure of the enzyme 
molecule through protein engineering. Such modifications can improve the affinity for the 
substrate (reducing KM) or improve the stability of the protein structure. An alternative (or 
complementary) approach, in cases where the substrate or product have a negative impact on 
performance, is to control the concentration of these reaction components. This can be effected 
through controlled substrate supply (e.g. feeding) and in-situ product removal strategies (Ramesh 
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et al. 2016). In cases where mass transfer is limiting, the most direct solution is to consider the 
reaction and reactor design: how substrate is introduced and transported to the enzyme, the 
choice of any co-solvents and choice of reactor and configuration of mixing, if any. Finally, in some 
cases (for all categories of limitation) the formulation and purity of the catalyst should also be 
considered. The choice between applying whole-cell catalysis, crude or purified soluble enzyme 
solutions or an immobilized preparation can have a great impact on both the activity and the 
stability of the catalyst as a whole. On the other hand, the choice of formulation also comes with 
a cost that can affect the feasibility of the process (Tufvesson et al. 2011b). 
The simulated reactions used to illustrate the methodology (Figure 2.1) are based on 
reaction kinetics for a one-way reaction that will run to completion, barring total loss of activity 
due to inactivation. However, the suggested methodology is fully applicable to 
equilibrium/thermodynamically limited reactions as well because the impact of catalyst load will 
be the same for an equilibrium reaction as for a non-reversible one. Further, varying the substrate 
load should not, for changes within an order of magnitude, drastically alter the equilibrium 
conversion in most cases. However, care should be taken when choosing substrate concentrations 
when studying two-substrate equilibrium reactions, because changing the concentration of only 
one of the substrates in such a case can change the expected conversion. 
The methodology presented in part here is intended as an addition to established 
experiment-based evaluation methods that are used to support process development. Ultimately, 
the best tool for the task at hand should be used. A single end-point measurement can thus be 
sufficient to verify that the reaction achieves required performance (i.e. conversion in a given 
time) for some cases. On the other hand, if detailed information regarding the kinetic parameters 
of the catalyst is required (for example to evaluate the success of a specific modification to the 
protein), an initial rate experiment under carefully controlled conditions is likely the most 
pragmatic option. The methodology presented here is thus meant to provide an alternative, 
limited-effort approach in cases where more qualitative information is required; to provide a 
sense of the characteristics of the reaction system of interest under process conditions and to 
guide further experimentation and development work. 
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2.4. Conclusions 
The methodology presented in this chapter presents a generic tool for assessing biocatalytic 
reactions. Distinct to these reactions is the prevalence of mass transfer limitations and potential 
instability of protein structures under process conditions. Both of these effects can be identified 
in a qualitative manner using this methodology. Furthermore, the mechanisms of limitation 
caused solely by enzyme kinetics (e.g. catalytic activity (kcat), substrate affinity (KM), or 
substrate/product inhibition) can be distinguished. The methodology is simple in terms of 
experimental effort and should be carried out at an early-stage of biocatalytic process 
development in order to better inform future directions for research investment. 
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Chapter 3. Setting process performance metric targets for the 
direction and evaluation of biocatalytic reactions 
This goal of this chapter was to better define a systematic way of addressing biocatalytic process 
development. A crucial aspect to biocatalytic reaction development is the need for industrially-
relevant reaction targets (i.e. synthesis route). An equally important facet to reaction 
development is a knowledge of the required process performance metrics in terms of reaction 
rate, product concentration, biocatalyst yield, conversion and selectivity, to name a few. These 
metrics place constraints and help direct biocatalytic reaction development, which can be 
especially useful in early-stages or for benchmarking. Therefore, these metrics are herein 
stipulated based on experience and calculation. A precise and simple methodology for reaction 
evaluation, which may be used to measure these metrics, is detailed in Chapter 2. A particular 
focus is placed on defining the value of metrics based on product market applications, estimating 
the biocatalyst yield through considering the cost of biocatalyst formulation, and perspectives on 
immobilisation to improve biocatalyst yields. 
 
The following is intended for publication. 
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3.1. Introduction 
When designing an enzyme-catalysed reaction from scratch, the first thing to be considered is 
what synthetic route or specific reaction is needed. This is likely to be inspired by a portfolio of 
known enzyme activities or the ease of expanding the substrate scope of a given enzyme to 
accommodate the reaction of interest. However, just as important is the understanding of what 
level of performance is required to meet the demands of the envisaged process. Such 
understanding will give indication to the direction in which a particular biocatalytic reaction must 
head in terms of, for example, eventual product concentration or rate of reaction. In this way, 
these process performance requirements help guide reaction design by establishing constraints 
during development. Towards this objective, a system of metrics are defined, which can be used 
as benchmarks when evaluating biocatalytic reactions. Targets for these metrics are proposed 
based on the value class of the product market (application). In this way, the process and reaction 
constraints are well-defined and based on techno-economic requirements. Different enzyme 
formulations will require different levels of reaction efficiency due to the associated cost 
contribution to the process margins. This is considered and addressed in this work. 
A basic assumption made in this work is that an enzyme candidate is already available for 
assessment (in its most suitable formulation) towards a specific reaction. These targets are 
therefore less relevant for enzyme discovery, however might give indication to viable candidates. 
Further, because these targets pertain to reaction performance, downstream specifics are not 
considered – although the inherent requirements of a feasible downstream separation are 
incorporated into this assessment through the metric targets (e.g. need for higher product 
concentrations). 
3.2. Process performance metrics 
Biocatalytic process performance can be gauged using a standard set of process metrics (Table 
3.1). These metrics may be benchmarked against industrial requirements, and the importance 
and value of each respective metric may differ depending on the value of the product and its 
intended market application. Using such generic process metrics, inspired by economic 
requirements, allows the avoidance of such detailed economic information (Lima-Ramos et al. 
2014). This is beneficial when this information might be sensitive or more likely unavailable. The 
simple nature of these metrics allows them to be calculated in a ‘back of the envelope’ fashion. 
Furthermore, they can then be used as ‘rules of thumb’ when trying to assess the feasibility of a 
biocatalytic reaction step, without the need for more complex knowledge of the full process, 
environmental or economic performance. 
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Whilst there is no particular order as to how the metrics are presented in this work, for 
different types of reactions there may be a hierarchy of importance. For example, processes to 
produce pharmaceutical intermediates might value selectivity above all other metrics. On the 
other hand, manufacturing processes for low-value products such as polymers might require the 
highest possible reaction yield given the predominance of substrate costs for these processes. 
Table 3.1. Biocatalytic process performance metrics. 
Process Metric Definition Unit 
Reaction conversion 
nsubstrate, initial − nsubstrate
nsubstrate,initial
× 100% % 
Reaction yield 
nproduct − nproduct, initial
nsubstrate,initial
× 100% % 
Yield on co-substrate 
nproduct − nproduct, initial
nco-substrate,initial
× 100% % 
Selectivity 
Reaction yield
Reaction conversion
 - 
Product concentration 
mproduct
Vreactor
 g L-1 
Productivity (or space-
time yield) 
mproduct
τ × Vreactor
 g L-1 h-1 
Specific productivity 
mproduct
τ × mbiocatalyst
 g gbiocat-1 h-1 
Biocatalyst yield 
mproduct
mbiocatalyst
 g gbiocat-1 
 
Reaction conversion and yield 
A fundamental requirement of an industrial reaction is to create value by making an adequate 
amount of product from a lower value substrate. The measure of how much product is produced 
from a certain amount of substrate is the reaction yield. In a single-product reaction with no by-
products or product degradation under the process conditions, the reaction yield will be 
equivalent to the reaction conversion. In some cases, the reaction yield is dictated by chemical 
equilibrium (thermodynamics). Reaction yield is especially critical for lower value, bulk volume 
products where process economics can largely be dictated by the cost of substrates and raw 
feedstocks. On the other hand, processes for high-value products might also require high reaction 
yields to avoid costly downstream separations of similar substrate and product molecules. Lastly, 
in some reactions the cost of co-substrates can be considerable. Therefore in these cases, it may 
be valuable to include a yield on co-substrate metric in order to take this into consideration. 
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Selectivity 
Selectivity is an important measure when multiple products are formed in a reaction (e.g. 
asymmetric reactions). The selectivity is an exact indication of the amount of product of interest 
that has been in formed in lieu of all other products. This is often a key metric when emphasising 
the benefits of biocatalysts over chemocatalysts. Naturally, reactions with higher selectivity will 
be more atom efficient, produce less waste by-products and have simpler downstream 
separations (Sheldon and Woodley 2018). 
Product concentration 
The product concentration leaving the reactor is an important metric for downstream process 
design. Higher product concentrations allow smaller, more cost-effective separation steps, which 
is critical when considering downstream costs are often significant towards process margins. 
Importantly, high product concentrations can often have an inhibitory effect on some enzymes 
because they are vastly different to reaction component concentrations encountered in Nature. 
The product concentration should also only be measured based on the volume passing 
downstream from the reaction step, which is distinct to processes using in situ product removal 
technologies. Here, the product is ideally concentrated into a second phase (e.g. water-immiscible 
organic solvent or solid phase) and will be separated from the reaction medium before being 
passed on for downstream separation and purification. Therefore for these cases, only the 
concentration of product in this second phase influences the cost of the downstream process and 
will be relevant. 
Productivity/space-time yield 
The productivity (or space-time yield) of a reaction dictates the scale of reactor and process 
required to produce a target amount of product in a given time, and is based on the total reaction 
volume. The space-time yield is a function of the enzyme dose (see biocatalyst yield, below) and 
the intrinsic activity of that enzyme preparation, as is the case with chemocatalysis. It can 
therefore be increased by simply adding more biocatalyst, however this comes at the expense of 
space in the reactor (for the case of immobilised preparations) as well as cost of the enzyme. For 
this reason, a trade-off between reaction volume, biocatalyst yield and the minimum required 
activity must be found. The connection between space-time yield and biocatalyst yield is covered 
in more detail in the case study of Chapter 4. 
Specific productivity and biocatalyst yield 
On the other hand, the specific productivity has the basis of amount of enzyme added rather than 
a volumetric basis, as is the case for space-time yield. For the case of biocatalytic reactions, the 
biocatalyst yield is effectively the yield of product on biocatalyst (not to be confused with the yield 
of biocatalyst from a fermentation). It is a measure of how much product can be produced per 
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amount of biocatalyst and should be measured over the entire period of a biocatalyst’s life in a 
process. The biocatalyst yield informs of the cost contribution of a biocatalyst towards the process 
(this is elaborated upon in Section 3.4). Since biocatalyst formulations vary, the units of 
biocatalyst yield also differs and must be scaled by the amount of actual target protein that is 
present in the formulation. Generally speaking, the more active an enzyme, the better the 
biocatalytic yield so this might stand as a generic target for protein engineering. However, not all 
processes for different value products have the same reliance on enzyme costs. The price of 
biocatalyst for large volume (low-value) applications is usually nominal and relatively stable 
(although a high product turnover is still required), whilst the cost of enzymes for higher value 
product markets might be less defined. Biocatalyst yield may also be improved by simply 
producing more product in a given batch (adding more substrate), lowering the dose of 
biocatalyst (at the expense of space-time yield), or recycling the biocatalyst in subsequent 
batches. Recycling an enzyme often requires it to be available in an immobilised preparation. It is 
crucial that an immobilised enzyme preparation has sufficiently high intrinsic activity and 
stability to justify the costs of immobilisation and space reduction in the reactor volume. 
Generally, only the crudest acceptable form of a biocatalyst should be considered in order to 
minimise the cost of enzyme in a process. 
3.3. Markets for biocatalysis applications and target process metrics 
It is important to recognise that while biocatalysis offers all the valuable process traits shown in 
Figure 3.1, the primary reasons for biocatalysis implementation in different markets is different 
(Wohlgemuth 2010; Woodley 2017). Most likely, this is linked to the complexity of the chemical 
reaction itself, where biocatalysis has become instrumental in the highly-selective synthesis of 
optically pure molecules often containing multiple chiral centres (Sheldon and Woodley 2018). 
However, the argument for the implementation of biocatalysis due to other factors, especially in 
lower value product markets, remains a challenge. In particular, the high development costs of 
engineered biocatalysts makes them too expensive to improve for bulk volume products. 
Additionally, processes producing low-value products require high product titres, even in excess 
of 100 g L-1, which almost always leads to some form of protein denaturation and/or inhibition 
because such concentrations far exceed those found in Nature. 
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Figure 3.1. Value of biocatalysis in different markets (adapted from Woodley (2017)). APIs – Active 
pharmaceutical ingredients. 
Table 3.2 summarises target process metrics for different value processes, compiled through 
cumulated experience and industrial collaboration. Lower value products will have smaller 
process margins and therefore the biocatalyst itself must be more efficient in terms of both 
productivity and product concentration output. In essence, 100% conversion, reaction yield and 
selectivity are always desirable, however sometimes this may be unachievable due to e.g. 
chemical equilibrium. If high conversions are required then the value of KM might become 
especially important because if it is too large reaction rates will become too slow at higher 
conversions. Furthermore, high-value products do not necessarily require a 100% conversion 
because process economics are less dependent on the price of feedstock for these cases. However, 
unreacted substrate can still be detrimental to downstream processes in these cases, especially 
when the substrate shares similar physical properties to the product (e.g. chiral resolutions). 
Table 3.2. Process performance metric targets for different product 
value classes. 
 Low-value 
Medium-
value 
High-value 
Product Price [€ kg-1] 5 20 100 
Product Titre [g L-1] 100 50 10 
Productivity [g L-1 h-1] 20 10 2 
 
The metrics in Table 3.2 are dictated by process constraints. The product concentrations and 
space-time yields stated here are such that realistic process margins may be achieved for different 
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scales of production. Further, these metric targets are minimum thresholds that must all be 
satisfied in order to realise an effective biocatalytic process. Improving process metrics beyond 
these values will always be beneficial for the cost-effectiveness and environmental impact of a 
given process. However, depending on the application, there may be a hierarchy of importance 
for the different metric targets. 
3.4. Cost contribution of biocatalysts: biocatalyst yield 
3.4.1. Estimating target biocatalyst yields 
Setting a target for biocatalyst yield is more complex, since it is not only a function of process 
constraints (the space-time yield will determine a required intrinsic activity), but also the 
intended market value-class and final formulation. Different biocatalyst formulations have 
different implications for processes. For example, isolated enzymes in (lyophilised) cell-free 
extracts can potentially be exposed to higher substrate/product concentrations or more harsh 
reaction environments because the issues of cell wall integrity and whole-cell viability are 
circumvented. Generally, if appropriate, the most crude form of a biocatalyst will always be 
selected above those which take more preparation (e.g. purified proteins or immobilised 
preparations) due to economic constraints (Woodley 2017). For this reason, only the following 
most typical biocatalyst formulations have been considered: fresh ‘wet’ whole-cells directly from 
a fermentation, dry whole-cells prepared through freeze-drying for longer term storage, cell-free 
extracts (liquid formulations), and lyophilised cell-free extracts. A set of guideline assumptions 
to convert between these different formulations must be assumed based on realistic 
biotechnological downstream processes (Table 3.3). 
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Table 3.3. Conversion factors for different biocatalyst formulations. DCW – dry cell weight (i.e. dry 
whole-cells); CWW – cell wet weight (i.e. wet whole-cells); CFE – cell-free extract; “prot” – total protein 
content; “biocat” – total soluble protein content (including target enzyme). 
Conversion Value and Units Source 
Dry cell weight from wet whole-cells 0.3 gDCW gCWW-1 * Bratbak and Dundas (1984) 
Cell-free extract from wet whole-cells 8.25 mLCFE gDCW-1 † Harrison et al. (2015) 
Cell-free extract density 1 gCFE mLCFE-1 Assumed 
Total protein in dry cell weight 0.5 gprot gDCW-1 Assumed 
Total soluble protein (i.e. usable biocatalyst) 0.5 gbiocat gprot-1 Assumed 
 
The only realistic way to benchmark different biocatalyst yields for different formulations is to 
base it on an economic cost per standardised unit of activity. Central to this is the cost of 
producing these different formulations (Table 3.4). Previously, an in-depth economic analysis of 
a 10 m3 (with 75% working volume) fed-batch fermentation for the production of 50 gDCW L-1 was 
made by Tufvesson et al. (2011). Capital expenses and operating expenses, including raw 
materials and labour, were considered for a plant located in Western Europe and production was 
assumed to take place in 35 annual batches of 48 h. Under these assumptions, the baseline 
production cost of one kilogram of (wet) cells was found to be 67 €. The corresponding mass of 
wet whole-cells, cell-free extract and protein in a lyophilised form was calculated based on the 
conversion factors in Table 3.3. From this, an overall base case fermentation cost of producing 
the corresponding mass of wet whole-cells could be calculated. Producing dry whole-cells might 
be of interest for longer term storage, and was assumed to follow directly from the base case 
fermentation with a freeze-drying step. An estimate cost of freeze-drying processes is 25 $ kg-1 of 
dried material (Snowman 1997), which was compounded with the cost of fermentation. 
Producing a cell-free extract would be achieved by homogenising wet whole-cells following 
fermentation and separating the unwanted solid fraction (e.g. cell debris) by centrifugation. The 
cost increase for these extra processing steps per kg of material was estimated to be 1.7-fold 
(Tufvesson et al. 2011). Lastly, a solid powder (lyophilisate) of this cell-free extract might be 
desired for long-term storage and use. Therefore, the same cost contribution of freeze-drying was 
compounded to the cost of producing cell-free extract in order to obtain an estimate for the cost 
per kg of lyophilised material. A block flow diagram showing the different processing routes for 
these biocatalyst formulations is given in Chapter 1. 
                                                             
* Based on Escherichia coli bacterial cells. Different hosts contain less water content, e.g. Bacillus subtilis and 
Pseudomonas putida cells contain 51.5% and 48.4% dry matter, respectively (Bratbak and Dundas 1984). 
† Based on the homogenisation of Escherichia coli cells in a downstream process for human insulin 
production (Harrison et al. 2015).  
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It is important to consider that accurate process costs are typically sensitive for industrial 
producers and not usually published. Therefore, the estimates given in Table 3.4 must be treated 
only as rough estimates. Interestingly, the extra cost of producing a lyophilised cell-free extract is 
only approximately 4-fold more than wet-whole cells. Furthermore, the process of lyophilising 
preparations of whole-cells or cell-free extracts only adds a marginal relative cost difference. It is 
also important to consider and address that biocatalyst activity may decrease during the process 
of lyophilisation or drying. 
Table 3.4. Cost estimates for different biocatalyst formulations. A basis of 50 gDCW L-1 from a 10 m3 fed-
batch fermentation (corresponding to 37.5 kgDCW) was used in order to match a previous analysis made 
by (Tufvesson et al. 2011). 
 Basis Cost Cost per kg 
Cost per kgCWW 
basis 
Wet whole-cells 119 kgCWW 
67 € kgCWW-1 × 
119 kgCWW = 8002 € 
67 € kgCWW-1 ‡ 67 € kgCww-1 
Dry whole-cells 37.5 kgDCW 
8002 € + (37.5 kgDCW × 
21 € kg-1)§ = 8787 € 
8787 € / 
37.5 kgDCW = 
234 € kgDCW-1 
74 € kgCww-1 
Cell-free extract 309 kgCFE 
114 € kgCFE-1 × 309 kgCFE 
= 35236 € 
1.7 x 67 € kgCWW-1 
= 114 € kgCFE-1 ** 
295 € kgCww-1 
Lyophilisate 9.4 kgbiocat 
35236 € + (9.4 kgbiocat × 
21 € kg-1)§ = 35432 € 
35432 € / 
9.4 kgbiocat = 
3779 € kgbiocat-1 
297 € kgCww-1 
 
The productivities and product concentrations for all value-classes given in Table 3.2 result in a 
theoretical process rate constant of 3.33 × 10-3 min-1 (which correlates to an average 
biotransformation batch length of 5 h). In a system with no kinetic limitations, the effective kcat of 
each biocatalyst formulation should therefore be equal to this process rate constant in order to 
meet the required product concentration in the given time-frame of 5 h. However, the effective 
dose of each biocatalyst (biocatalyst yield) must be scaled to accommodate the different product 
concentrations required by different value-classes as well as the appropriate conversions to 
extrapolate any formulation from a wet whole-cell fermentation (Table 3.3). Assuming a starting 
biocatalyst yield for each product value-class for any given formulation specifies the maximum 
                                                             
‡ Based on the fed-batch fermentation of 50 gDCW L-1 in 10 m3 (Tufvesson et al. 2011). 
§ An estimated step cost of 25 $ kg-1 of dry material was made for generic freeze drying processes 
(Snowman 1997).  
** The relative cost of crude enzyme (cell-free extract) from a whole-cell preparation was calculated to be 
1.7-fold higher on a cost per kg basis (Tufvesson et al. 2011). 
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allowable biocatalyst dose (= biocatalyst yield × product concentration) as well as the maximum 
allowable biocatalyst cost per kg (= biocatalyst yield × product value) for each formulation (Table 
3.5). 
A volumetric basis of 1000 L and average molecular weight of substrate and product of 
100 g mol-1 were assumed in order to calculate an overall activity or turnover required for each 
process to reach full conversion (where 1 unit of activity corresponds to 1 μmol min-1). A specific 
activity could then be estimated for each formulation based on the biocatalyst concentration, 
which was dictated by the assumed biocatalyst yield, and necessary kcat to reach full conversion. 
The required process activity and the specific activity of each formulation infers the exact dose of 
biocatalyst required for a 1000 L basis to reach full conversion (Table 3.5). 
Once the biocatalyst concentration to reach the required turnover is known, the exact cost 
of this concentration can be calculated using the specific cost of producing each formulation 
(Table 3.4). Furthermore, the maximum allowable cost can also be calculated based on the 
assumed biocatalyst yield and product value. This will be the same for all value-class products 
because the biocatalyst yield is normalised by the cost of product. The ratio of the actual cost to 
maximum allowable cost allows the feasibility of biocatalyst yield targets to be assessed on a cost 
per unit of required activity basis. 
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Table 3.5. Costs and activity model for different biocatalyst formulations. A volumetric basis of 1000 L 
and average molecular weight (MW) of substrate and product of 100 g mol-1 were assumed. 
Product value class Low-value 
Medium-
value 
High-value 
Maximum allowable biocatalyst concentration (=
Product Conc.
Biocatalyst yield
) [
g
L
∙
gbiocat
g
] 
Wet whole-cells [gCWW L-1] 1.69 3.37 3.37 
Dry whole-cells [gDCW L-1] 0.53 1.06 1.06 
Cell-free extract [gCFE L-1] 4.37 8.73 8.73 
Lyophilisate [gbiocat L-1] 0.13 0.26 0.26 
Maximum allowable specific biocatalyst cost (= Biocatalyst yield × Product value) 
Wet whole-cells [€ kgCWW-1] 297 297 297 
Dry whole-cells [€ kgDCW-1] 945 945 945 
Cell-free extract [€ kgCFE-1] 115 115 115 
Lyophilisate [€ kgbiocat-1] 3779 3779 3779 
Required batch activity (turnover) [U]†† 
(=
Product Conc.
MW
 × 1000 L × Process rate constant) 
3.33 × 106 1.67 × 106 3.33 × 105 
Required kcat [min-1] 3.33 × 10-3 3.33 × 10-3 3.33 × 10-3 
Minimum required specific activity (turnover) (=
Product Conc.
MW × Biocatalyst conc.
 × 𝑘𝑐𝑎𝑡) 
Wet whole-cells [U gCWW-1] 1.98 × 103 4.94 × 102 9.89 × 101 
Dry whole-cells [U gDCW-1] 6.30 × 103 1.57 × 103 3.15 × 102 
Cell-free extract [U gCFE-1] 7.64 × 102 1.91 × 102 3.82 × 101 
Lyophilisate [U gbiocat-1] 2.52 × 104 6.30 × 103 1.26 × 103 
Biocatalyst dose for 1000 L (= 
Req. batch activity
Minimum req.  specific activity
) 
Wet whole-cells [kgCWW] 1.7 3.4 3.4 
Dry whole-cells [kgDCW] 0.5 1.1 1.1 
Cell-free extract [kgCFE] 4.4 8.7 8.7 
Lyophilisate [kgbiocat] 0.1 0.3 0.3 
Actual biocatalyst cost per batch 
(= Biocatalyst dose × Cost per kg of production) 
Wet whole-cells [€] 113 226 226 
Dry whole-cells [€] 124 248 248 
Cell-free extract [€] 497 994 994 
Lyophilisate [€] 500 1000 1000 
Maximum allowable biocatalyst cost 
(= Biocatalyst dose × Max. allowable specific biocatalyst cost) 
Wet whole-cells [€] 500 1000 1000 
Dry whole-cells [€] 500 1000 1000 
Cell-free extract [€] 500 1000 1000 
Lyophilisate [€] 500 1000 1000 
                                                             
†† 1 unit of activity (U) = 1 μmol min-1 
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For the case of Table 3.5, target biocatalyst yields were the ultimate objective function and were 
calculated such that a break-even in enzyme cost margins would be reached for the most 
expensive formulation (lyophilised cell-free extract). Whole-cells are more than 4-fold cheaper to 
produce than lyophilisates, and thus might help relax a biocatalyst yield target if this formulation 
is appropriate for the biotransformation. Therefore, Table 3.6 summarises the upper and lower 
boundaries of target biocatalyst yields required to meet enzyme cost margins for wet whole-cells 
and lyophilised cell-free extracts, respectively. 
Table 3.6. Target biocatalyst yield metrics for different formulations. The lower 
and upper values use the basis of break-even enzyme cost margins for wet whole-
cells and lyophilisates, respectively. 
Product value class 
Low-value 
(5 € kg-1) 
Medium-value 
(20 € kg-1) 
High-value 
(100 € kg-1) 
Wet whole-cell yield [g gCWW-1] 15 – 60 3 – 15 0.7 – 3 
Dry whole-cell yield [g gDCW-1] 40 – 190 10 – 50 2 – 10 
Cell-free extract yield [g gCFE-1] 5 – 20 1 – 6 0.3 – 1 
Lyophilisate yield [g gbiocat-1] 170 – 760 40 – 190 10 – 40 
 
The yield targets in Table 3.6 are heavily dependent on the underlying assumptions used in the 
‘back of the envelope’ calculations preceding them. Therefore, they have been rounded off to 
better reflect their significant figures. Further, they only represent the biocatalyst yield required 
for one single batch, in which both the target productivity and product titre are reached. 
Regardless, although slightly lower, the ranges given in Table 3.6 reflect those previously 
estimated by Tufvesson et al. (2011). The biocatalyst yield target increases with increasing 
formulation purity (in terms of water reduction) because less biocatalyst is required to achieve 
the same reaction turnover, but also because these formulations are more expensive to produce. 
While some of the yields may appear quite high for many enzyme cases, there are exceptional 
examples of industrial biocatalytic processes featuring biocatalyst yields of up to  
2000 g gimmob-1 (Katchalski-Katzir and Kraemer 2000), 5000 g gimmob-1 (Jensen and Rugh 1987) 
and >7000 g gDCW-1 (Kobayashi et al. 1992) for the continuous production of 6-aminopenicillanic 
acid, high fructose corn syrup and acrylamide, respectively. A key to realising such yields could 
lie in the ability to reuse enzymes (further discussed in Section 3.4.3), the use of continuous 
processing or in the trade-off between biocatalyst concentration and space-time yield, which is a 
major discussion topic of Chapter 4. 
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3.4.2. Influence of poor substrate affinity and enzyme stability 
An enzyme limited by poor substrate affinity or stability will impact the required biocatalyst yield 
because more enzyme will be required to achieve the same baseline reaction activity. In order to 
assess this, the same cost-basis calculation methodology in Section 3.4.1 was followed. However, 
the following Michaelis-Menten expression was used to simulate conversion progress over time 
whilst incorporating expressions for both enzyme stability and substrate affinity: 
𝑑𝑝
𝑑𝑡
= 𝑎𝐸0𝑒
−𝑘𝑑∙𝑡
(𝑆0 − 𝑝(𝑡))
𝐾𝑚 + (𝑆0 − 𝑝(𝑡))
 
Where: p is the product concentration as a function of time, a is the specific activity of a biocatalyst 
(linear function of kcat), E0 and S0 are the respective initial enzyme and substrate concentrations, 
kd is the first-order inactivation rate constant, and KM is the Michaelis-Menten constant (measure 
of substrate affinity). 
In this way, kinetic parameters could be varied and their influence on specific activity 
observed. If the enzyme were to be limited by one of these parameters, the magnitude of required 
improvement to the specific activity (i.e. kcat) of the enzyme could be estimated. This would 
thereafter feed into the cost analysis as an increased demand on enzyme loading (and therefore 
biocatalyst yield target) to reach the same required process turnover, ultimately affecting the cost 
margins. This could then be benchmarked with the base case scenario in Section 3.4.1, where no 
limitations were present. 
If an enzyme were to have poor affinity for its substrate, the reaction velocity would drop 
prematurely while substrate is consumed during the reaction. The example case studied here 
assumes a KM of 25 mM, which corresponds to a substrate concentration of 2.5 g L-1 for a substrate 
of 100 g mol-1 molecular weight. Interestingly for cases such as these, only the cost of enzyme in 
high-value product classes suffers. This is because the starting substrate concentration of  
10 g L-1 for this value class is already close to the KM limit, whereas the other value class product 
concentrations are orders of magnitude larger (Table 3.2). This might be especially crucial when 
extremely high-value products are considered as they may only be present in minute 
concentrations in processes. Compared to a system with no limit for substrate affinity (KM << S0), 
high-value class products will require a 2.3-fold higher biocatalyst yield to compensate for the 
inefficient catalyst caused by Km limitations. Whilst medium-value and low-value products only 
require 1.3- and 1.1-fold higher biocatalyst yields. Retrospectively, protein engineering substrate 
affinity would have the greatest impact on higher value products, where the biocatalyst could 
effectively be made more than 2-fold more efficient. These results are shown graphically in Figure 
3.2. 
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Figure 3.2. Effect of substrate affinity on biocatalyst yield for different value-
class products. 
On the other hand, protein instability will affect enzymes for all value class products equally 
because (in this model) it is only a function of reaction time. Naturally, if the enzyme is denatured 
by other factors, e.g. high substrate/product concentrations, then this result would not translate. 
For a case where the enzyme exhibits poor stability (t½ = 10 h), the biocatalyst yield target would 
need to be increased 1.2-fold in order to counter the extra cost of activity required to push the 
reaction to completion. Likewise, an enzyme exhibiting more severe instability (t½ = 2.5 h) will 
need 1.8-fold higher biocatalyst yield targets (Figure 3.3). This again highlights the magnitude of 
cost reduction that might be achieved through protein engineering enzyme stability. It ought to 
be noted that, while in this single-use batch reaction model enzymes with a half-life of more than 
10 h will have little beneficial effect on reducing biocatalyst costs, this is indeed a prerequisite for 
biocatalysts that are to be recycled for subsequent uses. In such cases, a half-life as long as 
possible (e.g. days) can be instrumental to improving biocatalyst yields in processes. It also ought 
to be mentioned that biocatalytic processes rarely suffer from stability limitations if only single 
batches are required. 
 
Figure 3.3. Effect of enzyme stability on biocatalyst yield. 
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Protein engineering the increased activity of an enzyme will always benefit a process where the 
cost of enzyme is significant because theoretically less biocatalyst will then be required to 
perform the same turnover at the same space-time yield (i.e. increasing biocatalyst yield). 
Improving the expression of target protein in the final biocatalyst formulation will also have a 
dramatic effect on the specific activity, and this could be overlooked in enzyme development. 
Therefore, if the enzyme performs adequately in terms of stability and productivity, and further 
improvement can still be made towards its intrinsic activity, then this should remain a generic 
target for protein engineering. 
3.4.3. Cost-benefit of immobilisation 
A means of increasing the yield of a biocatalyst can also be to potentially recycle that same 
biocatalyst for further reaction batches. Every batch completed with the same biocatalyst 
effectively doubles its yield (Figure 3.4). The most common route to realising biocatalyst 
recycling is to immobilise a cell-free extract into a solid particle (Hanefeld et al. 2009). In essence, 
this concentrates the activity of a given biocatalyst to a small fraction of the reaction volume, 
simplifying the separation of catalyst from the medium. There are a multitude of available 
methods to achieve this such as: binding an enzyme to a carrier structure (using either physical, 
ionic or covalent interactions), encapsulating the enzyme in a microstructure with a polymer 
matrix, or cross-linking enzyme aggregates/crystals (Sheldon and van Pelt 2013). However, 
immobilisation comes at a cost, not only in terms of economy, but also activity. 
 
Figure 3.4. Effect of number of recycles on 
biocatalyst yield assuming a single batch yield of 
3 g gbiocat-1 and no activity loss upon recycle. 
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First, based solely on the cost of producing immobilised biocatalysts, Tufvesson et al. (2011) 
estimated that immobilised biocatalysts cost 3.6-fold more than cell-free extracts on a price per 
kg basis. This includes the cost of support material as well as the processing capital expenses and 
operating expenses. 
Secondly, there is an overall penalty on the intrinsic activity of immobilised biocatalysts 
when compared to their ‘free’ homogeneous counterparts. Immobilisation supports can only 
contain a certain loading of protein to begin with. A typical loading could be approximately 
30 gbiocat kgimmob-1 where usually 1:1 volumes of cell-free extract are immobilised (Guisan 2006). 
An immobilised biocatalyst can thus potentially hold approximately the same specific activity of 
a cell-free extract, however often some activity is lost during the immobilisation process itself. 
Furthermore, once immobilised, enzymes can lose conformational flexibility and therefore might 
have reduced activity. Any losses in activity during reaction due to environmental conditions (e.g. 
breakage caused by shear stresses), upon recycle, or during storage must also be taken into 
account. 
The most crucial drawback to immobilising enzymes however is the introduction of 
potential mass transfer limitations, as is the same for most heterogeneous catalysts (Moo-Young 
and Kobayashi 1972). Most of the immobilised activity is concentrated within the catalyst particle 
and access to substrate can only proceed via the slow process of substrate diffusion. The diffusion 
rate itself is a function of the support structure (e.g. particle size, pore channel diameter, porosity, 
etc.). This is also a drawback when an enzyme experiences product inhibition because the product 
will take longer to diffuse from the enzyme’s immediate environment within the catalyst particle. 
The reduced reaction rate due to mass transfer limitations can be quantitatively measured 
through a mathematical expression called the “effectiveness factor” (η) (Liese and Hilterhaus 
2013). The effectiveness factor is the ratio of the hypothetical maximum catalytic rate of a “free” 
enzyme (measured at the surface of the immobilised particle) and the rate of diffusion within the 
particle. A model output of this effectiveness factor as a function of immobilised particle diameter 
and enzyme loading on the support, based on real experimental kinetic parameters, is shown in 
Figure 3.5. A reaction rate reduction of 20-80% (η = 0.2-0.8) is therefore common, especially in 
larger immobilised particles or with higher enzyme loadings on the carrier material. 
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Figure 3.5. Effectiveness factor as a function of spherical particle radius for 
immobilised biocatalysts containing varying enzyme loadings (shown next to the 
curves as mg mLcarrier-1). The specific activity of the enzyme was 100 U mgbiocat-1 
(left) and 1000 U mgbiocat-1 (right); the substrate concentration at the surface was 
assumed to be 10-fold that of the immobilised enzyme KM; diffusivity of the 
substrate within the porous structure = 4 × 10-4 cm2 min-1 (parameters and 
diffusion models for immobilised enzyme catalysis obtained from Regan et al. 
(1974)). 
As enzymes are made more active, for example through protein engineering or improved 
expression, the efficiency factor is made worse. This is because diffusional limitations (which are 
independent of enzyme activity) far outweigh the speed of reaction at the surface of a particle. 
Figure 3.5 illustrates this effect where efficiency factor profiles within the same particle for an 
enzyme of 100 U mgbiocat-1 are compared to an enzyme engineered to have a specific activity an 
order of magnitude higher, which is not uncommon. Therefore, improving the activity of enzymes 
through protein engineering (as is common practice) has a detrimental impact on implementing 
immobilised biocatalysts in processes. Table 3.7 shows the particle size reduction required to 
maintain an efficiency factor of 0.8 between these two cases. At higher enzyme loadings, it is 
possible that the size of particulates would therefore need to be so small that their separation 
from a medium might be challenging, effectively defeating the objective of immobilising enzymes 
in the first place. Furthermore, such small particle sizes may not even be feasible to prepare. 
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Table 3.7. Immobilised particle radii required to maintain η = 0.8 for different 
loadings of enzymes for a specific activity of 100 U mg-1 and 1000 U mg-1. Porosity 
and minimum carrier diameter assumed to be 0.3 and 250 μm, respectively. 
Enzyme Loading 
on Carrier 
100 U mg-1 
specific activity 
1000  U mg-1 
specific activity 
Volume of Carrier for 
5000 U L-1 [mLcarrier L-1] 
200 mg mLcarrier-1 1.2 μm 0.4 μm 47 
50 mg mLcarrier-1 2.5 μm 0.8 μm 89 
10 mg mLcarrier-1 5.3 μm 1.7 μm 211 
5 mg mLcarrier-1 7.6 μm 2.4 μm 294 
1 mg mLcarrier-1 16.9 μm 5.3 μm 660 
 
All these limitations towards activity will impose a need for increased dose of immobilised 
biocatalyst compared to other biocatalyst formulations. However, there is an upper limit to this 
concentration of immobilised particles in a reactor based on the physical space they occupy 
within the reaction volume as well as the increased cost of using such amounts of immobilised 
preparations. 
Despite decades of research into enzyme immobilisation, there remains no clear generic 
method that is best suited for industrial reactions. This might be due to the complexity of some 
immobilisation mechanisms, cost, or even a general lack of vision for their suitability in an 
industrial biotransformation. Most studies lack comparative data between free enzyme forms and 
immobilised forms during biotransformations to see their relative performance. Process metrics, 
as described in this chapter, are rarely stated in these studies. Furthermore, the reaction cycles 
boasted in these studies are not necessarily with industrially relevant conditions (e.g. product 
concentrations) or reaction timeframes. That being said, there are a number of commercial 
biocatalytic processes relying on immobilised enzymes to allow continuous flow reactions (Rao 
et al. 2009). Therefore, with the right focus, enzyme immobilisation might yet find even wider 
application. 
3.5. Conclusions 
In conclusion, process performance metric targets are essential to help guide biocatalytic process 
development. Understanding the end-use market of the product of interest will either relax or 
impose more stringent process performance requirements based on the economic value of the 
product. The value of product coupled with the cost of producing different enzyme formulations 
and their respective specific activity infers the target biocatalyst yield to realise a feasible process. 
Using the metric targets as early as possible during reaction characterisation and 
evaluation stages allows a better understanding of process constraints and the reaction 
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environment. It also allows the benchmarking of reaction performance to check whether process 
improvement strategies will be necessary, and what these might entail. The feasibility of 
implementing these different improvement strategies can then be assessed at the earliest 
possible stage of process development. Thereby, leading to either continuing process 
development in a timely and resource efficient manner or redefining the reaction targets to better 
suit the achievable process performance. 
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Chapter 4. Case Study I – Scoping the enantioselective 
desymmetrisation of a poorly water-soluble diester by recombinant 
pig liver esterase and improving the process to handle higher 
substrate loads 
In this case study, the methodology relying on reaction trajectory analysis presented in Chapter 2 
was used to identify mass transfer limitations for a given system. This reaction was the 
enantioselective conversion of a poorly water-soluble diester (solubility < 60 mM in water) to a 
monoester. The substrate formed a second liquid phase. Previously, this reaction had been well-
characterised in terms of pH and temperature optima and some aspects of process performance. 
However, the precise influence of substrate mass transfer and poorly water-soluble nature of the 
substrate were not considered. Therefore, this work had this as a special focus. With the 
constraints of mass transfer on space-time yield considered, it was possible to evaluate and 
improve biocatalyst yield through increasing substrate concentrations. Eventually the complete 
conversion of approximately 75 g L-1 substrate was achieved in 3.65 h yielding an adequate 
productivity of 20 g L-1 h-1 with a biocatalyst yield of 4.36 g gbiocat-1. This work highlights the 
importance of scale-up during reaction characterisations, simplicity of applying the methodology 
from Chapter 2, and future directions for reaction improvement to address product inhibition and 
substrate supply. An important outcome from this chapter is to use benchmarking (with target 
process metrics as detailed in Chapter 3) to help guide future development by balancing over-
performing metrics (such as space-time yield in this case), ultimately satisfying all process 
performance requirements for industrial application. 
 
The following is intended for publication. 
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4.1. Introduction 
Biocatalysis has become an established branch of chemistry in its own right owing to the excellent 
stereo-, regio- and enantioselectivity of biocatalysts, importantly under mild reaction conditions 
(Straathof et al. 2002; Sheldon and Pereira 2017). Consequently, biocatalysts can realise more 
sustainable manufacturing processes, satisfying 10 of the 12 principles of green chemistry: waste 
prevention and high atom efficiency (avoiding the formation of by-products) through their high 
selectivity, less hazardous syntheses, suited towards safer solvents (most often carried out in 
water), low energy demand due to their operation under mild process conditions, origin from 
renewable sugar feedstocks through fermentation, avoidance of derivatization, their nature as 
catalysts and not as stoichiometric reagents, the ability to apply real-time process analytics to 
prevent pollution, and most importantly, inherently safer processes (Sheldon and Woodley 
2018). These traits also infer improved process economics. Additionally, biocatalysts have a 
unique feature in that they may be improved by protein engineering, offering an additional degree 
of freedom towards process implementation (Woodley 2013). Such improvements are gained 
through tailoring the amino acid sequences of enzymes to enhance stability, activity or selectivity 
(Strohmeier et al. 2011). Indeed, numerous biocatalytic processes have been successfully 
commercialised to date (Schmid et al. 2001; Sutton et al. 2012; Choi et al. 2015; Hughes and Lewis 
2018), however standardised methods of process development are lacking (Tufvesson et al. 
2013). One means of gauging reaction performance during development is to use process metrics 
inspired by techno-economic requirements for a given product value-class (Lima-Ramos et al. 
2014). A systematic method for scoping reactions and estimating such process metrics was 
detailed in Chapter 2. In this work, this procedure was applied to a reaction featuring a poorly 
water-soluble substrate. The system of interest is the enantioselective desymmetrisation of 
dimethyl cyclohex-4-ene-cis-1,2-dicarboxylate (1) to (1S,2R)-1-(methoxycarbonyl)cyclohex-4-
ene-2-carboxylic acid (2a) catalysed by recombinant pig liver esterase (ECS-PLE06; Scheme 4.1) 
(Wohlgemuth 2011; Süss et al. 2014). The diester substrate is poorly water-soluble 
(approximately 60 mM in water at 25 °C for structurally similar dimethyl 1,4-
cyclohexanedicarboxylate) and forms a second liquid phase. The monoester product of this 
reaction is of value as a pharmaceutical intermediate towards the synthesis of biologically active 
molecules (Scheme 4.1) (Boland et al. 1985), as well as the antibiotic plantencin (Yun et al. 2008), 
active pharmaceutical ingredients in treatments towards HIV (Andreini et al. 2011) and 
cytomegalovirus (Herpes) (Compton et al. 2006). 
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Scheme 4.1. Desymmetrisation of diester 1 to (1S,2R)-monoester 2a catalysed by recombinant pig 
liver esterase (ECS-PLE06) (adapted from Süss et al. (2014)). 
Previously, this reaction and enzyme strains were characterised in terms of pH and temperature 
optima as well as reaction performance (Süss et al. 2014; Süss et al. 2015; Hinze et al. 2016). A 
simple method of pH control was implemented that made use of inexpensive sodium bicarbonate 
breaking down in the presence of the carboxylic acid product 2a, thereafter forming benign CO2 
and passing from the reaction medium. This was found to be more effective than conventional 
titration of base to control the pH. Eventually this promising reaction showed adequate 
performance to convert 200 mM substrate with an enantiomeric excess of > 99.5% (Süss et al. 
2014). However, this eventual reaction performance arose from a series of improvised 
experiments and the bottleneck towards large-scale production has yet to be determined. 
Furthermore, the precise influence and nature of poorly water-soluble substrate was not directly 
addressed. Therefore, the aim of this work was to perform a bottleneck identification relying on 
time-course progression analyses to determine the major process limitation, according to the 
procedure detailed in Chapter 2. Using time-course measurements in this way it is possible to 
distinguish the dominating bottleneck for prospective performance of ECS-PLE06 under given 
conditions: enzyme kinetics (e.g. poor substrate affinity), enzyme stability or, more likely, 
substrate mass transfer. With this limitation in mind, the reaction was able to be further scaled-
up and its suitability for process implementation was assessed. 
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4.2. Materials and Methods 
Reagents 
All reagents were of analytical grade and supplied by Sigma-Aldrich (St. Louis, MO). Dimethyl 
cyclohex-4-ene-cis-1,2-dicarboxylate (1) and lyophilized recombinant pig liver esterase (ECS-
PLE06; EC 3.1.1.1) were kindly supplied by Enzymicals AG (Greifswald, Germany). 
Activity assay 
The activity of pig liver esterase was quantified using the same assay detailed by Süss et al. (2014) 
through spectrophotometric measurements of the degradation of p-nitrophenyl acetate (pNPA) 
to p-nitrophenolate. Reaction mixtures contained 850 μL of phosphate buffer (pH 7.5, 50 mM), 
50 μL of enzyme stock solution and 100 μL of pNPA in DMSO (10 mM). Initial rate measurements 
were taken at 400 nm (ε30 °C = 17759 L mol-1 cm-1) over 100 s at 30 °C. One unit (U) of esterase 
activity was defined as the generation of 1 μmol of p-nitrophenolate per minute under the 
standard activity assay conditions. Measurements were made using a UV-vis spectrophotometer 
(Specord 50, Analytik Jena AG, Jena, Germany). Reference samples contained dH2O and negative 
controls were performed with the absence of enzyme. 
Small-scale apparatus 
Small-scale reactions were performed in a 100 mL round bottom flask using a magnetic stirrer 
for mixing and an external water bath for temperature control at 40 °C. 40 mL of saturated 
NaHCO3 buffer (pH 8.15) was used to control the pH. ECS-PLE06 (≥ 0.3 U mg-1) was dosed to this 
medium, and the reaction was started by the addition of 0.6 g of 1 (80 mM). Samples (500 μL) 
were taken periodically and concentrations of substrate and product were determined using the 
procedure detailed in the analytical methods section. Reaction progress could be indirectly 
followed by use of a CO2 bubble counter fixed to the top of the apparatus. 
Fed-batch 250 mL stirred tank reactor 
Fed-batch experiments were performed in a 300 mL glass jacketed stirred tank reactor (STR). 
42 g of NaHCO3 (corresponding to a 2 M final concentration) was added with 1500 U of ECS-
PLE06 (6 U mL-1 final concentration) to 190 mL dH2O. Temperature was maintained at 40 °C by 
use of an external thermostat and mixing ensured by a pitched 4-blade turbine with overhead 
stirring motor at 300 rpm. pH was measured by an InLab Semi-Micro electrolyte sensor (Mettler 
Toledo, Colombus, OH) and was found to be 8.15 ± 0.38 (mean ± SD) over all experiments using 
the sodium hydrogen carbonate buffered system. 60 mL of substrate 1 (corresponding to a final 
concentration of 1.2 M) was fed by a R99-E syringe pump (Razel Scientific Instruments, Fairfax, 
VT) over the first 10 hours to make up a final reaction volume of 250 mL. Triplicate samples 
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(500 μL) were taken periodically over 24 h and concentrations of substrate and product were 
determined using the procedure detailed in the analytical methods section. 
Analytical methods 
Concentrations of 1 and 2a were quantified by GC-FID (TRACE 1310 Series, Thermo Fisher 
Scientific, Waltham, MA). Triplicate samples of 500 μL were taken from reaction media and 
acidified with 500 μL of concentrated HCl (1:1 volumes) to render 2a insoluble in the aqueous 
environment and to denature residual protein activity. Samples were then diluted and extracted 
with methyl tert-butyl ether (MTBE) containing n-decane (25 mM) as an internal standard 
through vortex on the highest setting and phase separation by centrifugation. 1 μL of the organic 
phase fraction was injected into a TR-1701 column (30 m x 0.25 mm x 0.25 μm; Thermo Fisher 
Scientific, Waltham, MA) where the oven temperature was ramped from 130 °C to 200 °C at a rate 
of 5 °C min-1 and thereafter held at an isotherm of 200 °C for 1 min. Injector and detector 
temperatures were maintained at 250 °C throughout. The carrier gas flow rate was 1.2 mL min-1 
with a split ratio of 35:1. Experimental substrate and product concentrations were determined 
using a standard curve generated by subjecting samples of known concentrations to the same 
acidification/solvent extraction procedure. 
4.3. Results and Discussion 
Understanding the influence of poorly water-soluble substrate on this system first required a 
series of time-course experiments with varied enzyme concentrations to identify potential mass 
transfer limitations. With this limitation on reaction rate considered, process performance 
metrics (as defined in Chapter 3) were assessed. Procedures (e.g. scale-up and fed-batch 
operation) were then followed with the goal of maximising product concentration. The best 
reaction performance was then benchmarked with target process performance metrics based on 
the high-value of the product and improvement strategies discussed. 
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The first step in this process was elucidating the major reaction limitation by varying 
enzyme loadings at a fixed, moderate substrate dose. Figure 4.1a shows these time-course 
progressions of reaction with incremental enzyme doses at a substrate concentration of 80 mM. 
Experiments were performed in a stirred round bottom flask (40 mL). Normalising the time axis 
by the varied parameter (enzyme concentration) revealed that the reaction becomes substrate 
mass transfer limited at enzyme doses greater than 6 U mL-1 because the reaction trajectories 
diverge (Figure 4.1b). Interestingly, the product was found to have a beneficial effect by better 
dispersing the substrate in the reaction medium since it acts as an emulsifier. Methanol was also 
formed as a by-product, which likely also helps improve substrate solubility in the medium. The 
slight improvement in reaction rate due to these factors can be observed after initial product 
formation, especially at the lowest enzyme doses. 
 
Figure 4.1. (a) Conversion as a function of time for the ECS-PLE06 catalysed 
reaction of 80 mM diester 1 to monoester 2a using 40 mL saturated NaHCO3 
as a buffer (pH 8.15) at 40 °C (left). (b) Data replotted with the x-axis 
normalised by enzyme concentration to reveal the major process limitation 
(right). ECS-PLE06 concentrations, [E0], were varied as follows:  
● – 1.54 U mL-1, ■ – 2.99 U mL-1, + – 4.50 U mL-1, * – 5.94 U mL-1,  
♦ – 8.72 U mL-1, ▲ – 11.37 U mL-1. 
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According to Figure 4.2, the upper limit of productivity due to substrate mass transfer limitations 
was 21 g L-1 h-1. Clearly, the expected linearly proportional response of space-time yield to 
enzyme concentration breaks down after this point, indicating a non-enzyme related limitation. 
On the other hand, biocatalyst yield appears to improve at lower enzyme concentrations because 
the same amount of substrate is still converted, although the reactions take longer. Another way 
of improving the biocatalyst yield metric is to increase the substrate loading thereby converting 
more substrate with the same amount of enzyme. In this manner, a better reflection of biocatalyst 
yield is obtained because, in reality, industrial processes should operate with the highest possible 
space-time yield in order to afford cost-effective processes (shorter batches and smaller reaction 
volumes). However, the biocatalyst yield should still be evaluated under conditions where the 
reaction is not kinetically limited. This is especially important to consider in cases such as this, 
which are limited by liquid-liquid mass transfer. 
 
Figure 4.2. Space-time yield (STY; ●) and biocatalyst yield (▲) as 
a function of enzyme activity dose with a fixed substrate 
concentration of 80 mM in all experiments. The dashed line 
indicates linearity through the origin. 
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Therefore, the substrate concentration was increased 5-fold (400 mM) and an enzyme dose of 
6 U mL-1 was maintained because mass transfer limitations occurred at higher enzyme 
concentrations. Full conversion and no kinetic limitations were observed at this higher substrate 
concentration, which was confirmed with the overlap of trajectories on a normalised time axis 
(Figure 4.3a). The resultant improvement in biocatalyst yield from 0.89 to 4.36 g gbiocat-1 at the 
same maximum space-time yield is shown in Figure 4.3b. 
 
Figure 4.3. (a) Reaction with 80 mM substrate (●) and 400 mM substrate (▲) 
in 40 mL saturated NaHCO3 buffer (pH 8.15) at 40 °C and with an enzyme 
dose of 6 U mL-1 on a normalised plot (left). (b) Space-time yield (STY; blue ●) 
and biocatalyst yield (red ▲) as a function of enzyme activity dose with 
80 mM substrate; data in yellow are those obtained with 400 mM substrate 
(right). 
In order to investigate the potential of further increasing substrate concentration, it was 
necessary to also increase the scale of reaction to a stirred tank reactor (250 mL). At this scale, 
better control and measurement of the reaction environment was made possible through defined 
stirring, temperature and pH control. Substrate concentrations greater than 500 mM caused the 
enzyme to agglomerate and denature. Therefore, three 400 mM batch doses of 1 were supplied 
at 3 h intervals in a fed-batch manner to mimic the previous reaction profiles observed at smaller 
scale. However, full conversion was not reached even after 24 h (data not shown). In order to rule 
out potential substrate inhibition caused by too large single substrate doses, a constant feed rate 
of substrate at 5.81 g min-1 was instead supplied to the reactor by use of a syringe pump. This 
would hypothetically result in a calculated 1.19 M product and a STY of 22.0 g L-1 h-1 in 9 h of 
reaction time if the reaction was not limited, as would be expected based on previous results. 
During fed-batch reaction, product formation ceased after 7 h after which substrate accumulated 
at a rate equal to that of the pump feed rate (Figure 4.4a). However, the mass balance of substrate 
to product was closed throughout indicating that indeed the reaction had stopped after 400 mM 
product formation (Figure 4.4b). It was postulated that either enzyme stability or product 
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inhibition or product induced deactivation could be the cause. In order to confirm this, the end-
point reaction medium was dosed with a fresh 6 U mL-1 of ECS-PLE06 and left to incubate at 40 °C 
for 48 h. Conversion was only marginally improved by approximately 10% (data not shown) 
indicating that product inhibition or product induced deactivation was the most likely cause of 
activity loss. 
 
Figure 4.4. (a) Fed-batch conversion of 1.2 M diester 1 (●) to monoester 2a 
(▲) in a 250 mL (end volume) stirred tank reactor. pH was maintained with 
saturated NaHCO3 buffer (pH 8.15) at 40 °C and included an enzyme dose of 
6 U mL-1 (above). (b) Mass balance corresponding to the sum of substrate 
and product in the reaction medium (●) and the actual fed-batch rate of 
substrate supply to the reactor by a syringe pump indicated with a dashed 
line (below). Error bars reflect 95CI (n = 3). 
Indeed, this was was confirmed after the stability of ECS-PLE06 was evaluated with respect to 
temperature (40 °C), high buffer strength solutions (saturated NaHCO3), and by-product 
methanol concentrations of up to 5% (v/v) (corresponding to a high molar concentration of 
~1.3 M; Figure 4.5). ECS-PLE06 showed a negligible activity loss after 24 h in the presence of all 
environmental factors. Furthermore, the enzyme gained activity whilst being incubated in 
NaHCO3 buffer and methanol, which might point towards an affinity of ECS-PLE06 for strongly 
buffered environments containing methanol.  
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Figure 4.5. Stability of ECS-PLE06 as a function of time at room temperature 
in 50 mM phosphate buffer at pH 7.5 (control, solid bars), at 40 °C in 50 mM 
phosphate buffer (pH 7.5; diagonal striped bars), at 40 °C in saturated 
NaHCO3 buffer (1.14 M, pH 8.15; opaque bars), and with 5% (v/v) methanol 
(~1.3 M) at 40 °C in saturated NaHCO3 buffer (horizontal striped bars). Error 
bars reflect 95CI (n = 4). 
In an attempt to address product inhibition/deactivation a simple in situ product removal (ISPR) 
technique using reactive crystallisation was attempted. Here, the charged product anion in 
solution would potentially precipitate from solution when bound to a metal cation. An ideal ‘self-
healing’ system could utilise a metal bicarbonate salt to both buffer the pH during reaction as well 
as simultaneously precipitate product and simplify downstream isolation steps without 
negatively affecting enzyme performance. Unfortunately all trials with the prospective metals 
Ca2+, La3+, Mn2+ and Ce3+ failed to crystallise the product from solution in the presence of Tris-HCl 
buffer under the reaction pH of 7-8. For this specific case, two-liquid phase approaches would not 
be feasible because the substrate, being hydrophobic, would partition more strongly than product 
into an organic phase. Instead, further focus could be made towards more expensive ISPR 
methods such as selective anion exchange resins (Bechtold et al. 2006) or charged membranes 
(Strathmann 2010). Another possibility could be to remove the product in an external loop 
through pH swing (precipitation) or cooling crystallisation, although this would require a means 
to retain the biocatalyst from the harsh conditions in the external loop (Buque-Taboada et al. 
2004; Buque-Taboada et al. 2006). 
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Nevertheless, in this work improved performance was achieved with final process 
metrics summarised in Table 4.1. The product of interest in this work is an intermediate towards 
an active pharmaceutical ingredient (API)/biologically active molecule. Based on the market 
application, this product can therefore be classed as high-value and the corresponding process 
metric targets from Chapter 3 could be used as benchmarks. The reaction performance far 
exceeded almost all the target metrics with the exception of biocatalyst yield (and specific 
productivity). However, a reaction must satisfy all required metrics in order to be viable for 
industrial applications. The simplest route of improving biocatalyst yield is to reduce biocatalyst 
loading at the expense of productivity, which was satisfactory by an order of magnitude. The 
enzyme was found to be robust and retained activity for well over 24 h so could be suited to 
extended batch lengths. Another more complex method to improve biocatalyst yield without 
compromising other metrics would be to address product inhibition allowing a higher product 
turnover for this particular reaction. Different techniques of in situ product removal (ISPR) were 
studied and discussed previously. The biocatalyst yield could also be improved by further 
optimising the expression of ECS-PLE06 in the lyophilised preparation, which would increase the 
specific activity of the biocatalyst affording smaller doses to achieve the same productivity. All-
in-all based on the process metrics, the reaction shows great promise for full-scale industrial 
implementation despite the mass transfer of poorly water-soluble substrate restricting the space-
time yield. 
Table 4.1. Benchmarking best process performance metrics for the ECS-PLE06-
catalysed desymmetrisation of 1 to 2a. 
Process Metric 
High-value Class 
Targets (100 € kg-1) 
Actual Values 
Reaction conversion [%] (100) 100 
Product concentration [g L-1] 10 74 
Space-time yield [g L-1 h-1] 2 20.2 
Specific productivity [g gbiocat-1 h-1] 1.7 – 7.6 1.20 
Biocatalyst yield [g gbiocat-1] 10 – 40 4.36 
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4.4. Conclusions and future perspectives 
This work points towards a promising biocatalytic reaction based on this performance of ECS-
PLE06. Scale-up of up to 400 mM batches of product can proceed with an expected biocatalyst 
yield and productivity of 4.36 g gbiocat-1 and 20.2 g L-1 h-1, respectively. Beyond this relatively high 
concentration limit (~75 g L-1), product inhibition will prevent further conversion of substrate. 
Biocatalyst yield can be improved to fall into the required window of 10-40 g gbiocat-1 (for high-
value products) by simply dosing with less enzyme, although the batch length will be 
proportionally extended. Alternatively, biocatalyst yield could be improved through increasing 
the specific activity of the lyophilised cell-free extract by further optimising the expression of ECS-
PLE06. If higher product concentrations are required then alternative ISPR techniques must be 
considered. Furthermore, substrate must be dosed in a fed-batch manner to avoid enzyme 
agglomeration and activity loss. Through the application of a standardised methodology relying 
on time-course progressions it was concluded that the reaction was limited by mass transfer. This 
was due to the low solubility of substrate in the water-based medium. ECS-PLE06 is a robust 
enzyme that is highly thermostable and tolerant towards solvents (Hinze et al. 2016), therefore 
mass transfer limits could still potentially be reduced by increasing temperature or adding water-
miscible co-solvents to this system to help improve substrate solubility in the aqueous reaction 
medium. This specific system also highlights the elegance of ‘self-healing’ systems where pH can 
easily be maintained by the reaction medium itself through an oversaturated benign carbonate 
buffer reacting with product cation species. 
5-1 
 
Chapter 5. Case Study II – Part A: Significance of analytical methods 
when characterising heterogeneous reactions 
This chapter forms the first of two detailing the assessment of an enzyme-catalysed system 
featuring a (gas)-solid-liquid Baeyer-Villiger oxidation. The inclusion of a solid-phase through 
poorly water-soluble macrocyclic ketones and lactones presented the highest levels of complexity 
in terms of experimental evaluation. The analytical challenges brought about by the presence of 
solid substrate with regards to sampling a heterogeneous medium and performing activity assays 
are described in this chapter, and in two parts.  
First, significant sample-to-sample variation of the solid-liquid reaction medium 
prevented more conventional direct liquid-phase sampling. Therefore, an online method of 
monitoring reaction progress using oxygen mass balance in the gas-phase of the reactor outlet 
was developed. The method was successfully validated and demonstrated by using two model 
reactions: firstly, the oxidation of glucose by glucose oxidase and, secondly, the Baeyer-Villiger 
oxidation of macrocyclic ketones to lactones. Initial reaction rate constants and time-course 
progressions calculated from the oxygen mass balance were validated against conventional 
online methods of dissolved oxygen tension and pH titration measurements. A feasible operating 
window and the sensitivity to dynamic changes of reaction rates was established by controlling 
oxygen transfer through the operating parameters of the reactor. Such kinetic data forms the 
basis for reaction characterisation, from which bottlenecks may be made evident and directed 
improvement strategies can be identified and implemented. 
Secondly, the presence of a solid-phase hindered conventional spectrophotometric 
activity assays. Consequently, an alternative activity assay was developed that made use of direct 
sacrificial sampling. 
What follows in Chapter 6 is a more detailed description of the Baeyer-Villiger oxidation 
reaction and the application of each analytical method. 
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5.1. Part I: Gas-phase measurements of oxygen mass balance to follow 
reaction kinetics 
This chapter has formed the basis of the following published peer-reviewed journal article:  
Murray P. Meissner, Mathias Norblad, John M. Woodley. 2018. Online Measurement of Oxygen-
Dependent Enzyme Reaction Kinetics. ChemBioChem, 19:106-113. 
5.1.1. Introduction 
Conventional wisdom holds that the characterisation of enzyme-catalysed reactions is best 
performed by time-course experiments as close to industrially relevant conditions as possible. 
However, this is rarely the case. Perhaps this is because process performance metrics have been 
poorly defined and applied during reaction evaluations (Chapter 3). Chapter 2 describes how the 
resulting reaction progress curves, under a range of defined conditions, may reveal performance 
limitations (or bottlenecks), such as enzyme stability, substrate/product inhibition or mass 
transfer (Blackmond 2005; Blackmond 2015). Central to this characterisation is the necessity for 
accurate analytics. 
Broadening the application of biocatalysis to a wider range of industrially useful 
substrates will require focus on how to deal with organic solvents and poorly water-soluble 
substrates (Schmid et al. 2001). Indeed, industrially relevant substrate/product loadings in 
excess of 50 g L-1 will most often exceed solubility limits, or induce inhibition, frequently 
necessitating the need for additional water-immiscible solvent phases (Lu et al. 2004; Süss et al. 
2014; Reimer et al. 2017; Sheldon 2017; Uthoff et al. 2017). This situation is increasingly common 
and brings the significant challenge of sampling heterogeneous mixtures, in such a way as to give 
representative and useful measurements (Domínguez de María and Hollmann 2015). 
Oxidation reactions form an important class of reactions in organic chemistry (Faber 
2011; Turner 2011). The continuous supply (and conversion) of oxygen during these reactions 
provides an alternative method for measuring reaction rate that is not dependent on sampling 
the reaction medium. Based on this premise, it was decided to use this method for kinetic 
characterisation. Hence, the objective of the work in this chapter is to document a relatively 
simple methodology to characterise oxygen-dependent reactions with poorly water-soluble 
components and/or two liquid-phases by eliminating the need for direct sampling of a multi-
phasic reaction medium. The method is based on using the oxygen mass balance measured by 
online gas-phase analysis. The primary advantage of this method is that it is insensitive to 
sampling heterogeneity (due to non-ideal mixing of multi-phasic mixtures) because it measures 
solely in the gas-phase. Additionally, the method is generic for any oxygen-dependent reaction; 
this means it can cope with different substrates, and the development of a new analysis method 
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for each new compound can be avoided. Furthermore, as an online method, it may also be used 
for process control because it yields real-time kinetic predictions. Inspired by similar applications 
of this approach in the fields of wastewater treatment (Kappeler and Gujer 1992), solid-state 
fermentation (Gumbira-Sa’id et al. 1993; Mitchell et al. 2000) and in more conventional 
fermentations by means of measuring respiratory quotients (Villadsen 2015), the application of 
this method to enzymatic reaction kinetic measurements is novel. Of particular interest is that 
the oxygen consumption rates (equating to productivities) of enzyme-catalysed reactions in an 
industrial setting are up to two orders of magnitude higher than those in the previous examples, 
which increases accuracy. 
To illustrate and validate the methodology, first the well-known, stable enzyme glucose 
oxidase (EC 1.1.3.4; GOx) was used to catalyse the oxidation of D-glucose to D-glucono-1,5-
lactone, which thereafter spontaneously hydrolysed to D-gluconic acid (Scheme 5.1). It should be 
noted that the effective 1:2 stoichiometry for oxygen:glucose conversion is due to the extra 
peroxide degradation loop catalysed by catalase (EC 1.11.1.6; Cat), which is unique to oxidase-
based reactions. 
 
Scheme 5.1. Reaction scheme catalysed by glucose oxidase (GOx) and catalase (Cat), which is used to 
decompose hydrogen peroxide, a harmful reaction intermediate. 1: D-glucose; 2: D-glucono-1,5-
lactone; 3: D-gluconic acid. 
The accuracy of the gas-phase analytical equipment with respect to differing productivities 
(achieved by adjusting oxygen transfer rates (OTRs) and enzyme loading) was estimated by 
comparison with glucose analysis in liquid-phase samples by HPLC and, in this way, feasible 
operating windows for the method were found. In addition, estimating initial rates and time-
course substrate consumptions by gas-phase measurements were also compared with other, 
more conventional online methods, such as dissolved oxygen tension (DOT) and pH titration 
measurements. The inherent challenges of applying these more conventional approaches are also 
discussed. Lastly, the method is also applied to a more complex, heterogeneous reaction involving 
co-solvent, which is catalysed by a Baeyer-Villiger monooxygenase (BVMO). This reaction was the 
oxidation of macrocyclic ketone 4 to lactone 5 (Scheme 5.2) by cyclododecanone monooxygenase 
(EC 1.14.13.x; CDMO) from Rhodococcus ruber SC1 (Schumacher and Fakoussa 1999; Kostichka 
et al. 2001). Cofactor regeneration was facilitated by glucose dehydrogenase (GDH; EC 1.1.1.47), 
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which catalysed the analogous reaction of GOx in Scheme 5.1, however without the need for 
molecular oxygen. The BVMO-catalysed reaction demonstrated not only the usefulness of such an 
online method for following reaction progress if standard liquid-phase sampling is made 
problematic, but also the generality of applying gas-phase mass balances to any system requiring 
oxygen. An explanation of the theory and nomenclature used in the application of this method 
follows. 
 
Scheme 5.2. Oxidation of macrocyclic ketones to lactones catalysed by cyclododecanone 
monooxygenase from Rhodococcus ruber SC1 (CDMO). Reduced nicotinamide adenine dinucleotide 
phosphate (NADPH) cofactor was recycled by using glucose dehydrogenase (GDH), which accepted D-
glucose (1) as a co-substrate and produced D-glucono-1,5-lactone (2). 4: cyclopentadecanone; 5: 
cyclopentadecanolide. 
5.1.2. Theory 
A black box approach over the gas-phase during biocatalytic oxidation was applied (Figure 5.1). 
 
Figure 5.1. Black box schematic of reaction apparatus. FC = gas flow controller; FM = gas flow meter; 
yO2M = gas-phase oxygen fraction meter (reproduced from Meissner et al. (2018), with permission 
from John Wiley and Sons). 
The number of moles of oxygen in the gas outlet stream, ṅO2,out [mol h-1], can be calculated by 
applying the ideal gas law to the total volumetric gas flow rate, νout [sL h-1], and oxygen fraction in 
the gas-phase, yO2,out [-], which are measured variables: 
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?̇?𝑂2,𝑜𝑢𝑡 =
𝑃∙𝜈𝑜𝑢𝑡
𝑅𝑇
× 𝑦𝑂2,𝑜𝑢𝑡 (5.1) 
The number of moles of oxygen flowing into the system is calculated during a steady-state where 
no reaction is taking place because the following simplification holds: 
?̇?𝑂2,𝑖𝑛 = ?̇?𝑂2,𝑜𝑢𝑡 (5.2) 
During reaction, the oxygen consumption rate, RO2 [mol L-1 h-1], can then be found by mass 
balance, and the glucose consumption rate from reaction stoichiometry for glucose oxidase* 
(Scheme 5.1): 
𝑅𝑂2 =
𝑑𝐶𝑂2
𝑑𝑡
=
?̇?𝑂2,𝑖𝑛−?̇?𝑂2,𝑜𝑢𝑡
𝑉
=
1
2
𝑅𝑔𝑙𝑢𝑐𝑜𝑠𝑒 (5.3) 
The initial rate of reaction is found in a similar manner from an initial portion of data when the 
reaction velocity can be considered linear. Replacing ṅO2,out with an averaged oxygen flow rate, 
ṅO2,avg, observed during this period of steady-state reaction, allows the calculation of the initial 
rate. The 95% confidence intervals were determined using the total sample size of data that were 
averaged to calculate each initial rate (n > 100 in almost all instances). 
The off-gas mass balance can also be combined with classic two-film theory to yield the 
following overall expression, where kLa [h-1] is the overall volumetric mass transfer coefficient, 
and C*O2 and CO2 [mol L-1] are the dissolved oxygen (DO) concentrations at saturation and in the 
bulk medium, respectively: 
?̇?𝑂2,𝑖𝑛−?̇?𝑂2,𝑜𝑢𝑡
𝑉
=
𝑑𝐶𝑂2
𝑑𝑡
= 𝑘𝐿𝑎(𝐶𝑂2
∗ − 𝐶𝑂2)  (5.4) 
5.1.3. Materials and Methods 
Reagents 
All reagents were of analytical grade and supplied by Sigma-Aldrich (Buchs, Switzerland). HiQ® 
Synthetic Air 5.0 was supplied by AGA A/S (Copenhagen, Denmark). Lyophilised catalase from 
bovine liver (≥ 2000 U mg-1; EC 1.11.1.6) and superoxide dismutase (SOD) from bovine 
erythrocytes (≥ 3000 U mg-1; EC 1.15.1.1) were purchased from Sigma-Aldrich. Glucose oxidase 
from Aspergillus niger (EC 1.1.3.4) was provided by DuPont Industrial Biosciences (Wageningen, 
The Netherlands) in the form of lyophilised cell free extract. Cyclododecanone monooxygenase 
from Rhodococcus ruber SC1 (EC 1.14.13.x) was provided by InnoSyn BV (Geleen, The 
Netherlands) in the form of cell free extract. Lyophilised glucose dehydrogenase (EC 1.1.1.47) for 
                                                             
* For CDMO RO2 = Rglucose due to reaction stoichiometry. 
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NADPH cofactor regeneration was provided as GDH280 by evoxx technologies GmbH (Monheim 
am Rhein, Germany). 
GOx batch reaction conditions 
Experiments were performed in a sealed 250 mL bioreactor with a working volume of 150 mL 
(MiniBio with my-Control software from Applikon Biotechnology (Delft, The Netherlands)). The 
bioreactor included stirring (500-1000 rpm), aeration through a sintered frit (0.5-2.0 aeration 
volumes per reactor volume per minute (vvm)), pH and temperature control capabilities. The 
operating temperature was maintained at 25 °C and pH at 7.5 by potassium phosphate buffer 
(200 mM). pH-stat experiments by titration of NaOH (1 M) were performed in the absence of 
buffer. Reaction kinetics were determined through complete oxidation of glucose (200 mM) by 
the addition of, unless otherwise stated, GOx (200 mg L-1) and catalase (10 000 U L-1) to ensure 
total H2O2 removal. Samples of 1 mL were periodically taken for analysis by HPLC. Dissolved 
oxygen in the liquid-phase was measured by a Solvent-Resistant Oxygen Probe (PyroScience 
GmbH, Aachen, Germany). To improve measurement accuracy, the gas-phase at the reactor outlet 
was dried by use of a condenser and sequential drying tube filled with silica drying beads before 
being passed through a Smart-Trak® 50 Series Digital Mass Flow Meter (Sierra Instruments, Inc., 
Monterey CA, USA) and BlueInOne CO2/O2 Gas Analyser (BlueSens gas analyser GmbH, Herten, 
Germany). 
BVMO batch reaction conditions 
The oxidation of macrocyclic ketones to lactones catalysed by CDMO were also performed in the 
same bioreactor used for GOx reactions (working volume of 150 mL). Reaction temperature was 
controlled at 30 °C and pH at 7.5 by NaOH (6 M) addition and potassium phosphate buffer 
(100 mM). D-Glucose (200 mM) and GDH280 (25 U mL-1) were used for cofactor regeneration. 
NADP+ (2.5 mM), FAD (0.1 mM), catalase (150 U mL-1), and SOD (20 U mL-1) were for their 
stabilising effect on BVMOs (Goncalves et al. 2017). Antifoam 204 (0.5% (v/v)) was added to 
prevent foam formation. Cyclopentadecanone substrate (100 mM) was added to the reaction 
medium dissolved in methanol co-solvent (20% (v/v)). Lastly, the reaction was initiated by the 
addition of CDMO cell free extract (5% (v/v); protein concentration and specific BVMO activity 
not available). 
GC analysis 
End-point analyses of the BVMO experiment reaction medium could only be carried out after 
reaction completion due to the formation of a well-dispersed emulsion. 5 replicate samples of 1 
mL were drawn from the reactor and substrate/product extraction was facilitated by 1:1 volumes 
of ethyl acetate containing naphthalene (1.5 g L-1) as an internal standard. After vigorous mixing 
by vortex for 30 s and separation of organic from aqueous components by centrifugation, 300 μL 
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of the organic fraction was analysed by Clarus 500 GC-FID (Perkin Elmer). 1 μL of sample was 
injected into an Elite-5 column (Perkin Elmer) where the oven temperature was ramped from 
150 °C to 200 °C at 4 °C per minute and thereafter at a rate of 40 °C per minute to a final isotherm 
at 300 °C for 1 minute. 0.60 mL min-1 helium with a split ratio of 10:1 was used as carrier gas. 
Injector and detector temperatures were maintained at 280 °C throughout. Experimental 
substrate and product concentrations were determined using a standard curve generated by 
subjecting samples of known concentrations to the same solvent extraction procedure. 
HPLC analysis 
Glucose analyses were carried out by HPLC following the identical procedure detailed by 
Toftgaard Pedersen et al. (2017). 
Solubility measurements 
The solubility of the macrocyclic ketone and lactone, cyclopentadecanone and 
cyclopentadecanolide, was measured in triplicate by accurately weighing an amount of each into 
a 1 L volumetric flask containing dH2O. The solution was mixed by orbital shaking and incubated 
at 30 °C for 3 days to allow for equilibration. The mixtures were then filtered, dried, and weighed 
again. The difference in mass from beginning to end was taken to be the amount dissolved in 
water (solubility). 
5.1.4. Results and Discussion 
Oxygen mass balance method validation 
As a brief validation that time-course reaction progression and initial rate estimations made by 
oxygen mass balance in the gas-phase correlate to standard HPLC analyses, an example of data 
output from gas-phase measurements is shown in Figure 5.2. The initial oxygen transfer rate 
calculated by the difference (ṅO2,in - ṅO2,avg)/V was found to be 33.42 ± 0.54 mmol L-1 h-1 
(mean ± 95CI). The predicted Rglucose was therefore, from reaction stoichiometry, 
66.84 ± 1.08 mmol L-1 h-1, which was within a 98% agreement with the rate measured by HPLC 
(68.19 ± 2.05 mmol L-1 h-1). Indeed, the closeness of prediction over the full time-course using 
gas-phase analysis can be seen in Figure 5.3. 
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Figure 5.2. Measured total volumetric flow rate of gas in the outlet stream (green) and oxygen fraction 
in the off-gas (blue) as a function of time. The number of moles of oxygen (red) were calculated 
through the ideal gas law and the grey dashed line indicates reaction initiation by the addition of 
200 mg L-1 GOx. pH was maintained at 7.5 by titration of 1 M NaOH. Steady-state periods that were 
taken as references for initial rate calculations are indicated. Agitation rate = 1000 rpm; aeration 
rate = 1.0 vvm (reproduced from Meissner et al. (2018), with permission from John Wiley and Sons). 
 
Figure 5.3. Predictions of dynamic glucose concentrations during a time-course experiment using the 
off-gas mass balance method (yellow), dissolved oxygen measurements (blue) and pH titration 
method (green) compared with measurements by HPLC (black circles). The grey dashed line indicates 
reaction initiation by the addition of 200 mg L-1 GOx. The reaction was performed in the absence of 
buffer with the titration of 1 M NaOH for pH control. Agitation rate = 1000 rpm; aeration 
rate = 1.0 vvm (reproduced from Meissner et al. (2018), with permission from John Wiley and Sons). 
Method accuracy at different OTRs 
Next, the validity of the off-gas oxygen method was tested at a range of reaction rates in order to 
ascertain a feasible operating window under which it might be applied. A possible strategy to fix 
the reaction rate was to ensure the reaction was purely limited by oxygen transfer kinetics and 
not enzyme kinetics. In order to do so, each experiment was dosed with an excess of GOx. The 
reaction performance could therefore be controlled by the OTR by adjusting physical reactor 
parameters: stirrer speed and aeration rate, independent of enzyme activity. In all instances, 
except under the highest OTR (98.89 ± 1.44 mmol L-1 h-1), 200 mg L-1 GOx was sufficient to reach 
this oxygen limited reaction state, which was confirmed by observing the same kinetics in a 
duplicate experiment under the same conditions with double the enzyme dose (data not shown). 
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The upper limit of this operating window was dictated by the maximum allowable reactor 
settings. Increasing scale or changing the reactor will therefore redefine the window under which 
this method may be applied. 
Clearly the accuracy of the method varies with the ability to match oxygen supply and 
consumption in the reaction. If either the reaction rate or oxygen transfer rate are too low, then 
an inadequate response from the gas sensors may lead to inaccurate kinetic predictions. On this 
basis it was reasoned that a useful operating range for the method must be investigated. The 
range of OTRs and results are summarised in Table 5.1. Narrow 95% confidence intervals (< 3% 
on average) point towards a high precision of the method. This may be attributed to the large 
sample size of data that was used to calculate initial rates, an inherent benefit of using such online 
measurements with a quick data collection capacity. 
Table 5.1. Summary of initial reaction rates obtained under various oxygen transfer rate settings 
(Rx = mean ± 95CI). Accuracy reflects the closeness of gas-phase mass balance prediction with that of 
HPLC analysis. 
Agitation Rate 
Aeration 
Rate 
Measured RO2 
[mmol L-1 h-1] 
Predicted Rglucose 
[mmol L-1 h-1] 
HPLC Rglucose 
[mmol L-1 h-1] 
Accuracy [%] 
500 rpm (P/V 
= 0.2 kW m-3) 
0.5 vvm 15.12 ± 1.07 30.25 ± 2.14 36.37 ± 0.32 83.2 
1.0 vvm 23.20 ± 1.08 46.39 ± 2.17 47.23 ± 0.15 98.2 
2.0 vvm 40.76 ± 0.91 81.52 ± 1.82 65.12 ± 0.53 74.8 
1000 rpm (P/V 
= 1.6 kW m-3) 
0.5 vvm 50.93 ± 0.45 101.87 ± 0.91 83.09 ± 2.02 77.4 
1.0 vvm 55.56 ± 0.62 111.12 ± 1.23 113.99 ± 2.77 97.5 
2.0 vvm 59.31 ± 1.27 118.61 ± 2.54 116.00 ± 1.00 97.8 
2.0 vvm† 98.89 ± 1.44 197.79 ± 2.88 173.71 ± 3.02 86.1 
 
Figure 5.4 illustrates the accuracy of rate estimations based on the online method relative to those 
obtained through HPLC analyses in a parity plot. For the sake of generality, initial reaction rates 
have been presented as space-time yields (STYs) in g L-1 h-1. The two methods show a high degree 
of linear correlation (R2 = 0.9556). The method appears to have a slight bias towards 
overestimating the reaction rate; however, most of the data points for the two methods fall within 
85% of each other. 
                                                             
† Double GOx dose = 400 mg L-1. 
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Figure 5.4. Parity plot of space-time yields (STYs; productivities) 
measured by HPLC vs. those predicted by oxygen mass balance. Data 
were taken from all experiments and were adjusted to represent more 
typical reactions where the stoichiometric coefficient of oxygen to 
product is equal. Dashed lines indicate 85% similarity; dotted line 
indicates unity (reproduced from Meissner et al. (2018), with 
permission from John Wiley and Sons). 
Sensitivity to dynamic changes 
The response of the off-gas method towards dynamic rate changes was observed by starting a 
reaction with 30 mg L-1 GOx and then doubling the reaction rate after some time by dosing the 
reaction with a further 30 mg L-1 GOx (Table 5.2). Oxygen supply was adequate at a volumetric 
mass transfer coefficient (kLa) of 85 h-1 owing to the fact that no rate limitations were observed. 
Although a slightly higher reaction rate was predicted by the gas-phase mass balance method 
when compared to that obtained by HPLC analyses, the increase in rate after doubling the enzyme 
loading was exactly as expected at 1.95-fold the previous value. Therefore, it was concluded that 
the method could accurately predict dynamic rate changes caused by the corresponding enzyme 
addition. It follows that the method could therefore also cope with dynamic rate variations 
encountered in other oxidation reactions. Generally it was found that the sensors had a response 
time of less than 5 s to disturbances in steady-states, although this is dependent on the gas holdup 
of the reactor. 
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Table 5.2. Initial reaction rates as a function of dynamic enzyme dose 
from oxygen mass balance and HPLC analysis. 
GOx Dose 
Predicted 
Rglucose 
[mmol L-1 h-1] 
Predicted 
Rglucose 
Increase 
HPLC Rglucose 
[mmol L-1 h-1] 
HPLC 
Rglucose 
Increase 
30 mg L-1 29.91 
1.95x 
23.81 2.07x 
60 mg L-1 58.18 49.27 
 
Comparison with online methods 
Lastly, the off-gas method was put into context with two other online methods that can be used 
to monitor reaction kinetics: DOT measurements and alkali titration for pH maintenance. 
Predicting rates by dissolved oxygen measurements requires an estimation of the kLa of 
the system under the conditions that are to be run in a time-course experiment. In this instance, 
the oxygen transfer characteristics of the 150 mL reactor used were estimated using the dynamic 
gassing-out method (de Figueiredo and Calderbank 1979) through dissolved oxygen 
measurements under standard conditions: in water at 25 °C and 1 atm. The kLa as a function of 
stirring speed and aeration rate is shown in Figure 5.5. 
 
Figure 5.5. Average kLa as a function of stirring speed and aeration rate 
in 150 mL water at 25 °C and 1 atm (SD < 1% in all instances; n = 5; 
reproduced from Meissner et al. (2018), with permission from John 
Wiley and Sons). 
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Measurements of the DOT over time during an experiment (Figure 5.6) converted through 
Henry’s law to oxygen concentrations in the liquid medium allow the OTR to be calculated at each 
instance of the experiment. The prediction of glucose consumption follows from the calculated 
OTR and reaction stoichiometry (Figure 5.3). 
 
Figure 5.6. Time-course reaction performed in the absence of buffer solution with 1 M NaOH as base 
titrant. The grey line indicates reaction initiation by the addition of 200 mg L-1 GOx. Dissolved oxygen 
tension (DOT) is shown in blue and the net alkali pump volume is shown in green. Agitation 
rate = 1000 rpm; aeration rate = 1.0 vvm (reproduced from Meissner et al. (2018), with permission 
from John Wiley and Sons). 
The number of moles of oxygen or substrate consumed during such a reaction should also 
correlate with the number of moles of NaOH base titrated to maintain the pH in an unbuffered 
system since the resultant reaction product is an acid. The number of moles of base added can be 
calculated from the measured alkali pump volume and known concentration of the base solution 
(Figure 5.6). 
The glucose consumption kinetics predicted by each method and those established by 
HPLC analyses are presented in Figure 5.3 and initial rates compared in Table 5.3. Each method 
was able to follow the reaction to an extent, although with varying degrees of accuracy. In terms 
of both initial rate and predicted kinetics over the full time-course of the experiment, the gas-
phase mass balance method was most comparable to HPLC analysis, which was considered to be 
the benchmark being the standard analytical method for this reaction. A weakness of predictions 
by dissolved oxygen measurements is that an accurate measurement of kLa under actual reaction 
conditions is essential, as opposed to a kLa estimated under standard conventions. kLa is 
dependent on medium properties such as the presence of salts, sugars or the enzyme itself 
(Pulido-Mayoral and Galindo 2004), which could be a reason for an inaccurate kLa estimate found 
under conventional standard conditions using the dynamic gassing out method. Using 
oversaturated enzyme reactions (i.e. reactions performed under OTR limited conditions) to 
measure kLa was postulated to be superior to conventional methods such as the dynamic gassing 
out method because it inherently incorporates a more realistic medium composition, required by 
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the enzymatic reaction itself (Ortiz-Ochoa et al. 2005; Garcia-Ochoa and Gomez 2009). In the case 
of this experiment, the kLa during reaction is closer to 96.7 h-1 rather than the estimated 84.7 h-1, 
which is why the predicted glucose consumption kinetics were slower than those obtained by 
HPLC analyses. The accuracy of the pH titration method for kinetic predictions was most likely 
reduced due to the difficulty in making an accurate measurement of the peristaltic pump flow 
rate. Furthermore, any residual buffer salts in solution could cause a deviation of alkaline addition 
from that which is specifically required to neutralise the acidic product formation. Clearly a 
method relying on pH titration is less generic because not all reactions feature acids or bases. In 
any case, the method of gas-phase kinetic prediction does not suffer from these drawbacks and 
can be applied more generally to any oxidation reaction without the need for liquid-phase 
measurements. 
Table 5.3. Comparison of initial rates predicted by three online methods 
for oxidation kinetic predictions (Rx = mean ± 95CI). Accuracy reflects 
the closeness of each method’s prediction with that of HPLC analysis. 
Method 
Predicted Rglucose 
[mmol L-1 h-1] 
HPLC Rglucose 
[mmol L-1 h-1] 
Accuracy 
[%] 
Off-gas Measurement 66.84 ± 1.08 
68.19 ± 2.05 
98.0 
DO Measurement 58.41 ± 0.10 85.7 
pH Titration 51.81 ± 0.12 76.0 
 
Method application to BVMO catalysed reactions 
To demonstrate the broader applicability of gas-phase mass balances, a further reaction catalysed 
by CDMO was tested featuring a poorly water-soluble substrate and product (25.4 ± 4.7 and 
24.2 ± 5.7 mg L-1 (mean ± SD, n = 3), respectively), and methanol co-solvent phase to enhance 
substrate solubility. Due to the low solubility of both substrate and product, the reaction medium 
was heterogeneous, appearing turbid. Reaction monitoring by direct, liquid-phase sampling 
turned out to be unfeasible due to inconsistencies caused by large sample-to-sample variation. 
However, this oxygen-dependent reaction could be monitored using the online off-gas method 
previously validated using the glucose oxidase system. An example of experimental output is 
shown in Figure 5.7. 
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Figure 5.7. Reaction kinetics of the oxidation of cyclopentadecanone to cyclopentadecanolide 
catalysed by CDMO. The grey line indicates reaction initiation by the addition of 5% (v/v) CDMO cell 
free extract. The fraction of oxygen in the outlet gas stream (yO2,out) is shown in blue and the predicted 
concentration of lactone product made by oxygen mass balance is shown in green (reproduced from 
Meissner et al. (2018), with permission from John Wiley and Sons). 
At this enzyme loading, more than 25 g L-1 product was produced in 15 h resulting in a space-time 
yield of 1.92 g L-1 h-1. An end-point analysis of the reaction medium by gas chromatography (GC-
FID) confirmed the final conversion to be 92%. 
The oxygen consumption trend by off-gas analysis shows two distinct reaction rate 
periods separated by a step change at 2.5 h. This behaviour was consistent with previous 
experiments and was distinct for this BVMO reaction, having not been observed in reactions with 
GOx. We hypothesise that this may be caused by loss of methanol co-solvent by gas stripping. 
There may exist a critical surface tension or methanol concentration under which poorly-soluble 
ketone or oxygen availability becomes limiting. It is also possible that the first reaction rate period 
reflects the unhindered rate of CDMO converting all dissolved substrate in the medium containing 
co-solvent, followed by the next reaction rate region wherein the mass transfer of 
cyclopentadecanone into the medium then dominates (this scenario would likely be solvent 
independent). A different cause for reaction rate decrease may be due to product inhibition after 
a limiting amount of product has formed during reaction. However, this is less likely to be the case 
considering the sharp step change nature of rate response. 
Regardless, such an experiment highlights the strength of such an online method to 
discover kinetic effects in real-time, which is difficult to achieve through discrete sampling and 
analysis. Furthermore, these results satisfy the scope of demonstrating the more general 
application of gas-phase mass balances to other reaction systems. This application is further 
demonstrated in Chapter 6. 
Effects of scale, limitations and advantages 
One challenge with the gas-phase method is the measurable net difference in molar oxygen flow 
between reactor inlet and outlet. Assuming considerable reaction rate, the net difference will 
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depend on both kLa and gas-phase holdup, both of which increase with scale (Stocks 2013). Since 
kLa values are up to 5-fold higher at larger scales, so too can OTRs be expected to be higher and 
therefore overall reaction rates are vastly improved from smaller-scales if oxygen mass transfer 
has been found to be limiting. Therefore, it is expected that method accuracy should improve with 
scale due to more oxygen being consumed in reaction. The online method could also prove 
advantageous in large-scale applications for monitoring and control of (bio)oxidation reactions 
where manual sampling of the reactor could be challenging due to e.g. overpressure, sterility, 
heterogeneity, safety, manpower or analytics. However, larger gas holdups expected at industrial 
scales might also affect the dynamic sensitivity of the method (i.e. the ability to detect sudden 
changes). Because of the reliance of the method on a net difference in molar oxygen in the gas-
phase, it is also doubtful that this method will be as accurate at space-time yields lower than those 
encountered in this study (< 1 g L-1 h-1), which might be prevalent at smaller scales. 
If a reactor overpressure or increased temperature is required, deviations from standard 
conditions (1 atm, 25 °C) will be seen. Such effects from these cases could be accounted for by 
adjusting the assumptions behind calculating molar quantities using volumetric flow 
measurements and the ideal gas law (see Section 5.1.2 for more details). 
The online methodology followed in this work could potentially be automated to a degree 
by generating an appropriate software; doing so would enable an increased throughput for 
experiments. 
With respect to the generality of the method, only the oxygen consumption/liberation 
from a net reaction is measured and not from individual half-reactions as is the case of (oxygen) 
uncoupling from product formation (e.g. with P450 monooxygenases) or when multiple reaction 
products are formed. Therefore, the black box approach to estimating kinetics from oxygen mass 
balances will make it difficult to distinguish uncoupling or to follow enantioselective reactions. In 
such instances, direct substrate/product analyses would remain the benchmark for performing 
kinetic characterisations. However, this method should find useful application with systems 
involving challenging substrates where liquid-phase sampling is made impractical (e.g. 
heterogeneous reactions or enzyme-catalysed surface modifications of solids (Fischer-Colbrie et 
al. 2006)) as exemplified with the BVMO case described in the previous section. 
5.1.5. Conclusions 
This study proves that the method of gas-phase oxygen mass balance is able to adequately predict 
bio-oxidation kinetics. In order to apply the method, an operating window of space-time yields 
under which it may be applied must be established. In this study, this window was found to be 
between 1-15 g L-1 h-1, which was inherently linked to the oxygen transfer capabilities of the lab-
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scale apparatus used in this study. Therefore, the generic concept of using oxygen mass balance 
to determine kinetics holds, and this could find application in the studies of heterogeneous 
reactions, as well as for industrial measurement and control of oxidation processes. 
5.2. Part II: A substitute activity assay method independent of 
spectrophotometric measurements 
The Michaelis-Menten kinetics for the oxidation of cyclopentadecanone by CDMO was 
determined using a standard spectrophotometric assay (Figure 5.8). Vmax was found to be 
2.56 U mLCFE-1 and Km was found to be 24 μM. Therefore, at a substrate saturation of 113 ± 21 μM 
(Meissner et al. 2018) the reaction should always proceed at Vmax. 
 
Figure 5.8. Enzyme activity as a function of substrate concentration. 
The Michaelis-Menten kinetic prediction is represented by the dotted 
line. Assays were determined spectrophotometrically by the 
consumption of NADPH causing an absorbance decrease at 340 nm. 
Reactions were carried out at 30 °C in 1 mL cuvettes with 50 mM Bis-
Tris-propane buffer at pH 9.0, 0.3 mM NADPH, and 5% (v/v) CDMO 
CFE. Substrate was dissolved in 5% (v/v) n-propanol as co-solvent. 
However, considerable variance was encountered whilst assessing the activity of CDMO using this 
conventional spectrophotometric assay (Figure 5.8). This could be due to insoluble substrate 
particles or background protein activity from the cell-free extract interfering with the 
spectrophotometric measurement. Therefore, an alternative activity assay was devised making 
use of direct substrate and product analyses by GC following solvent extraction by ethyl acetate 
from sacrificial reaction samples of 1 mL. This method presented more accurate activity 
measurements, especially under dilute conditions ([S] < 250 μM). It is also important to note that 
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no activity was measurable without the addition of co-solvent. An example of one such activity 
measurement performed under dilute conditions over a period of one hour is shown in Figure 
5.9. Importantly, the rate of substrate consumption and product formation are equivalent over 
the first half the experiment indicating that the mass balance in measurement closes. The 
apparent decreased product formation rate thereafter could potentially be due to product 
degradation at pH 7.5 through lactone ring hydrolysis. The exact methods and analytical 
protocols as well as the application of this method to evaluate enzyme stability are detailed 
further in Chapter 6. 
 
Figure 5.9. Cyclopentadecanone consumption, cyclopentadecanolide 
formation and product yield as a function of reaction time. Measurements 
made by GC analyses of an extract from a sacrificial reaction sample (1 mL). 
Reactions carried out at 28 °C in 50 mM Tris/HCl buffer pH 7.5, 0.3 mM 
NADPH, 0.1% (v/v) CDMO CFE, and 0.25 mM substrate dissolved in n-
propanol (5% (v/v)) as well as 25 U mL-1 glucose dehydrogenase and 0.5 M 
glucose for cofactor regeneration. Error bars reflect 95CI (n = 3). 
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Chapter 6. Case Study II – Part B: Reaction scoping for the oxidation 
of macrocyclic ketones catalysed by cyclododecanone 
monooxygenase (CDMO) 
In this chapter, the analytical methods described in Chapter 5 were applied to assess the 
multiphasic Baeyer-Villiger oxidation of macrocyclic ketones to lactones catalysed by 
cyclododecanone monooxygenase (CDMO). First, enzyme-catalysed Baeyer-Villiger oxidations 
and the means to address poorly water-soluble solid substrates are briefly reviewed. 
Experimental evaluations followed to study the effect of different types of co-solvents on the 
activity as well as stability of CDMO. Based on this, an ideal co-solvent was selected and an optimal 
temperature and co-solvent fraction was determined using a Design of Experiments approach by 
making use of time-course reaction profiles (measured using the online oxygen mass balance 
analytical method detailed in Chapter 5). Finally, the primary process limitation was assessed 
using the methodology detailed in Chapter 2 and the route for further process development 
discussed after benchmarking with the metric targets from Chapter 3. 
 
The structure of the chapter follows that of a manuscript as it is ultimately intended for publication. 
As such there is some repetition with the previous chapter. Although minimal, it allows the chapter to 
stand-alone as a potential publication. 
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6.1. Introduction 
Oxidations in the chemical industry are a particularly challenging class of reactions that are 
limited by the necessary use of harmful oxidants, unwanted side reactions, and poor selectivity 
(Kroutil et al. 2004; Faber 2011; Turner 2011). Oxygen-dependent biocatalysts offer solutions to 
many of these limitations, and come in many varieties each offering their own specialised 
activities: oxidases, mono- and dioxygenases, dehydrogenases, and peroxidases, to name a few 
(Hollmann et al. 2011). The most important traits of oxygen-dependent enzymes towards 
synthetic application lie in their facility to use molecular oxygen and their outstanding selectivity. 
Baeyer-Villiger monooxygenases (BVMOs) are oxidoreductases that act on their substrate 
and are bound with a co-factor, which is usually a flavin moiety (Mascotti et al. 2015; Romero et 
al. 2018). Whilst Baeyer-Villiger oxidation has been understood for over a century, their 
successful implementation to date has been moderate (ten Brink et al. 2004; Sutton et al. 2012). 
Enzymatic Baeyer-Villiger oxidation was first recognized and reported in 1948, in the biocatalytic 
degradation of steroids (Turfitt 1948). Following this, subsequent studies showed that Baeyer-
Villiger oxidations facilitated by BVMOs are abundant in fungi and other prokaryotic organisms, 
as reported by Fried and co-workers and Peterson and co-workers in 1953 (Fried et al. 1953; 
Peterson et al. 1953). Over the years, several BVMOs have been made available in recombinant 
forms, which greatly increased the diversity of substrates upon which BVMOs can act through 
protein engineering. Furthermore, recombinant DNA technology has allowed the expression of 
BVMOs in benign host organisms which has enhanced their potential for industrial application. 
BVMOs catalyse the transformation of three major types of substrates: cyclic ketones, aryl 
ketones and linear ketones (Iwaki et al. 2002; Kamerbeek et al. 2003; Kyte et al. 2004; Mihovilovic 
et al. 2005a; Rehdorf et al. 2007) to their respective lactones. Extensive reviews of Baeyer-Villiger 
oxidations using several types and forms of BVMOs along with their applications in synthetic 
chemistry have been published by Mihovilovic and co-workers (2005b) as well as Alphand and 
Wohlgemuth (2010). 
Lactones are an interesting product class and derive from either the oxidation of cyclic 
ketones (Walton and Stewart 2002; Mihovilovic et al. 2002; Carboni-Oerlemans et al. 2006; Rioz-
Martínez et al. 2009; Kotlewska et al. 2011; Fink et al. 2013; Kara et al. 2013) or the esterification 
of hydroxy acids (Antczak et al. 1991; Sharma and Chattopadhyay 1999; Efe et al. 2008; Götz et 
al. 2013). They find numerous applications as, sometimes specialty, monomers for polymer 
synthesis (Knani et al. 1993; Moore et al. 2005; Lange et al. 2007; Kobayashi 2009; Heise and 
Palmans 2010), intermediates in flavour and fragrance synthesis (Serra et al. 2005; Fink et al. 
2011), benign solvents (Alonso et al. 2013)  or even as fuel additives (Horváth et al. 2008; Bond 
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et al. 2010). Therefore, lactones in these target markets can be classified as low- to medium-value 
products. 
Despite their unique chemistry, BVMOs have only found application in one large-scale 
process (Alphand et al. 2003), where even gram-scale preparative reports are rare (Schulz et al. 
2005). This process makes use of recombinant whole-cell Escherichia coli expressing 
cyclohexanone monooxygenase from Acinetobacter calcoaceticus (Doig et al. 2001) to oxidise the 
model substrate (–)-(1S,5R)-bicyclo[3.2.0]hetp-2-en-6-one to an asymmetric pair of lactones. The 
bottleneck of this process was the inhibitory and/or toxic nature of both substrate and products 
on the whole-cell biocatalyst (Kim et al. 2007). Overcoming substrate inhibition was attempted 
by making use of a substrate feeding strategy, although the problem of product inhibition 
remained (Doig et al. 2002). A better approach was to make use of an adsorbent resin that could 
facilitate in situ substrate supply (ISSS) and in situ product removal (ISPR) simultaneously, aptly 
named as an in situ substrate feeding and product removal (SFPR) strategy (Hilker et al. 2004a,b). 
In this case, the product has a stronger partition to the resin allowing substrate to be released 
into the reaction medium and, at the same time, to maintain product under inhibitory 
concentration limits. The high oxygen demand of both oxidation and whole-cell metabolism as 
well as resin and whole-cell viability were satisfied using a 1-litre bubble column with a sintered 
glass sparger (Hilker et al. 2006). Eventually, 20-25 g of combined product was isolated from the 
resin after a reaction window of about 20 h leading to a space-time yield of 1.2 g L-1 h-1. This 
corresponds to a reaction yield of up to 80% with each lactone exhibiting excellent enantiomeric 
excess (ee > 99%) (Hilker et al. 2005; Hilker et al. 2008).  
To date, most reported Baeyer-Villiger oxidations of cyclic ketones have pertained to five 
or six membered ring ketones with little focus towards macrocyclic ketones (Iwaki et al. 2006; 
Fürst et al. 2017; Delgove et al. 2018b). A limitation in the enzymatic oxidation of macrocyclic 
ketones is their poor solubility in an aqueous reaction medium. Macrocyclic ketones, being highly 
hydrophobic, are therefore not as readily available for enzymatic reactions as compared to 
smaller ring size ketones and other more water-soluble substrates (Delgove et al. 2018a). 
Unlocking this branch of oxidations using biocatalysis would therefore require a successful 
solution in dealing with the low substrate capacity for these reactions (Schmid et al. 2001). 
Furthermore, industrially-relevant substrate/product loadings of more than 50 g L-1 would in 
many cases also lead to a heterogeneous reaction mixture as well as potential substrate and/or 
product inhibition (Lu et al. 2004; Süss et al. 2014; Reimer et al. 2017; Sheldon 2017). A low 
substrate solubility can result in a poor driving force for diffusive mass transfer, which can 
hamper the productivity (or rate) or such processes. Hence, achieving productivity targets in such 
cases frequently requires an additional agent to aid in solubilising the substrate. A common 
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means to achieve enhanced substrate miscibility in an aqueous reaction mixture is to use organic 
co-solvents. 
There are a few considerations which should be properly investigated before choosing a 
co-solvent for a biocatalytic reaction. The presence of a specific solvent may have an effect on an 
enzyme’s molecular structure, which could have implications towards its activity or stability 
during reaction. The relative activity of most enzymes is highest when placed in aqueous 
environments because extensive hydrogen bonding and dipolar interactions with the polypeptide 
chains of the enzyme drastically decrease their conformational mobility, thereby stabilising the 
enzyme (Stepankova et al. 2013). Hence, altering the environment surrounding the enzyme by 
introducing co-solvents may expedite enzyme denaturation or alter the active site of an enzyme 
(Owusu and Cowan 1989; Iyer and Ananthanarayan 2008). 
Additionally, the ability of different solvents to improve substrate solubility should also 
be considered. This is a cumulative function of several properties of the solvent in question, such 
as: dielectric constant, hydrogen bonding, polarity index, hydrophobicity, inertness towards the 
substrate and product and the partition coefficient (PO/W). The natural logarithm of the partition 
coefficient (Log PO/W) is a measure of the hydrophobicity or hydrophilicity of a solvent. Laane and 
co-workers (1987) was one of the first to analyse the relationship between the activity of lipase 
towards catalysing the transesterification of tributyrin and heptanol and the Log PO/W constants 
of different solvents used in the transformation. A sigmoidal function was found, and it has been 
concluded that for very low values of Log PO/W < 1 (corresponding to highly water-miscible 
solvents), biocatalytic activity was low or insignificant. Organic co-solvents with Log PO/W less 
than 2 caused distortion of the geometry of water molecules at the enzyme surface, which led to 
inactivation and a lower activity of lipase. For Log PO/W values between 2 and 4, the activity can 
be variable depending on the solvent, while for Log PO/W greater than 4 (corresponding to water-
immiscible solvents), the biocatalyst showed high and constant activity. Choosing a solvent 
having higher Log PO/W values (greater than 3), typically leads to a biphasic system consisting of 
an organic solvent phase and an aqueous phase containing the enzyme. Whilst the enzyme 
present in the aqueous phase may be unaffected, if the substrate is also hydrophobic with high 
Log PO/W, it will partition preferentially into the organic fraction. The formation of a biphasic 
system may therefore introduce substrate mass transfer limitations and interfacial adsorption of 
an enzyme protein (Straathof 2003). This may not be prevalent in cases with lipases because they 
have the unique ability to work at organic-aqueous interfaces. A co-solvent which provides a 
balance between the loss of enzyme activity or stability and increased substrate solubility should 
therefore be selected to maximize the productivity or rate of biocatalysis. 
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However, when substrate or product inhibition limits the rate of biocatalytic reaction, the 
purposeful addition of a second liquid phase (by means of organic solvent) can also be an 
important in situ substrate supply (ISSS) and in situ product removal (ISPR) technique (Freeman 
et al. 1993; Woodley et al. 2008). Inhibition is mitigated through substrate/product partitioning 
into the organic phase, avoiding accumulation in the aqueous reaction phase, and thereby 
enhancing productivity. The same effect may also be achieved using solid phase 
adsorbents/absorbents, which can be more benign towards enzyme structures than organic co-
solvents (Guo et al. 2010; Schmölzer et al. 2012; Hilker et al. 2004a). 
Alternative routes of utilising poorly water-soluble substrates in biocatalytic reactions 
have focused on the development and application of supercritical carbon dioxide and ionic liquids 
(van Rantwijk and Sheldon 2007; Jessop 2011; Claus et al. 2018). 
Apart from using co-solvents, surface active agents such as surfactants may also aid 
substrate mass transfer through the formation of micro-emulsions and micellar structures. These 
emulsions feature vastly higher interfacial areas than traditional two-liquid phase reaction 
media. 
The aim of this study was to demonstrate a BVMO-based process oxidising the poorly 
water-soluble bulky cyclic ketone, cyclopentadecanone, to its corresponding lactone. The final 
process was successfully scaled-up to 100 L with similar productivities not reported since the 
first reported large-scale BVMO-based process (Alphand et al. 2003; Hilker et al. 2008). To this 
end, cyclododecanone monooxygenase (CDMO; EC 1.14.13.x) from Rhodococcus ruber SC1 was 
selected for its activity towards larger-ring size cyclic ketones and stability (Schumacher and 
Fakoussa 1999; Kostichka et al. 2001). Reduced nicotinamide adenine dinucleotide phosphate 
(NADPH) cofactor was recycled using glucose dehydrogenase (GDH; EC 1.1.1.47) by converting 
the co-substrate, D-glucose, to D-glucono-1,5-lactone. D-Glucono-1,5-lactone then spontaneously 
hydrolysed to gluconic acid in the presence of water. The overall reaction is shown in Scheme 6.1. 
 
Scheme 6.1. BVMO-catalysed oxidation of poorly water-soluble cyclopentadecanone (1) to 
cyclopentadecanolide (2) by CDMO from Rhodococcus ruber SC1. NADPH cofactor was recycled using 
GDH, which converts glucose to glucono-1,5-lactone (thereafter spontaneously hydrolysing to 
gluconic acid). 
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First, the substrate and product physical properties in an aqueous medium were studied. A 
crystallisation experiment was performed to verify if similarly hydrophobic product would 
crystallise after formation on the surface of substrate particles, which could potentially further 
hinder substrate mass transfer. 
Following this, four solvents were selected for their potential to help improve substrate 
solubility. Ranging in water-miscibility (Log PO/W), their influence during an activity assay was 
established. The activity assay was based on sacrificial sampling and total extraction of 1 mL 
aliquots for analysis by gas chromatography (GC). This was done to ensure accuracy when dealing 
with the poorly water-soluble compounds that otherwise caused disturbances in a standard 
spectrophotometric assay. 
The stability of CDMO towards these co-solvents was then evaluated by exposing the 
enzyme to each solvent over a period of 12 h (assumed to be a reasonable window of operation 
for a batch process). Relative activity was measured every 4 h with reference to the enzyme’s 
initial activity by using the sacrificial sampling activity assay. Additionally, CDMO stability 
towards gas-liquid interfaces as well as oxygen in solution were measured by sparging an enzyme 
stock solution with nitrogen gas and synthetic air, respectively. 
Showing a robustness towards solvents even at high concentrations, CDMO was then 
tested under trial process conditions. A method employing oxygen mass balances in the gas-phase 
of a reactor was previously demonstrated and validated in order to overcome sampling 
challenges brought about by heterogeneity caused by poorly water-soluble substrates (Meissner 
et al. 2018). This method was used to follow reaction time-course progressions, and the end-point 
conversion measured by GC analysis. A full factorial experimental design with mid-point 
replicates was used to find operating optima for co-solvent fraction in the medium and reaction 
temperature. Also, the influence of stabilisers, shown to have a beneficial effect by Goncalves and 
co-workers (2017), was tested during reaction. 
At this stage the process performance was ready to be benchmarked at lab-scale in order 
to identify the major bottleneck towards reaction kinetics. The utility of the methodology detailed 
in Chapter 2 was assessed and used to identify and confirm that substrate mass transfer was in 
fact limiting. In light of this, future outlooks on process development are discussed. 
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6.2. Materials and Methods 
Reagents 
All reagents were of analytical grade and supplied by Sigma-Aldrich. CDMO from Rhodococcus 
ruber SC1 (EC 1.14.13.x) was supplied in the form of cell-free extract by Innosyn BV (Geleen, The 
Netherlands; specific protein content or BVMO activity not available). GDH (EC 1.1.1.47) for 
NADPH regeneration was supplied as lyophilised GDH280 powder by evoxx technologies GmbH 
(Monheim am Rhein, Germany). 
Sacrificial sampling activity assays 
A bulk reaction mixture for activity assays was prepared in a 25 mL volumetric flask and 
comprised of: Tris/HCl buffer at pH 7.5 (50 mM), D-glucose (2.5 mM in buffer) and GDH for 
cofactor regeneration (25 U mL-1), NADPH (0.15 mM in buffer), cyclopentadecanone (0.25 mM) 
in 5% (v/v) n-propanol (unless otherwise stated), and CDMO cell-free extract. 1 mL aliquots of 
this mixture was then pipetted into separate 15 mL test tubes and placed into an orbital shaker 
at 30 °C and 150 rpm. The large headspace and shaking ensured oxygen transfer by diffusion was 
enhanced to not become limiting in activity measurements. Enzyme was dosed such that the full 
time-course of reactions would last for at least 45 min to allow enough time between sampling 
for stopping the reaction by extraction. At 5 min intervals individual samples were taken by 
extracting the full contents of a test tube in a 1:1 volume of ethyl acetate containing internal 
standard. Substrate and product concentrations in the organic fraction were then analysed by GC. 
Specific activity was calculated from the linear portion of substrate depletion data. 
Small-scale batch reaction conditions 
Lab-scale experiments were performed in a sealed 250 mL MiniBio stirred tank reactor from 
Applikon Biotechnology (Delft, The Netherlands). The reaction medium, which had a working 
volume of 150 mL, comprised of: D-glucose (200 mM) and GDH (25 U mL-1) for cofactor 
regeneration, NADP+ (0.5-2.5 mM), potassium phosphate buffer at pH 7.5 (100 mM), 
cyclopentadecanone substrate (50-100 mM) dissolved in methanol (5-20% (v/v)), and finally 
CDMO cell-free extract (5% (v/v)) to initiate the reaction. Experiments to assess the influence of 
stabilising agents also included flavin adenine dinucleotide (FAD; 0.1 mM), catalase (150 U mL-1) 
and superoxide dismutase (20 U mL-1) at optimal doses found by Goncalves and co-workers 
(2017). pH control was maintained by the titration of NaOH (6 M) and reaction temperature 
controlled with a heating jacket. The stirring speed was set to 1000 rpm, which corresponded to 
a power input of 1.5 kW m-3, and oxygen supply was achieved by sparging the medium with air at 
1.0 volumes per reactor volume per minute (vvm). Reaction kinetics were calculated through gas-
phase mass balance (Meissner et al. 2018). The volumetric flow rate of gas leaving the reactor 
was measured using a Smart-Trak 50 Series digital mass flow meter (Sierra Instruments, Inc., 
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Monterey CA, USA) and oxygen fraction with a BlueInOne CO2/O2 gas analyser (BlueSens GmbH, 
Herten, Germany). The off-gas was dried before measurement by being passed through a 
condenser and sequential drying tube filled with silica drying beads. 
Design of Experiments (DoE) 
Models for the full-factorial experimental design were developed in MATLAB Release 2016b 
using the Interactive response surface modelling toolbox “rstool”, The Mathworks, Inc. (Natwick 
MA, USA). 
GC analysis 
End-point analyses of substrate and product concentrations (conversions) in reaction media 
were made by a Clarus 500 GC-FID (PerkinElmer) equipped with an Elite-5 column (PerkinElmer) 
following solvent extraction with 1:1 (v/v) of ethyl acetate containing naphthalene (1.5 g L-1) as 
internal standard. The detailed procedure and temperature profile is outlined by Meissner and 
co-workers (2018). 
6.3. Results and Discussion 
6.3.1. Substrate and product physical properties 
Understanding the substrate and product physical properties in water was an important step in 
realising their use in a biocatalytic reaction. Substrate and product solubility in water was 
determined to be, 25.4 ± 4.7 and 24.2 ± 5.7 mg L-1 (mean ± SD, n = 3), respectively (Meissner et al. 
2018). 
Being very poorly soluble in water, product would precipitate from solution upon 
formation. It was plausible that because the substrate and product were of similar molecular 
structure and physical properties, crystallisation of product may occur on the surface of substrate 
particles in solution. This newly formed product layer could then prevent substrate from diffusing 
into solution, and mass transfer would be limited or even eventually prevented. To confirm 
whether or not this phenomenon was taking place, product was supersaturated in water at high 
temperature (60 °C). The solution was then slowly cooled to 4 °C forcing the product to 
precipitate out of solution. At the same time, a substrate particle was added to the water to act as 
a seed crystal. It was observed, and further confirmed by GC, that completely separate product 
formation occurred even in the presence of substrate particles (Figure 6.1). Therefore, substrate 
mass transfer would not be limited by product formation during reaction. 
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Figure 6.1. Photograph of separate crystals 
formed from crystallising product 
(highlighted in blue) in the presence of an 
externally added substrate crystal (circled in 
red). 
6.3.2. Effect of co-solvents on activity 
When assessing the activity of CDMO towards cyclopentadecanone, considerable variance was 
found when performing a conventional assay relying on the absorbance decrease of NADPH at 
340 nm. This could be due to insoluble substrate particles or background protein activity from 
the cell-free extract interfering with the spectrophotometric measurement. To avoid this 
possibility, direct substrate and product analyses by GC following solvent extraction by ethyl 
acetate from sacrificial reaction samples of 1 mL was employed. This method generated more 
accurate activity measurements, especially under dilute conditions ([S] < 250 μM) and is 
described in more detail in Chapter 5. It is also important to note that no activity was measurable 
without the addition of co-solvent. 
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Four co-solvents were selected to solubilise cyclopentadecanone and ranged in Log PO/W 
such that this effect may be observable on the activity of CDMO (Figure 6.2). These four solvents 
were also selected due to their availability in chemical processing as conventional solvents. The 
volume fraction of co-solvent was kept to 5% (v/v) such that all substrate could be solubilised, 
however deleterious effects of co-solvent on e.g. enzyme stability would be limited (although this 
was later quantified). The co-solvents were as follows: cyclohexane (Log PO/W = 3.2), methanol  
(Log PO/W = -0.76), n-propanol (Log PO/W = 0.28), and acetonitrile (Log PO/W = -0.33). These 
solvents are common in industrial processing and vary in water solubility as well as reported 
enzyme compatibility. 
 
Figure 6.2. Substrate (cyclopentadecanone) concentration 
profiles during sacrificial sampling activity assays solubilised in 
5% (v/v) cyclohexane (squares), methanol (triangles),  
n-propanol (diamonds), and acetonitrile (circles). Dotted lines 
indicate the linear portion of activity taken to be initial rates. 
Clearly, the substrate partitions too strongly into an organic phase consisting of water-immiscible 
solvent, such as cyclohexane, to permit enzymatic activity under these dilute conditions. Instead, 
either the substrate loading in the organic-phase needs to be vastly increased, or water-miscible 
solvents with lower Log PO/W are more appropriate for solubilising substrate. However, this could 
come at the trade-off of enzymatic stability over longer periods of time. Therefore, this was 
investigated in the following section. 
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6.3.3. Effect of temperature, co-solvents, gas-liquid interfaces and oxygen on 
stability 
The stability of CDMO was assessed by exposing a stock solution of enzyme to an environmental 
stress, which would be encountered during reaction at process-scale. To isolate these effects, only 
one factor was changed at a time to allow the independent study of stability. In each circumstance 
a negative control was also performed, which simply involved leaving the enzyme stock solution 
at room temperature without any other medium enhancement. Because most industrial batch 
processes are running in a window of 12 h or less (one working day), stability was only assessed 
over this period. Stability was measured by the loss in enzymatic activity from beginning to end 
by relative activity, periodically every 4 h. 
First, the effect of temperature on CDMO was studied because at higher temperatures 
reaction rates could be elevated and mass transfer improved, however this may come at the 
expense of enzyme stability. Indeed, the relative activity of CDMO at 40 °C showed an increase to 
129% above that observed at 30 °C. However, all activity was lost after 4 h at 40 °C, whilst the 
relative activity of enzyme kept at 30 °C remained stable over the full time-course of an 
experiment (data not shown). 
The effect of co-solvents at high concentration (20% (v/v)) was then studied (Figure 6.3). 
As expected, the solvent with the highest Log PO/W, cyclohexane, was favourable towards the 
enzyme. However, it was previously shown to limit substrate availability due to its own water-
immiscibility, and was therefore not considered appropriate for process applications. 
Interestingly, CDMO showed good stability in the presence of most of the other lower Log PO/W 
solvents as well. No measurable activity was seen when the enzyme was exposed to acetonitrile 
at 20% (v/v), rather denatured protein precipitates were observed. n-Propanol caused a loss of 
approximately 60% activity after 12 h, whilst methanol had no effect on activity loss. This result 
demonstrates not only the robustness of CDMO towards organic solvents, but also that 
conventional understanding regarding the relation between Log PO/W and enzyme stability may 
not always apply. Instead, enzyme tolerance towards different solvents should always be tested 
on a case-by-case basis. 
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Figure 6.3. CDMO stability as a function of exposure to 20% (v/v) 
co-solvents. Solid bars = negative control; diagonal striped bars 
= methanol; horizontal striped bars = cyclohexane; opaque bars 
= n-propanol. Enzyme exposed to acetonitrile showed no 
activity throughout. Error bars reflect 95CI (n = 3). 
Oxygen supply is conventionally achieved by sparging and dispersing gas bubbles into the liquid 
medium in large-scale processes. In some instances, the presence of gas-liquid interfaces has been 
shown to have a destabilising effect on enzymes (Ganesh et al. 2000; Patil et al. 2000; Bommarius 
and Karau 2005; Bhagia et al. 2018). In others, stability is further compromised due to dissolved 
oxygen or peroxide in solution oxidising sensitive amino acids in the structure of an enzyme (e.g. 
cysteine residues) and causing inactivation (Stauffer and Etson 1969; Scott Willett and Copley 
1996; Slavica et al. 2005). Naturally these effects should always be studied on all oxygen-
dependent enzymes to ensure their process viability. A negligible deactivating effect of gas-liquid 
interfaces on CDMO was observed when sparging a stock solution with nitrogen gas (Figure 6.4). 
However, oxygen concentration appeared to have a deleterious effect on enzyme activity wherein 
approximately 50% residual activity remained after 12 h. If it were possible to identify and 
remove non-critical, oxygen sensitive amino acids in the structure of CDMO by protein 
engineering, an improved stability towards aeration may be realised. 
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Figure 6.4. CDMO stability as a function of gas-liquid interfaces 
(bubbling with N2 gas; diagonal striped bars) and oxygen 
concentration (bubbling with air; horizontal striped bars). Solid 
bars reflect the negative control. Error bars reflect 95CI (n = 3). 
6.3.4. Scoping initial reaction conditions 
Now that the effects of stability were better understood, the reaction could be worked up to a lab-
scale reactor to allow the collection of time-course process performance data as well as better 
temperature, pH and dissolved oxygen control. 
Methanol at high concentration (20% (v/v)) showed no deleterious effect on enzyme 
performance and whilst elevated temperatures of 40 °C prevented enzyme activity after 4 h, it 
remained to be seen if instead there was some optima towards process performance at a lower 
methanol concentration or temperature between 30-40 °C. To investigate this window, a full-
factorial experimental design approach was employed (Box et al. 2005). The design of 
experiments (DoE) relied on gathering process performance data at the boundary conditions to 
build a model, which was thereafter validated using three replicates at the mid-point of these 
experimental conditions (Table 6.1). Process performance was gauged on the final product 
concentration and conversion, which were derived from full time-course progression 
experiments with 50 mM substrate and 5% (v/v) CDMO cell-free extract. This resulted in 
experimental windows of up to 12 h, which allowed the effects of enzyme stability under these 
different process conditions to surface. Product formation over time was measured and predicted 
using oxygen mass balances in the gas-phase of the reactor (Meissner et al. 2018), and final 
conversions were confirmed using GC analysis. Higher concentrations of substrate hindered the 
stirring capabilities of the small-scale apparatus due to the increased presence of solid particles 
in the medium. 
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Table 6.1. Design of Experiments (DoE) for testing CDMO 
performance towards methanol co-solvent fraction and 
reaction temperature. ‘+’ and ‘-’ refer to boundary conditions 
and ‘Zero’ conditions refer to mid-point replicates. 
Variable 
Name 
Property ‘+’ ‘-’ Zero 
X1 Methanol fraction [% (v/v)] 20 5 12.5 
X2 Temperature [°C] 40 30 35 
 
The resulting model was found to be valid at the 95% confidence interval because experimental 
error collected at the mid-point of the DoE overlapped model prediction variance. The 
experimental results are shown in Table 6.2 and the model output predictions in Figure 6.5. The 
results simply confirm that process performance is only achieved at low temperature (30 °C) and 
high methanol fraction in the medium (20% (v/v)), and not at some local maxima in between. 
Under these conditions, the highest overall product concentration and conversion was observed 
in both experiments and by model prediction. 
Table 6.2. Experimental results for DoE. 
Variable 
X1 
Variable 
X2 
Product 
Concentration [g L-1] 
Conversion 
[%] 
- - 13.3 45.7 
+ - 13.4 92.6 
- + 6.60 62.0 
+ + 2.37 9.58 
Zero Zero 10.2 87.6 
Zero Zero 12.0 90.6 
Zero Zero 7.03 90.2 
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Figure 6.5. DoE model output for final product concentration (left) as well as 
conversion (right) as a function of temperature and co-solvent (methanol) 
fraction. 
Additionally, a simple experiment to test the influence of stabilising agents, which had been 
reported to have a beneficial effect on BVMO stability (Goncalves et al. 2017), was performed. 
These stabilisers included superoxide dismutase and catalase for dealing with residual oxygen 
radicals and hydrogen peroxide as well as an excess of cofactors: 0.1 mM flavin adenine 
dinucleotide (FAD) and 2.5 mM NADPH. Most important of these was the large NADPH 
requirement since this would be significantly expensive at large-scales. Two experiments were 
performed: one including all the stabilisers, and one without and at a much lower concentration 
NADPH (0.5 mM; Figure 6.6). The overlay of conversion profiles for each instance revealed that 
there was no observable difference from experimental variance in process performance to be 
gained by adding stabilisers. This may result from a number of reasons, however the most 
prominent of these is that CDMO itself is already a very robust enzyme (as shown by its resistance 
to large fractions of water-miscible polar co-solvents). Furthermore, the original benefit of adding 
stabilisers might be more pronounced when dealing with purified BVMOs and not cell-free 
extracts. This is because cell-free extracts may already contain a number of similar active proteins 
and cofactors that help in stabilising the BVMO. Therefore, it is important that the formulation of 
biocatalyst is considered during stability studies, especially when purified enzymes are involved. 
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Figure 6.6. Conversion profile of 5% (v/v) CDMO converting 
50 mM cyclopentadecanone in 20% (v/v) methanol with 
stabilising agents (including 2.5 mM NADPH; green) and without 
(0.5 mM NADPH; blue). 
6.3.5. Bottleneck identification 
With this characterisation work forming a basis of understanding for how best to handle CDMO 
and poorly water-soluble cyclopentadecanone in reaction, the major process limitation, or 
bottleneck, for this reaction was elucidated. Time-course experiments are a powerful means to 
achieve this (Blackmond 2005; Blackmond 2015). Chapter 2 presents a methodology with which 
the bottleneck towards process implementation may be identified. A reference experiment is 
compared with another wherein the catalyst concentration is doubled (Figure 6.7a). If the 
reaction rate also doubles, then there is no kinetic limitation. This can be seen graphically as an 
overlay of the two data sets in a Selwyn plot (1965). 
 
Figure 6.7. (a) Time-course conversion profiles of CDMO converting 50 mM 
cyclopentadecanone in 20% (v/v) methanol (left). (b) Selwyn plot of the same 
data sets (right). The reference experiment contained a catalyst loading of 
5% (v/v) CDMO cell-free extract (blue) and the second experiment contained 
double the enzyme concentration (10% (v/v) CDMO cell-free extract; green). 
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The two data sets do not overlap in a Selwyn plot (Figure 6.7b). Furthermore, doubling the 
catalyst loading did nothing to improve the rate of reaction. These phenomena confirm substrate 
mass transfer as the limiting bottleneck for kinetics. This could either point towards 
cyclopentadecanone mass transfer or oxygen transfer as being limiting. 
Oxygen mass transfer is strongly dependent on the physical apparatus used for reaction 
and can be influenced by power input, operating with pure oxygen instead of air, type of aeration, 
and even scale (Stocks 2013). It was hypothesised therefore that oxygen mass transfer was more 
likely to be the limiting factor at this small-scale because the power input was limited to reflect 
that of large-scale processes (approximately 1.5 kW m-3). The resulting effect was that the 
capacity for oxygen supply was reduced, and this could be reflected in the data. 
6.3.6. Final metrics, benchmarking and future outlook 
Eventually the substrate concentration was also doubled to 100 mM, although the reaction 
proceeded at the same rate owing to the bottleneck of oxygen supply at this scale. The final 
process metrics are given in Table 6.3. A lactone product could find application as a monomer for 
polymer synthesis, flavour and fragrance intermediate, benign solvent or fuel additive and is 
therefore classed as a low- to medium-value product. In this case the achieved process 
performance falls short in all metrics due to the demanding process requirements of low- to 
medium-value product classes. Converting approximately 4-fold more substrate to meet the 
target product concentration metric should not be too problematic due to the robust nature of 
the BVMO, however the rate of reaction was deficient by an order of magnitude. Space-time yield 
was found to be limited by the rate of oxygen transfer, which is especially critical for low-value 
products. The simplest strategy to improve oxygen transfer in this case would be to scale-up the 
reaction system. Indeed, the volumetric mass transfer coefficient (kLa) can also be improved by 
an order of magnitude through scale-up (Stocks 2013). The rate of oxygen transfer (and therefore 
reaction under oxygen limited circumstances) can therefore be improved approximately 5-fold 
due to mixing at scale (Noorman 2016). Other strategies for improving the rate of oxygen transfer 
could include using pure oxygen instead of air, operating the reactor under pressure, or 
alternative oxygen supply methods (such as membrane aeration). However considering the low-
value of the product, these alternatives might prove more costly and thus less appropriate. 
Nevertheless even after addressing the space-time yield and product concentration requirements 
in these ways, the biocatalyst yield will still be insufficient. The only option for improvement in 
this case would be to look at increasing the specific activity of the cell-free extract through either 
protein engineering or further optimising the expression of active CDMO contained within. 
Therefore, this case shows the value of benchmarking to direct future research efforts at an early-
stage in the development cycle. 
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Table 6.3. Benchmarking process performance metrics for the CDMO-catalysed oxidation of 
cyclopentadecanone. 
Process Metric 
Low-value Class 
Targets (5 € kg-1) 
Medium-value 
Class Targets 
(20 € kg-1) 
Actual Values 
Reaction conversion [%] (100) (100) 92.6 
Product concentration [g L-1] 100 50 22.3 
Space-time yield [g L-1 h-1] 20 10 1.58 
Specific productivity [g mLCFE-1 h-1] 1.0 – 4.6 0.3 – 1.1 0.03 
Biocatalyst yield [g mLCFE-1] 5 – 20 1 – 6 0.45 
 
The difference in potential success between this case and that of Chapter 4 is linked to the end-
product value class. Previously, ECS-PLE06 had relatively little trouble with reaching target 
process performance metrics for a high-value product (e.g. APIs), especially when an asymmetric 
reaction was involved. On the other hand, low- and medium-value products usually require more 
development effort as is showcased here. Perhaps the limited number of cases of BVMO 
implementation in industry is due to a lack of scope towards high-value products, which would 
otherwise balance the already challenging demands of a complex (e.g. gas-liquid-solid) oxidation 
reaction. 
6.4. Conclusions 
The enzyme-catalysed oxidation of macrocyclic ketones was only made possible through the 
application of a water-miscible solvent. Furthermore, CDMO presents a robust BVMO that is 
stable even in the presence of high solvent (methanol) concentrations. This case exemplifies the 
usefulness and necessity of alternative analytical techniques when trying to perform biocatalysis 
involving poorly water-soluble substrates. Such techniques were applied to characterise the 
reaction, and oxygen mass transfer was found to be the limiting bottleneck. Therefore, it is 
recommended that the most pragmatic way of furthering the process development of this 
reaction would be to increase the scale of reaction because OTRs are significantly improved at 
scale due to higher gas hold-ups. This was indeed observed in subsequent scale-up studies at a 
scale of 100 L. 
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Chapter 7. General discussion 
In hindsight of the work carried out in previous chapters, the following chapter is a general 
discussion of the most relevant considerations for the biocatalysis of poorly water-soluble 
substrates. The discussion starts with a suggested route of assessment for early-stage biocatalytic 
reactions. This protocol includes the order and types of experiments that, if followed, will 
elucidate a comprehensive understanding of the given reaction’s performance in a structured and 
efficient manner. The outcome of such a protocol may be used for: benchmarking with target 
process performance metrics (Chapter 3), conceiving the most feasible improvement strategies 
as well as subsequent process development and scale-up. Particularly relevant for poorly water-
soluble substrates is the influence of scale on reaction performance, which is reflected during 
reaction assessments performed within this protocol. Therefore, this is also discussed. Finally, 
the use of non-aqueous biocatalysis is presented as a means not only to nullify this influence of 
scale, but ultimately the other challenges of implementing poorly water-soluble substrates 
encountered in this thesis. 
7.1. A protocol for early-stage process conceptualisation 
Despite several hundred biocatalytic processes being implemented to date (and sometimes 
outperforming their more conventional chemocatalytic counterparts (Ma et al. 2010; Savile et al. 
2010)), the number of viable processes is disproportionate to the research effort that has been 
undertaken on improving biocatalysts across various fields, such as protein engineering 
(Strohmeier et al. 2011). Indeed, significant advances have led to well-established methods of 
engineering enzymes (Reetz 2011; Bommarius et al. 2011; Bornscheuer et al. 2012), however 
there are very few cases where these methods have been used to match enzymes for specific 
process applications. There is also often little focus on attaining an adequate expression of 
engineered enzymes, which has implications for achieving a necessary specific activity (and 
biocatalyst yield) of a biocatalyst formulation in a process setting. Further, a disconnect in process 
development often occurs in the early-stages, where standardised methods of evaluating a 
biocatalytic reaction are lacking and the envisaged process itself may be poorly understood 
(Tufvesson et al. 2013). For all these reasons it is therefore inevitable that the development of a 
biocatalytic reaction or biocatalyst is all too often carried out blindly without the final process in 
mind, leading to failure or irrelevance towards industrial implementation. 
The analyses carried out in the earlier case studies of this thesis (Chapters 4-6) were 
central to proposing a standardised protocol. Based on what was observed, established and learnt 
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in those case studies, a proposed flow for conceptualising this initial phase of reaction scoping 
was developed and is shown in Figure 7.1. 
 
Figure 7.1. Flow of early-stage biocatalytic process development. 
Creating a viable biocatalytic process from scratch requires a systematic development that should 
always hold industrial process performance targets as well as reaction targets (or synthesis 
route) at the forefront. Here, “scratch” means that a product of interest and a suitable enzyme 
candidate towards its synthesis have so far been identified. In such a scheme, the nature of both 
targets will ideally identify and feed process constraints to the next stage of reaction evaluation, 
and then proceed to influence each subsequent step in the process development cycle. The 
fundamental target that must first be decided is the precise synthesis reaction to be performed 
by an enzyme. While this sounds trivial, the reaction target needs to be decided through 
collaboration of retrosynthetic chemists for their expertise in organic pathway synthesis, 
molecular biologists for their expertise in known enzyme activities and potential for expanding 
substrate scopes, as well as chemical engineers. All should have the final product goal or 
subsequent synthesis steps towards that goal in mind. The intended product market will 
determine its value-class and therefore the necessary process performance to meet economically 
viable process margins (i.e. profit from a given process based on the values of product, substrate 
and reaction yield). One way of establishing the required process performance is to set additional 
targets for process metrics based on the product value-class (Chapter 3).  
The target process metrics give an indication of feasible enzyme doses, the required speed 
of reaction (intrinsic activity) and required product concentration from the reaction step. 
However, under these process constraints, some knowledge of the reaction must first be 
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established. Such an initial reaction characterisation should include investigating the substrate 
and product physical properties under reaction conditions (especially relevant for poorly water-
soluble substrates). This includes investigating potential substrate and product degradation 
under ranges of reaction conditions (e.g. pH, temperature, or presence of co-solvents) as well as 
the analytical procedures required to measure their component fractions during a reaction 
(Chapter 5). In addition, at this stage the enzyme’s tolerance to specific reaction conditions must 
also be assessed to establish pH and temperature optima. These optima need to strike a balance 
between enzyme activity, enzyme stability as well as substrate/product degradation (if 
applicable). The Michaelis-Menten kinetics of an enzyme in question should be assessed at this 
stage in order to understand the maximum possible activity and affinity towards the substrate 
(Ringborg and Woodley 2016). It is important that the formulation of this enzyme is also taken 
into account – a purified protein will exhibit different activities and stability than a cell-free 
extract or whole-cell preparation – because protein expression and isolation steps become 
relevant. The selection of this formulation should be based on economic viability, ease of use in 
an industrial process (e.g. long-term viability during storage at preferably room temperature), 
and suitability for required process performance. Lastly, the combination of all these factors 
should lead to an understanding of the reaction kinetics, where all these effects (e.g. enzyme 
stability, substrate mass transfer, enzyme kinetics, thermodynamics) are compounded. The final 
experimental output from this stage to be used in further reaction development is a standardised 
time-course conversion profile under realistic reaction conditions. 
The immediate goal of this early-stage development methodology is to identify a major 
limitation/bottleneck to process performance. A full reaction characterisation and/or 
optimisation is superfluous in terms of both time and experimental effort. Thus, in Chapter 2 a 
simple methodology relying on the graphical analysis of time-course progressions under different 
reaction conditions (enzyme and substrate loading) was described to demonstrate the 
identification of such a process bottleneck in an efficient and simple manner. The outcome 
suggests whether the reaction is limited by intrinsic activity (as is the case of zero-order reaction 
kinetics), enzyme stability, enzyme kinetics, or substrate mass transfer. The exact mechanism of 
enzyme stability or kinetic limitation (e.g. substrate affinity or substrate/product inhibition) can 
also be elucidated simultaneously. If substrate mass transfer is found to be limiting, it will 
dominate all other kinetic effects and reaction performance will be hindered unless resolved 
through reaction engineering (Chapter 1). Furthermore, Chapter 5 highlights some experimental 
challenges and their solutions when trying to scope heterogeneous reactions using this 
methodology. 
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If process performance falls short of the metric targets after benchmarking, the 
contributing bottleneck would have been identified following the methodology described in 
Chapter 2, and a directed improvement strategy formulated. The key implication of knowing 
which improvement strategy to choose is that the feasibility of implementation is also considered. 
As was mentioned in Chapter 1, improving an enzyme by protein engineering can have the 
highest return in terms of reaction performance (even in excess of 100-fold), however this comes 
at the greatest cost in terms of both time and research investment. Instead, if there is only need 
to improve the enzyme moderately, and the option exists, then improvement through reaction 
engineering may be more pragmatic for the whole process development chain. Regardless, having 
a specific target for improvement (e.g. kcat, KM, substrate mass transfer, inhibition) is invaluable 
at the earliest possible stage so that a more efficient process development and faster 
implementation can be realised. Shorter development times are essential if biocatalysis is to 
better secure its position as a viable technology in, most importantly, the pharmaceutical industry 
due to short patent lifetimes (Truppo 2017). If the improvement strategy appears to be 
unfeasible, then the targets for reaction (exact synthesis step) can be revised with the help of 
retrosynthesis and the early-stage development cycle restarted (Turner and O’Reilly 2013; de 
Souza et al. 2017). 
Following this protocol for conceptualising a biocatalytic reaction should instil confidence 
in eventual process implementation. Outside of this development cycle, Tufvesson et al. (2013) 
detailed systematic procedures for further improvements towards the fermentation step, 
biocatalyst, process and downstream. Here, there is more focus on physicochemical data and 
process models, which would otherwise be too detailed for the early-stage process development 
methodology presented here. Eventually, scale-up of the designed process should feature an 
adequately performing biocatalyst that is able to meet economic requirements. 
7.2. Influence of scale when evaluating heterogeneous reactions 
A factor to consider when evaluating biocatalytic reactions is that reaction performance at small-
scale often may not reflect that of the large-scale under the same conditions. This is important 
because early-stage conceptualisation and reaction characterisations will always begin at the 
smallest allowable scale to allow minimal use of materials. 
Often a major reason for such deviance across scales is due to substrate mass transfer. 
Enzymes as catalysts require at least some water to be present in their environment in order to 
be active (Adlercreutz 2008). Frequently organic substrates and products of synthetic interest 
are poorly soluble in an aqueous reaction medium (Meyer et al. 2013), which instigates mass 
transfer limitations – as is prevalent throughout this thesis. This limitation extends to gas-liquid 
7-5 
 
systems, such as important enzyme-catalysed oxidation reactions (Hollmann et al. 2011) due to 
the similarly poor water-solubility of oxygen. On the other hand, conventional catalysis is most 
often performed in homogeneous gas-phase reactors or organic solvents. Under these 
circumstances reaction scale-up is more dependent on adequate heat transfer and reactor design, 
which is less relevant for biocatalysis performed under mild conditions. Interestingly, the 
mechanism for scale-dependence of gas-liquid mass transfer and more conventional liquid-liquid 
mass transfer differs (Table 7.1). 
Table 7.1. Effect of scale on gas-liquid and liquid-liquid mass transfer. Arrows reflect 
improvement and hindrance for mass transfer. 
 Gas-Liquid Mass Transfer Liquid-Liquid Mass Transfer 
 Dispersion (i.e. 
bubble size) 
Hold-up* 
Dispersion (i.e. droplet 
size / coalescence)† 
Hold-up 
Small-scale ↑ ↓↓ ↑ N/A 
Large-scale ↓ ↑↑ ↓ N/A 
 
Mixing is a function of power input, which can vary significantly with scale (Noorman 2016). Put 
simply, it is easier to thoroughly mix a smaller volume to achieve good dispersion (high power 
input per unit volume) than it is to mix a large volume. As dispersion increases so does the specific 
interfacial area of the second phase component (i.e. smaller bubbles or droplets), which leads to 
improved mass transfer. However when considering gas-liquid mass transfer, an even bigger 
influence is the increased gas-hold up at larger scales, allowing an increase in overall volumetric 
mass transfer coefficients (kLa) (Stocks 2013). Liquid-liquid systems are not affected by hold-up 
because the phase component remains in the reaction volume unlike gases, which pass upwards 
through a reactor. Furthermore, liquid-liquid systems have a unique ability to be emulsified by 
adding surfactants which results in a homogeneous medium that is not dependent on mixing. 
Thus this makes liquid-liquid systems largely scale-independent. While solid-liquid systems are 
not the focus in this analysis, similar parallels can be drawn between these systems. However, 
they are less dependent on mixing to ensure a high interfacial area and are rather influenced more 
by particle size. 
Another reason why some process metrics measured at small-scale may not reflect those 
of larger scales is because scale-up can afford better control over the reaction environment. This 
raises the question: what can we learn at different scales about prospective process performance 
                                                             
* The extent of effect of hold-up on mass transfer is more or less pronounced for plug-flow or well-mixed 
regimes, respectively (Noorman 2016). 
† Stable emulsions create a homogeneous medium that will be independent of mixing. 
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when a given reaction is limited by mass transfer? Table 7.2 summarises different types of 
apparatus at different scales, and the process metrics that can be reliably ascertained. It is 
advantageous to be able to quantify realistic process metrics in as small a scale as possible to 
allow fast and efficient process scale-up using less, often expensive, material. 
Table 7.2. Experimental systems for the process evaluation of a biocatalytic reaction that is mass 
transfer limited (scale-dependent). GC – gas chromatography; HPLC – high-performance liquid 
chromatography. 
Volume 
(Scale) 
Example 
Apparatus 
Types of 
Experiments 
Types of Analytical 
Measurements 
Process Metric 
< 10 mL 
Vials; Eppendorf 
tubes; Shake 
flasks; Microtitre 
plates 
End-point 
analyses 
GC/HPLC; 
Spectrophotometric 
Reaction conversion; 
Reaction yield; 
Selectivity 
10 mL – 1 L 
Round bottom 
flasks (or similar); 
Small-scale 
stirred tank 
reactors 
Time-course 
progressions‡; 
End-point 
analyses 
GC/HPLC; Online 
analytical methods 
(Chapter 5) 
Reaction conversion; 
Reaction yield; 
Selectivity; Product 
concentration; 
Biocatalyst yield 
> 1 L 
Stirred tank 
reactors 
Actual process 
performance 
GC/HPLC; Online 
analytical methods 
(Chapter 5) 
Reaction conversion; 
Reaction yield; 
Selectivity; Product 
concentration; 
Biocatalyst yield; 
Productivity; Specific 
productivity 
 
At the smallest scales (e.g. Eppendorf tubes, vials, microtitre plates) the simplest and most 
common type of assessment is an end-point measurement made after a standardised reaction 
time. These experiments are an efficient means to gauge if an enzyme has activity towards a 
certain substrate as well as what conversion, yield and selectivity can be achieved after a certain 
length of time. However, it is difficult to decouple specific mechanisms for process performance 
because they are all aggregated into a single data point. Instead, time-course reaction 
progressions performed in a slightly larger scale with adequate control over the reaction 
environment (e.g. pH, temperature) ensures this more detailed knowledge of process 
performance. In addition, more convenient online methods of analysing reactions can be 
implemented at these larger-scales (Chapter 5). It is important to consider the scale at which 
these experiments are performed because some reactions that are limited by mass transfer (e.g. 
                                                             
‡ Time-course reaction progressions can reveal kinetic effects (e.g. stability, inhibition, extent of mass 
transfer limitation) and can give indication to the space-time yield (Chapter 2). 
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gas-liquid systems) may not proceed at representative rates in small-scale apparatus. The most 
important metric to evaluate under these circumstances is the biocatalyst yield and maximum 
product concentration output. These indicate if the catalyst is sufficiently efficient and if enough 
product can be generated in a reasonable amount of time. In addition, if enzyme stability or 
substrate/product inhibition caused by high concentration occurs, this may also be identified 
using such time-course progressions before large-scale trials are conducted (Chapter 2). Time-
course progressions will also give an indication of the expected productivity of a reaction, and 
already at this stage, reactions that proceed too slowly may be earmarked for improvement. 
Naturally, only metrics assessed at large-scale can be considered true process metrics, however 
understanding how to gauge a reflection of the metrics at smaller scales is invaluable to the 
effectiveness of process development. 
7.3. Non-aqueous biocatalysis 
An alternative solution to the challenges posed in this thesis as well as the influence of scale 
during reaction assessments is to abandon water as a solvent altogether. Biocatalysis carried out 
in non-aqueous media has been long established, although is still limited in applications when 
compared to aqueous biocatalysis (Pollard and Kosjek 2008). Strictly speaking the term “non-
aqueous” is not entirely accurate because enzymes must have water present on a molecular level 
in order to be active (Zaks and Klibanov 1988). Another more accurate name for this medium 
would be “monophasic organic solvents”, which can be either water-immiscible (nearly 
anhydrous) or water-miscible where the organic solvent forms the predominant component 
fraction of the medium (Dordick 1989; Carrea and Riva 2008). The exact amount of water 
necessary to ensure activity differs from enzyme to enzyme. On one end of the spectrum, 
chymotrypsin retained full activity in an n-octane medium with only 50 molecules of water per 
enzyme molecule (Zaks and Klibanov 1986). This is indeed a miniscule amount of water when 
considering the size of most enzymes is about 50 000 Da. By comparison other enzymes such as 
horseradish peroxidase and polyphenol oxidase required 1.8 × 107 (0.25% (v/v)) (Zaks and 
Klibanov 1988) and 3.5 × 107 (0.5% (v/v)) (Kazandjian and Klibanov 1985) molecules of water 
per enzyme molecule in chloroform and toluene, respectively. Enzymes such as proteases, lipases, 
esterases, dehydrogenases and some cytochrome P450s are especially suited to low water 
conditions because they are naturally found in hydrophobic environments near or bound to cell 
membranes (Dordick 1989). 
The most practical way of determining the water concentration in a medium will have 
either a molar, mass or volumetric basis. Enzyme activity in low water environments is however 
only a function of water actually bound to the enzyme molecule itself, and not how much water is 
in the medium as a whole (Zaks and Klibanov 1988). Instead, thermodynamic water activity or 
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relative humidity (Halling 1990) has been accepted to be the best measure when studying the 
kinetics of enzymes in low water environments (Bell et al. 1995). A water activity of 1 reflects a 
completely aqueous medium and 0 reflects a dry organic medium. Water activity at equilibrium 
is the same in all phases even if the volumetric concentration of water differs. Therefore, it is most 
conveniently measured in the gas phase of a reactor by use of a sensor. This system can also be 
used for drying or wetting control of the medium (Won and Lee 2001; Petersson et al. 2007). 
The key advantage of using non-aqueous solvent systems is the vastly increased solubility 
of nonpolar, hydrophobic substrates, such as those encountered in this thesis. Although there are 
also many other advantages of such systems, for example: thermodynamic equilibria can be 
shifted, side-reactions involving water are avoided, subsequent product recovery is made easier 
especially with the use of low boiling point solvents, biocatalyst recovery is also made easier by 
simple filtration since enzymes are often insoluble in organic media, enzyme thermostability is 
usually increased in low water environments, microbial contamination of the medium cannot 
occur, and lastly biocatalysis may be made more compatible with more traditional chemical 
processes through the use of similar organic media (Halling 1987; Dordick 1989; Klibanov 2001). 
Despite these advantages a major disadvantage to using enzymes in low water 
environments is a tendency to reduced activity. Substrate solvation in more compatible organic 
environments reduces the binding availability of substrate with an enzyme, thereby effectively 
increasing the apparent KM, even by two orders of magnitude (van Erp et al. 1991). It should be 
noted that lipases are exceptional cases where instead increased water activity can have an 
inhibiting effect on reaction kinetics (increasing the apparent KM) because of their action at phase 
interfaces (Bovara et al. 1993; Valivety et al. 1993). The quantitative effect of solvation on kinetic 
parameters can be made through considering the thermodynamic properties of different solvents 
(Halling 1994). 
The trade-off in process metrics under low-water conditions between increased solubility 
and reduced activity (through increased apparent KM) is shown in Table 7.3 for a medium-value 
class product. Here it can be seen that the influence of decreased reaction rate due to solvation 
was not as severe because the required substrate concentration turnover is far in excess. For this 
case 11% more biocatalyst would need to be dosed in order to achieve the same activity as for a 
water-mediated reaction. Instead, there was a prominent 4-fold increase in overall space-time 
yield. This was due to the smaller reaction volume required because of the increased solubility of 
substrates in monophasic organic solvents. The influence of solvation on process performance is 
less and more pronounced for low- and high-value processes due to different substrate loading 
requirements. For these cases, approximately 5% and 60% more biocatalyst would need to be 
supplied to achieve the same 4-fold increase in space-time yield for the production of low- and 
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high-value products, respectively. It is important to note that similar gains could be seen for 
oxidation processes due to the increased solubility of oxygen in organic media (Sato et al. 2014; 
Ramesh et al. 2016). This effect would be similar to the concept of using “oxygen vectors” to 
increase the rate of oxygen supply (and therefore reaction rate for oxygen-limited reactions) 
(Quijano et al. 2010). Enzymes are often vastly more thermostable in low-water conditions 
(Rupley and Careri 1991; Toscano et al. 1994), one exceptional case of α-chymotrypsin even 
maintaining full activity when exposed to 126 °C for 4 h (Mozhaev et al. 1991). This affords the 
possibility to further increase reaction rates by increasing temperature without destabilising 
otherwise more temperature sensitive enzymes, however only if the thermostability of reactants 
and products allows. 
Table 7.3. Process metrics as a function of water activity for the 
conversion of poorly water-soluble substrates into medium-value 
products (20 € kg-1). Apparent KM was assumed to increase by a factor 
of 100-fold in low-water conditions due to solvation (van Erp et al. 
1991). The corresponding overall decrease in reaction rate under 
these conditions is countered through an elevated biocatalyst yield 
requirement to reach a standardised process rate constant of 
3.33 × 10-3 min-1. Reaction volume decreases with the use of 
monophasic organic solvents because of the vastly increased solubility 
of substrate in the medium (approximate value taken from the 
solubility of 2-hydroxybiphenyl in various solvents (Tomlin 2004)). 
Substrate/product molecular weight assumed to be 100 g mol-1. 
Water activity [-] 1 < 0.1 
Product concentration [g L-1] 50 50 
Substrate solubility [g L-1] < 1 400 
Apparent KM [mM] 0.1 10 
kcat [min-1] 3.33 × 10-3 3.00 × 10-3 
kcat/KM [min-1 M-1] 33 0.30 
Required biocatalyst yield [g gbiocat-1] 189 210 
Reaction volume [L] 1000 250 
Space-time yield [g L-1 h-1] 10 40 
 
Enzyme activity in non-aqueous solvents depends largely on their formulation. Water allows 
enzyme structures to be pliable. Therefore in the absence of water, enzymes have a high 
conformational rigidity. Biocatalysts prepared by lyophilisation for use in anhydrous media 
therefore exhibit a ‘memory’ of their previous conformation in the preceding aqueous 
preparation (Klibanov 1995). This memory influences their activity based on pre-lyophilisation 
exposure to, for example, pH optima or ligand additives. The conformational state due to pH 
especially influences the enzyme activity in non-aqueous media because pH is not a characteristic 
7-10 
 
property of organic solvents. Non-conventional means to control pH through “organic phase 
buffers” which make use of zwitterions and their sodium salts do, however, exist (Blackwood et 
al. 1994; Harper et al. 2000). 
In most cases lyophilised enzymes are insoluble in organic media.§ Insoluble biocatalyst 
suspensions in reaction media are actually desirable for process handling because biocatalyst 
recovery (and potential reuse) can be facilitated through simple filtration. In some instances 
enzyme agglomeration and consequential activity loss can occur when lyophilised preparations 
are directly added to organic solvents, although this is only possible at elevated water 
concentrations (Yamane et al. 1989; Stevenson and Storer 1991; Kim and Lee 1996). Sometimes 
the solid enzyme particulates forming the suspensions can bring about substrate diffusional 
limitations due to the enzyme molecules clumping together. This will mask the true kinetics of an 
enzyme’s performance, as was discussed through mass transfer limitations in Chapter 2. In such 
cases immobilisation could be considered for better dispersing the effective surface area for 
catalysis for use in non-aqueous media. One aspect of immobilisation which is improved in non-
aqueous systems is that activity loss through leaching of an enzyme into the reaction medium is 
less common due to the insolubility of enzymes in organic solvents. Therefore, more simple 
methods of immobilisation such as deposition onto glass beads can be used (Kazandjian and 
Klibanov 1985; Kazandjian et al. 1986). This avoids intraparticle diffusion limitations and 
structural efficacy loss caused by covalent bonding. However, “overcrowding” caused by multiple 
enzyme layers bound to the support must be avoided through optimisation to avoid internal 
diffusion limitations (Dordick 1989). Properties of the immobilisation support itself can also be 
used to help an enzyme in a non-aqueous environment. More specifically, some supports can be 
used to provide the necessary hydration for enzymes to work most effectively (Reslow et al. 1988; 
Adlercreutz 1992). Nevertheless, immobilisation should still be avoided if at all possible because 
the disadvantages of immobilisation covered in Chapter 3 still hold in non-aqueous systems. 
Enzymes can also be engineered for improved stability in polar non-aqueous solvents 
(Arnold 1990). Previous studies have, however, only involved protein engineering one such 
enzyme, subtilisin, through site directed mutagenesis. Instead, a better target might be to 
engineer higher activity or substrate affinity since a largely reduced speed of reaction is almost 
always seen in non-aqueous environments. This is due to a higher apparent KM caused by 
substrate solvation, as already discussed. Considering the power of modern protein engineering 
techniques such as directed evolution, there exists a huge potential for enzyme improvements for 
                                                             
§ However, there are few examples of homogeneous enzyme catalysis in organic solvents where the 
enzymes were modified by pairing an ion from a surfactant with the protein structure to become soluble 
in the medium (Mozhaev et al. 1991; Paradkar and Dordick 1994). 
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use in non-aqueous environments. Indeed, this capability could be key for realising the 
implementation of many new enzyme classes beyond hydrolases in anhydrous solvents. 
In conclusion, there remains great potential in monophasic organic solvents as media for 
improving the performance and application of biocatalysts in synthetic chemistry (Klibanov 
2001). However as is evident from the lack of new literature, there is a need to revisit this field 
with renewed focus and also incorporating modern protein engineering techniques. In particular, 
there is a great need for more kinetic studies in the presence and absence of water to better 
understand the mechanistic specifics of implementing biocatalysts in monophasic organic 
solvents (e.g. Marty et al. 1992; Chatterjee and Russell 1992; Chatterjee and Russell 1993) – 
especially with different enzyme classes (other than hydrolases). Moreover there is also the need 
to study the effect of solvation on specificity (Wescott and Klibanov 1993; Parida and Dordick 
1993) for other enzyme classes. Monophasic organic solvents as media might prevent the use of 
ISPR in cases where product inhibition occurs. However, it would be of interest to study the 
phenomenon of product inhibition in low-water conditions because the conformational rigidity 
of enzymes might play a central role towards the mechanism of inhibition. Furthermore, the need 
for high product concentrations might not be as crucial when using monophasic organic solvents 
as media because the evaporation of water, which is also the most energy intensive step in the 
downstream, will no longer be necessary. Such studies will help clarify the underlying causes of 
activity loss in anhydrous media and how to prevent it, as well as many other fundamental 
questions (Klibanov 1989). Klibanov (2001) has stated on the prospects of using enzymes in neat 
organic solvents: “In fact, there is no fundamental reason why enzymes could not be more active 
in such media than in water.” If this were to be realised, all the difficulties of biocatalytic reactions 
featuring poorly water-soluble substrates could be solved. In essence this would open the 
prospect for enzymes to be even better suited to industrial (organic solvent based) conditions. 
8-1 
 
Chapter 8. Conclusions 
The aim of this thesis was to address the challenges of handling poorly water-soluble substrates 
in biocatalytic reaction characterisations. Furthermore, generic guidelines for assessing these 
reactions during early-stage reaction scoping were proposed in order to support the overall aim. 
Based on the work and arguments presented in this thesis, the following specific conclusions 
regarding the biocatalysis of poorly water-soluble substrates can be drawn: 
Biocatalysis is now an established branch of synthetic chemistry in its own right. Within 
this field poorly water-soluble substrates are prevalent, and these substrates pose a number of 
challenges through the introduction of heterogeneous reaction media. Such challenges include: 
quantifying and dealing with limitations caused by poor mass transfer of substrate into the 
aqueous reaction medium, the representative sampling of heterogeneous media, as well as the 
stability of enzymes in media requiring co-solvents for improving substrate solubility. 
In Chapters 2,  4 and 6 it was shown that reaction trajectory analysis can be used in early 
stages of reaction scoping to determine if a particular reaction is limited by substrate mass 
transfer (caused by poor aqueous solubility), enzyme kinetics or enzyme stability. Knowing 
which of these factors is the limiting bottleneck can direct further research and development 
efforts. 
It is important to classify a biocatalytic reaction being considered according to its target 
end-use market value. In Chapter 3 it was shown that the value of the resultant product dictates 
the necessary process performance metrics of the reaction in order to meet process margin 
constraints. The production of low- and medium-value products requires more demanding 
reaction performance than that of high-value products to meet economically viable process 
margins. These process metrics include: product concentration (into the downstream), 
conversion, selectivity, space-time yield, and importantly biocatalyst yield. The biocatalyst yield 
requirement is further a function of the final intended formulation and the cost associated with 
its production, where lyophilised cell-free extracts are 4-fold more expensive to produce than 
using wet-whole cells directly from fermentation. 
It is important to understand the primary limitation of a given system so that its influence 
on process performance metrics can be considered. Mass transfer can mask true enzyme kinetics 
and biocatalyst yields may be misleading under these limited conditions. 
Benchmarking with target process performance metrics can reveal the simplest 
improvement strategy for a given biocatalytic reaction to satisfy all metrics, which is a 
8-2 
 
prerequisite for industrial implementation. For example, in Chapter 4 it was found that by dosing 
the reaction with less enzyme, the reaction would then reach all process metric targets (including 
biocatalyst yield) even though the space-time yield would be reduced. Therefore, further 
increasing the product concentration from 74 g L-1 through process development (e.g. ISPR to 
overcome inhibition), nor protein engineering or expression efforts would be strictly necessary 
to meet reaction performance requirements. 
Special analytical online methods, such as oxygen measurements in the gas-phase of a 
reactor and sacrificial sampling activity assays, which were demonstrated in Chapter 5, are 
invaluable to following complex heterogeneous biocatalytic reactions. These accurate analytical 
procedures give confidence to the measured trends especially when poorly water-soluble 
substrates are involved, further improving the outcome of assessments using reaction trajectory 
analysis (as covered in Chapter 2). 
The use of water-miscible and -immiscible solvents for improving substrate solubility 
must be carefully considered and the enzyme’s tolerance (stability) and activity in their presence 
must always be quantified. The use of co-solvents is essential to realise a fast enough reaction 
when dealing with poorly water-soluble substrates through increasing their mass transfer into 
an aqueous medium for biocatalysis. For example, the biocatalytic Baeyer-Villiger oxidation of 
macrocyclic ketones could only proceed in the presence of a co-solvent. Here, an eventual space-
time yield of 1.6 g L-1 h-1 was achieved with the addition of 20% (v/v) methanol as a co-solvent. 
It has been previously shown that oxygen transfer is dependent on scale. Therefore, 
oxygen supply at smaller scales influences the results of characterisation experiments in 
oxidation reactions. Furthermore, mixing has a similar yet less pronounced effect on liquid-liquid 
mass transfer through dispersion. It is therefore important that the scale of experiments is always 
considered when performing experiments featuring poorly water-soluble substrates. 
The success of biocatalysis towards industrial implementation is inextricably linked to its 
ability to meet target process performance metrics, and is easier for high-value products. 
Therefore for successful industrial implementation, reaction targets (or synthetic routes) must 
be chosen wisely so that an enzyme candidate is able to meet the required process performance 
metrics. 
Overall this thesis shows the successful development and application of generic 
guidelines for assessing biocatalytic reactions involving poorly water-soluble substrates during 
early-stage reaction design, and proposes a pragmatic methodology for characterising the 
challenges of handling such biocatalytic reactions. 
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Chapter 9. Future perspectives 
Since poorly water-soluble substrates are so prevalent in chemical processing the unique aspects 
they impose on biocatalytic processes will remain in the future. By no means have all these 
aspects been addressed in this thesis, and scope remains to explore those aspects that have not 
been studied and considered, further. Future avenues for research relevant to the studies and 
findings in this thesis are considered here. The initial recommendations are more significant and 
pertain to more general cases of biocatalysis, whilst the final perspectives only involve the specific 
case studies that were covered in this thesis. 
9.1. Standardised methodologies for biocatalytic process conceptualisation 
and assessment 
A systematic research flow for developing an enzyme-catalysed reaction from scratch through to 
later stages of process development was proposed in Chapter 2 and Chapter 7. A key outcome 
was the ability to formulate directed improvement strategies and assess their feasibility of 
implementation. It would be highly useful to see this methodology applied to further cases of 
biocatalytic reaction design to further establish whether it does indeed streamline the research 
process. Furthermore, the simple and efficient methodology relying on reaction trajectory 
analysis presented in Chapter 2 could be applied as the standard for reaction scoping and to 
measure process performance metrics in a reliable way in appropriate reactions. 
At the heart of this development protocol is the need for representative process metric 
targets. Whilst they are intended to be used as simplified ‘rules of thumb’, their exact values 
should still be refined to better reflect the demands of industry. A more detailed study into the 
costing of biocatalytic processes would likely improve the fidelity of space-time yield and product 
concentration targets for different value-class products. This should take into account the 
different types of processing encountered for products of different values, for example: low-value 
products are typically manufactured in large volumes in dedicated plants and high-value 
products are more likely to be produced in several batch campaigns during the course of a year 
in rented plant equipment. A sensitivity analysis on the various metrics would also be particularly 
useful to distinguish if some metrics are more influential towards process economics than others. 
9.2. Online analytical methods 
For further biocatalytic reactions, alternative online methods should also be explored owing to 
their usefulness and accuracy in reaction characterisations. These online methods also hold 
potential for process monitoring and control because of their scalability. Standardised online 
analytics should therefore be prioritised in future biocatalytic reaction development instead of 
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offline manual sampling methods, especially when heterogeneous mixtures are involved. Notable 
measurements could make use of colorimetric assays, conductivity, pH control, CO2 
consumption/liberation, to name a few. Where appropriate, these methods could also be 
indirectly coupled to a reaction of choice by using an alternative medium element (e.g. additional 
enzyme, indicator or carbonate buffer that produces CO2 whilst controlling the pH as was done in 
Chapter 4). 
9.3. Alternative water-free media for biocatalysis 
Non-aqueous media or monophasic organic solvents are promising alternatives for reactions 
featuring poorly water-soluble substrates. However, future research should have more focus into 
the kinetic mechanisms underlying the general trend of enzyme activity loss in low-water 
environments – especially with different enzyme classes other than hydrolases. Effective protein 
engineering techniques such as directed evolution could be better applied to non-aqueous 
biocatalysis, ideally improving the performance of enzymes under these conditions. There also 
remains a huge potential for better cost- and performance-effective methods of immobilising 
enzymes. Ultimately, only if significant progress is made on both of these aspects of 
immobilisation could a generic technique that works for all biocatalytic applications be realised. 
Biocatalysts and their development have made massive strides since the bulk of research into 
non-aqueous biocatalysis was carried out. Therefore with these updated more efficient enzymes 
and techniques, the problems facing this field outlined in this thesis may be overcome in the 
future. In this way, poorly water-soluble substrates may no longer pose challenging for 
biocatalysis. 
9.4. Biocatalyst formulation 
All the cases studied in this thesis show the importance of target protein expression in the cell-
free extract. Improving expression will have a direct impact on the specific activity of a given 
biocatalyst formulation, and therefore biocatalyst yield. This is because a higher expression of 
target protein (without the formation of inclusion bodies) will result in more activity within the 
cell. Furthermore, it is generally simpler to improve expression through fermentation 
optimisation than it is to engineer a protein to have an improved activity. Therefore, achieving 
decent expression should receive more focus during enzyme development. The cost of 
lyophilising cell-free extracts should also be decreased through optimising the processes of freeze 
drying and cell lysis. By doing so, the biocatalyst yield requirement from lyophilised cell-free 
extracts might be relaxed. 
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9.5. Case studies specific to this thesis 
The esterase-catalysed desymmetrisation reaction is ready for scale-up based on this assessment 
which indicates adequate performance and enzyme robustness. However, the biocatalyst yield 
for such a high-value product must first be improved by dosing with less enzyme (at the expense 
of space-time yield, as discussed in Chapter 4). Alternative (and more complicated) methods for 
improving biocatalyst yield include: in situ product removal to overcome product inhibition and 
allow higher substrate turnovers, as well as protein engineering or optimising the expression of 
ECS-PLE06 in the lyophilised preparation. There is also the potential to further study increasing 
the reaction temperature and using co-solvents to help reduce the mass transfer limitation 
threshold. 
On the other hand, the BVMO oxidation reaction suffered poor process performance in a 
number of aspects. Oxygen limitation was the most predominant, although there exist many 
routes to address this and potentially meet productivity requirements for low- to medium-value 
products: scale-up, the use of pure oxygen or pressurised reactors should all be considered. Even 
though the BVMO was robust (especially in comparison to most observed in literature), there is 
still the potential to improve its activity, and therefore biocatalyst yield, through optimising 
CDMO expression in the cell-free extract, protein engineering or selecting an alternative, more 
active candidate (e.g. polycyclic ketone monooxygenase (Fürst et al. 2017)). 
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